id	sid	tid	token	lemma	pos
cord-302115-r39ser2c	1	1	key	key	NN
cord-302115-r39ser2c	1	2	:	:	:
cord-302115-r39ser2c	2	1	cord-302115-r39ser2c	cord-302115-r39ser2c	JJ
cord-302115-r39ser2c	2	2	authors	author	NNS
cord-302115-r39ser2c	2	3	:	:	:
cord-302115-r39ser2c	2	4	Matricardi	Matricardi	NNP
cord-302115-r39ser2c	2	5	,	,	,
cord-302115-r39ser2c	2	6	Paolo	Paolo	NNP
cord-302115-r39ser2c	2	7	Maria	Maria	NNP
cord-302115-r39ser2c	2	8	;	;	:
cord-302115-r39ser2c	2	9	Dal	Dal	NNP
cord-302115-r39ser2c	2	10	Negro	Negro	NNP
cord-302115-r39ser2c	2	11	,	,	,
cord-302115-r39ser2c	2	12	Roberto	Roberto	NNP
cord-302115-r39ser2c	2	13	Walter	Walter	NNP
cord-302115-r39ser2c	2	14	;	;	:
cord-302115-r39ser2c	2	15	Nisini	Nisini	NNP
cord-302115-r39ser2c	2	16	,	,	,
cord-302115-r39ser2c	2	17	Roberto	Roberto	NNP
cord-302115-r39ser2c	2	18	title	title	NN
cord-302115-r39ser2c	2	19	:	:	:
cord-302115-r39ser2c	2	20	The	the	DT
cord-302115-r39ser2c	2	21	first	first	JJ
cord-302115-r39ser2c	2	22	,	,	,
cord-302115-r39ser2c	2	23	holistic	holistic	JJ
cord-302115-r39ser2c	2	24	immunological	immunological	JJ
cord-302115-r39ser2c	2	25	model	model	NN
cord-302115-r39ser2c	2	26	of	of	IN
cord-302115-r39ser2c	2	27	COVID‐19	covid‐19	NN
cord-302115-r39ser2c	2	28	:	:	:
cord-302115-r39ser2c	2	29	implications	implication	NNS
cord-302115-r39ser2c	2	30	for	for	IN
cord-302115-r39ser2c	2	31	prevention	prevention	NN
cord-302115-r39ser2c	2	32	,	,	,
cord-302115-r39ser2c	2	33	diagnosis	diagnosis	NN
cord-302115-r39ser2c	2	34	,	,	,
cord-302115-r39ser2c	2	35	and	and	CC
cord-302115-r39ser2c	2	36	public	public	JJ
cord-302115-r39ser2c	2	37	health	health	NN
cord-302115-r39ser2c	2	38	measures	measure	NNS
cord-302115-r39ser2c	2	39	date	date	NN
cord-302115-r39ser2c	2	40	:	:	:
cord-302115-r39ser2c	2	41	2020	2020	CD
cord-302115-r39ser2c	2	42	-	-	HYPH
cord-302115-r39ser2c	2	43	05	05	CD
cord-302115-r39ser2c	2	44	-	-	HYPH
cord-302115-r39ser2c	2	45	02	02	CD
cord-302115-r39ser2c	2	46	journal	journal	NN
cord-302115-r39ser2c	2	47	:	:	:
cord-302115-r39ser2c	2	48	Pediatr	Pediatr	NNP
cord-302115-r39ser2c	2	49	Allergy	Allergy	NNP
cord-302115-r39ser2c	2	50	Immunol	Immunol	NNP
cord-302115-r39ser2c	2	51	DOI	DOI	NNP
cord-302115-r39ser2c	2	52	:	:	:
cord-302115-r39ser2c	3	1	10.1111	10.1111	CD
cord-302115-r39ser2c	3	2	/	/	SYM
cord-302115-r39ser2c	3	3	pai.13271	pai.13271	XX
cord-302115-r39ser2c	4	1	sha	sha	NNP
cord-302115-r39ser2c	4	2	:	:	:
cord-302115-r39ser2c	4	3	782edc699ba9abc492206e67ad9b3bc015a05fd6	782edc699ba9abc492206e67ad9b3bc015a05fd6	CD
cord-302115-r39ser2c	4	4	doc_id	doc_id	NNPS
cord-302115-r39ser2c	4	5	:	:	:
cord-302115-r39ser2c	4	6	302115	302115	CD
cord-302115-r39ser2c	4	7	cord_uid	cord_uid	NNS
cord-302115-r39ser2c	4	8	:	:	:
cord-302115-r39ser2c	5	1	r39ser2c	r39ser2c	NNP
cord-302115-r39ser2c	6	1	The	the	DT
cord-302115-r39ser2c	6	2	natural	natural	JJ
cord-302115-r39ser2c	6	3	history	history	NN
cord-302115-r39ser2c	6	4	of	of	IN
cord-302115-r39ser2c	6	5	COVID‐19	covid‐19	NN
cord-302115-r39ser2c	6	6	caused	cause	VBN
cord-302115-r39ser2c	6	7	by	by	IN
cord-302115-r39ser2c	6	8	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-302115-r39ser2c	6	9	is	be	VBZ
cord-302115-r39ser2c	6	10	extremely	extremely	RB
cord-302115-r39ser2c	6	11	variable	variable	JJ
cord-302115-r39ser2c	6	12	,	,	,
cord-302115-r39ser2c	6	13	ranging	range	VBG
cord-302115-r39ser2c	6	14	from	from	IN
cord-302115-r39ser2c	6	15	asymptomatic	asymptomatic	JJ
cord-302115-r39ser2c	6	16	or	or	CC
cord-302115-r39ser2c	6	17	mild	mild	JJ
cord-302115-r39ser2c	6	18	infection	infection	NN
cord-302115-r39ser2c	6	19	,	,	,
cord-302115-r39ser2c	6	20	mainly	mainly	RB
cord-302115-r39ser2c	6	21	in	in	IN
cord-302115-r39ser2c	6	22	children	child	NNS
cord-302115-r39ser2c	6	23	,	,	,
cord-302115-r39ser2c	6	24	to	to	IN
cord-302115-r39ser2c	6	25	multi‐organ	multi‐organ	JJ
cord-302115-r39ser2c	6	26	failure	failure	NN
cord-302115-r39ser2c	6	27	,	,	,
cord-302115-r39ser2c	6	28	eventually	eventually	RB
cord-302115-r39ser2c	6	29	fatal	fatal	JJ
cord-302115-r39ser2c	6	30	,	,	,
cord-302115-r39ser2c	6	31	mainly	mainly	RB
cord-302115-r39ser2c	6	32	in	in	IN
cord-302115-r39ser2c	6	33	the	the	DT
cord-302115-r39ser2c	6	34	eldest	eld	JJS
cord-302115-r39ser2c	6	35	.	.	.
cord-302115-r39ser2c	7	1	We	-PRON-	PRP
cord-302115-r39ser2c	7	2	propose	propose	VBP
cord-302115-r39ser2c	7	3	here	here	RB
cord-302115-r39ser2c	7	4	the	the	DT
cord-302115-r39ser2c	7	5	first	first	JJ
cord-302115-r39ser2c	7	6	model	model	NN
cord-302115-r39ser2c	7	7	,	,	,
cord-302115-r39ser2c	7	8	explaining	explain	VBG
cord-302115-r39ser2c	7	9	how	how	WRB
cord-302115-r39ser2c	7	10	the	the	DT
cord-302115-r39ser2c	7	11	outcome	outcome	NN
cord-302115-r39ser2c	7	12	of	of	IN
cord-302115-r39ser2c	7	13	first	first	JJ
cord-302115-r39ser2c	7	14	,	,	,
cord-302115-r39ser2c	7	15	crucial	crucial	JJ
cord-302115-r39ser2c	7	16	10‐15	10‐15	NN
cord-302115-r39ser2c	7	17	days	day	NNS
cord-302115-r39ser2c	7	18	after	after	IN
cord-302115-r39ser2c	7	19	infection	infection	NN
cord-302115-r39ser2c	7	20	,	,	,
cord-302115-r39ser2c	7	21	hangs	hang	VBZ
cord-302115-r39ser2c	7	22	on	on	IN
cord-302115-r39ser2c	7	23	the	the	DT
cord-302115-r39ser2c	7	24	balance	balance	NN
cord-302115-r39ser2c	7	25	between	between	IN
cord-302115-r39ser2c	7	26	the	the	DT
cord-302115-r39ser2c	7	27	cumulative	cumulative	JJ
cord-302115-r39ser2c	7	28	dose	dose	NN
cord-302115-r39ser2c	7	29	of	of	IN
cord-302115-r39ser2c	7	30	viral	viral	JJ
cord-302115-r39ser2c	7	31	exposure	exposure	NN
cord-302115-r39ser2c	7	32	and	and	CC
cord-302115-r39ser2c	7	33	the	the	DT
cord-302115-r39ser2c	7	34	efficacy	efficacy	NN
cord-302115-r39ser2c	7	35	of	of	IN
cord-302115-r39ser2c	7	36	the	the	DT
cord-302115-r39ser2c	7	37	local	local	JJ
cord-302115-r39ser2c	7	38	innate	innate	JJ
cord-302115-r39ser2c	7	39	immune	immune	JJ
cord-302115-r39ser2c	7	40	response	response	NN
cord-302115-r39ser2c	7	41	(	(	-LRB-
cord-302115-r39ser2c	7	42	natural	natural	JJ
cord-302115-r39ser2c	7	43	IgA	IgA	NNP
cord-302115-r39ser2c	7	44	and	and	CC
cord-302115-r39ser2c	7	45	IgM	IgM	NNP
cord-302115-r39ser2c	7	46	antibodies	antibody	NNS
cord-302115-r39ser2c	7	47	,	,	,
cord-302115-r39ser2c	7	48	Mannose	Mannose	NNP
cord-302115-r39ser2c	7	49	Binding	Binding	NNP
cord-302115-r39ser2c	7	50	Lectin	Lectin	NNP
cord-302115-r39ser2c	7	51	)	)	-RRB-
cord-302115-r39ser2c	7	52	.	.	.
cord-302115-r39ser2c	8	1	If	if	IN
cord-302115-r39ser2c	8	2	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-302115-r39ser2c	8	3	runs	run	VBZ
cord-302115-r39ser2c	8	4	the	the	DT
cord-302115-r39ser2c	8	5	blockade	blockade	NN
cord-302115-r39ser2c	8	6	of	of	IN
cord-302115-r39ser2c	8	7	this	this	DT
cord-302115-r39ser2c	8	8	innate	innate	JJ
cord-302115-r39ser2c	8	9	immunity	immunity	NN
cord-302115-r39ser2c	8	10	and	and	CC
cord-302115-r39ser2c	8	11	spreads	spread	VBZ
cord-302115-r39ser2c	8	12	from	from	IN
cord-302115-r39ser2c	8	13	the	the	DT
cord-302115-r39ser2c	8	14	upper	upper	JJ
cord-302115-r39ser2c	8	15	airways	airway	NNS
cord-302115-r39ser2c	8	16	to	to	IN
cord-302115-r39ser2c	8	17	the	the	DT
cord-302115-r39ser2c	8	18	alveoli	alveolus	NNS
cord-302115-r39ser2c	8	19	in	in	IN
cord-302115-r39ser2c	8	20	the	the	DT
cord-302115-r39ser2c	8	21	early	early	JJ
cord-302115-r39ser2c	8	22	phases	phase	NNS
cord-302115-r39ser2c	8	23	of	of	IN
cord-302115-r39ser2c	8	24	the	the	DT
cord-302115-r39ser2c	8	25	infections	infection	NNS
cord-302115-r39ser2c	8	26	,	,	,
cord-302115-r39ser2c	8	27	it	-PRON-	PRP
cord-302115-r39ser2c	8	28	can	can	MD
cord-302115-r39ser2c	8	29	replicate	replicate	VB
cord-302115-r39ser2c	8	30	with	with	IN
cord-302115-r39ser2c	8	31	no	no	DT
cord-302115-r39ser2c	8	32	local	local	JJ
cord-302115-r39ser2c	8	33	resistance	resistance	NN
cord-302115-r39ser2c	8	34	,	,	,
cord-302115-r39ser2c	8	35	causing	cause	VBG
cord-302115-r39ser2c	8	36	pneumonia	pneumonia	NN
cord-302115-r39ser2c	8	37	and	and	CC
cord-302115-r39ser2c	8	38	releasing	release	VBG
cord-302115-r39ser2c	8	39	high	high	JJ
cord-302115-r39ser2c	8	40	amounts	amount	NNS
cord-302115-r39ser2c	8	41	of	of	IN
cord-302115-r39ser2c	8	42	antigens	antigen	NNS
cord-302115-r39ser2c	8	43	.	.	.
cord-302115-r39ser2c	9	1	The	the	DT
cord-302115-r39ser2c	9	2	delayed	delayed	JJ
cord-302115-r39ser2c	9	3	and	and	CC
cord-302115-r39ser2c	9	4	strong	strong	JJ
cord-302115-r39ser2c	9	5	adaptive	adaptive	JJ
cord-302115-r39ser2c	9	6	immune	immune	JJ
cord-302115-r39ser2c	9	7	response	response	NN
cord-302115-r39ser2c	9	8	(	(	-LRB-
cord-302115-r39ser2c	9	9	high	high	JJ
cord-302115-r39ser2c	9	10	affinity	affinity	NN
cord-302115-r39ser2c	9	11	IgM	IgM	NNP
cord-302115-r39ser2c	9	12	and	and	CC
cord-302115-r39ser2c	9	13	IgG	IgG	NNP
cord-302115-r39ser2c	9	14	antibodies	antibodies	NNP
cord-302115-r39ser2c	9	15	)	)	-RRB-
cord-302115-r39ser2c	9	16	that	that	WDT
cord-302115-r39ser2c	9	17	follows	follow	VBZ
cord-302115-r39ser2c	9	18	,	,	,
cord-302115-r39ser2c	9	19	causes	cause	VBZ
cord-302115-r39ser2c	9	20	severe	severe	JJ
cord-302115-r39ser2c	9	21	inflammation	inflammation	NN
cord-302115-r39ser2c	9	22	and	and	CC
cord-302115-r39ser2c	9	23	triggers	trigger	VBZ
cord-302115-r39ser2c	9	24	mediator	mediator	NN
cord-302115-r39ser2c	9	25	cascades	cascade	NNS
cord-302115-r39ser2c	9	26	(	(	-LRB-
cord-302115-r39ser2c	9	27	complement	complement	NN
cord-302115-r39ser2c	9	28	,	,	,
cord-302115-r39ser2c	9	29	coagulation	coagulation	NN
cord-302115-r39ser2c	9	30	,	,	,
cord-302115-r39ser2c	9	31	and	and	CC
cord-302115-r39ser2c	9	32	cytokine	cytokine	NN
cord-302115-r39ser2c	9	33	storm	storm	NN
cord-302115-r39ser2c	9	34	)	)	-RRB-
cord-302115-r39ser2c	9	35	leading	lead	VBG
cord-302115-r39ser2c	9	36	to	to	IN
cord-302115-r39ser2c	9	37	complications	complication	NNS
cord-302115-r39ser2c	9	38	often	often	RB
cord-302115-r39ser2c	9	39	requiring	require	VBG
cord-302115-r39ser2c	9	40	intensive	intensive	JJ
cord-302115-r39ser2c	9	41	therapy	therapy	NN
cord-302115-r39ser2c	9	42	and	and	CC
cord-302115-r39ser2c	9	43	being	being	NN
cord-302115-r39ser2c	9	44	,	,	,
cord-302115-r39ser2c	9	45	in	in	IN
cord-302115-r39ser2c	9	46	some	some	DT
cord-302115-r39ser2c	9	47	patients	patient	NNS
cord-302115-r39ser2c	9	48	,	,	,
cord-302115-r39ser2c	9	49	fatal	fatal	JJ
cord-302115-r39ser2c	9	50	.	.	.
cord-302115-r39ser2c	10	1	Low‐moderate	low‐moderate	JJ
cord-302115-r39ser2c	10	2	physical	physical	JJ
cord-302115-r39ser2c	10	3	activity	activity	NN
cord-302115-r39ser2c	10	4	can	can	MD
cord-302115-r39ser2c	10	5	still	still	RB
cord-302115-r39ser2c	10	6	be	be	VB
cord-302115-r39ser2c	10	7	recommended	recommend	VBN
cord-302115-r39ser2c	10	8	.	.	.
cord-302115-r39ser2c	11	1	However	however	RB
cord-302115-r39ser2c	11	2	,	,	,
cord-302115-r39ser2c	11	3	extreme	extreme	JJ
cord-302115-r39ser2c	11	4	physical	physical	JJ
cord-302115-r39ser2c	11	5	activity	activity	NN
cord-302115-r39ser2c	11	6	and	and	CC
cord-302115-r39ser2c	11	7	hyperventilation	hyperventilation	NN
cord-302115-r39ser2c	11	8	during	during	IN
cord-302115-r39ser2c	11	9	the	the	DT
cord-302115-r39ser2c	11	10	incubation	incubation	NN
cord-302115-r39ser2c	11	11	days	day	NNS
cord-302115-r39ser2c	11	12	and	and	CC
cord-302115-r39ser2c	11	13	early	early	JJ
cord-302115-r39ser2c	11	14	stages	stage	NNS
cord-302115-r39ser2c	11	15	of	of	IN
cord-302115-r39ser2c	11	16	COVID‐19	covid‐19	NN
cord-302115-r39ser2c	11	17	,	,	,
cord-302115-r39ser2c	11	18	facilitates	facilitate	VBZ
cord-302115-r39ser2c	11	19	early	early	JJ
cord-302115-r39ser2c	11	20	direct	direct	JJ
cord-302115-r39ser2c	11	21	penetration	penetration	NN
cord-302115-r39ser2c	11	22	of	of	IN
cord-302115-r39ser2c	11	23	high	high	JJ
cord-302115-r39ser2c	11	24	numbers	number	NNS
cord-302115-r39ser2c	11	25	of	of	IN
cord-302115-r39ser2c	11	26	virus	virus	NN
cord-302115-r39ser2c	11	27	particles	particle	NNS
cord-302115-r39ser2c	11	28	in	in	IN
cord-302115-r39ser2c	11	29	the	the	DT
cord-302115-r39ser2c	11	30	lower	low	JJR
cord-302115-r39ser2c	11	31	airways	airway	NNS
cord-302115-r39ser2c	11	32	and	and	CC
cord-302115-r39ser2c	11	33	the	the	DT
cord-302115-r39ser2c	11	34	alveoli	alveolus	NNS
cord-302115-r39ser2c	11	35	,	,	,
cord-302115-r39ser2c	11	36	without	without	IN
cord-302115-r39ser2c	11	37	impacting	impact	VBG
cord-302115-r39ser2c	11	38	on	on	IN
cord-302115-r39ser2c	11	39	the	the	DT
cord-302115-r39ser2c	11	40	airway	airway	NN
cord-302115-r39ser2c	11	41	’s	’s	POS
cord-302115-r39ser2c	11	42	mucosae	mucosae	NNP
cord-302115-r39ser2c	11	43	covered	cover	VBN
cord-302115-r39ser2c	11	44	by	by	IN
cord-302115-r39ser2c	11	45	neutralizing	neutralize	VBG
cord-302115-r39ser2c	11	46	antibodies	antibody	NNS
cord-302115-r39ser2c	11	47	.	.	.
cord-302115-r39ser2c	12	1	This	this	DT
cord-302115-r39ser2c	12	2	allows	allow	VBZ
cord-302115-r39ser2c	12	3	the	the	DT
cord-302115-r39ser2c	12	4	virus	virus	NN
cord-302115-r39ser2c	12	5	bypassing	bypass	VBG
cord-302115-r39ser2c	12	6	the	the	DT
cord-302115-r39ser2c	12	7	efficient	efficient	JJ
cord-302115-r39ser2c	12	8	immune	immune	JJ
cord-302115-r39ser2c	12	9	barrier	barrier	NN
cord-302115-r39ser2c	12	10	of	of	IN
cord-302115-r39ser2c	12	11	the	the	DT
cord-302115-r39ser2c	12	12	upper	upper	JJ
cord-302115-r39ser2c	12	13	airways	airways	NNP
cord-302115-r39ser2c	12	14	mucosa	mucosa	NN
cord-302115-r39ser2c	12	15	in	in	IN
cord-302115-r39ser2c	12	16	already	already	RB
cord-302115-r39ser2c	12	17	infected	infect	VBN
cord-302115-r39ser2c	12	18	,	,	,
cord-302115-r39ser2c	12	19	young	young	JJ
cord-302115-r39ser2c	12	20	and	and	CC
cord-302115-r39ser2c	12	21	otherwise	otherwise	RB
cord-302115-r39ser2c	12	22	healthy	healthy	JJ
cord-302115-r39ser2c	12	23	athletes	athlete	NNS
cord-302115-r39ser2c	12	24	.	.	.
cord-302115-r39ser2c	13	1	In	in	IN
cord-302115-r39ser2c	13	2	conclusion	conclusion	NN
cord-302115-r39ser2c	13	3	,	,	,
cord-302115-r39ser2c	13	4	whether	whether	IN
cord-302115-r39ser2c	13	5	the	the	DT
cord-302115-r39ser2c	13	6	virus	virus	NN
cord-302115-r39ser2c	13	7	or	or	CC
cord-302115-r39ser2c	13	8	the	the	DT
cord-302115-r39ser2c	13	9	adaptative	adaptative	JJ
cord-302115-r39ser2c	13	10	immune	immune	JJ
cord-302115-r39ser2c	13	11	response	response	NN
cord-302115-r39ser2c	13	12	reach	reach	VBP
cord-302115-r39ser2c	13	13	the	the	DT
cord-302115-r39ser2c	13	14	lungs	lung	NNS
cord-302115-r39ser2c	13	15	first	first	RB
cord-302115-r39ser2c	13	16	,	,	,
cord-302115-r39ser2c	13	17	is	be	VBZ
cord-302115-r39ser2c	13	18	a	a	DT
cord-302115-r39ser2c	13	19	crucial	crucial	JJ
cord-302115-r39ser2c	13	20	factor	factor	NN
cord-302115-r39ser2c	13	21	deciding	decide	VBG
cord-302115-r39ser2c	13	22	the	the	DT
cord-302115-r39ser2c	13	23	fate	fate	NN
cord-302115-r39ser2c	13	24	of	of	IN
cord-302115-r39ser2c	13	25	the	the	DT
cord-302115-r39ser2c	13	26	patient	patient	NN
cord-302115-r39ser2c	13	27	.	.	.
cord-302115-r39ser2c	14	1	This	this	DT
cord-302115-r39ser2c	14	2	“	"	``
cord-302115-r39ser2c	14	3	quantitative	quantitative	JJ
cord-302115-r39ser2c	14	4	and	and	CC
cord-302115-r39ser2c	14	5	time‐sequence	time‐sequence	NNP
cord-302115-r39ser2c	14	6	dependent	dependent	JJ
cord-302115-r39ser2c	14	7	”	"	''
cord-302115-r39ser2c	14	8	model	model	NN
cord-302115-r39ser2c	14	9	has	have	VBZ
cord-302115-r39ser2c	14	10	several	several	JJ
cord-302115-r39ser2c	14	11	implications	implication	NNS
cord-302115-r39ser2c	14	12	for	for	IN
cord-302115-r39ser2c	14	13	prevention	prevention	NN
cord-302115-r39ser2c	14	14	,	,	,
cord-302115-r39ser2c	14	15	diagnosis	diagnosis	NN
cord-302115-r39ser2c	14	16	,	,	,
cord-302115-r39ser2c	14	17	and	and	CC
cord-302115-r39ser2c	14	18	therapy	therapy	NN
cord-302115-r39ser2c	14	19	of	of	IN
cord-302115-r39ser2c	14	20	COVID‐19	COVID‐19	NNP
cord-302115-r39ser2c	14	21	at	at	RB
cord-302115-r39ser2c	14	22	all	all	DT
cord-302115-r39ser2c	14	23	ages	age	NNS
cord-302115-r39ser2c	14	24	.	.	.
cord-302115-r39ser2c	15	1	Most	Most	JJS
cord-302115-r39ser2c	15	2	serological	serological	JJ
cord-302115-r39ser2c	15	3	data	datum	NNS
cord-302115-r39ser2c	15	4	currently	currently	RB
cord-302115-r39ser2c	15	5	available	available	JJ
cord-302115-r39ser2c	15	6	in	in	IN
cord-302115-r39ser2c	15	7	the	the	DT
cord-302115-r39ser2c	15	8	literature	literature	NN
cord-302115-r39ser2c	15	9	refer	refer	NN
cord-302115-r39ser2c	15	10	to	to	IN
cord-302115-r39ser2c	15	11	patients	patient	NNS
cord-302115-r39ser2c	15	12	examined	examine	VBN
cord-302115-r39ser2c	15	13	mostly	mostly	RB
cord-302115-r39ser2c	15	14	in	in	IN
cord-302115-r39ser2c	15	15	the	the	DT
cord-302115-r39ser2c	15	16	acute	acute	JJ
cord-302115-r39ser2c	15	17	phase	phase	NN
cord-302115-r39ser2c	15	18	of	of	IN
cord-302115-r39ser2c	15	19	the	the	DT
cord-302115-r39ser2c	15	20	disease	disease	NN
cord-302115-r39ser2c	15	21	.	.	.
cord-302115-r39ser2c	16	1	Therefore	therefore	RB
cord-302115-r39ser2c	16	2	,	,	,
cord-302115-r39ser2c	16	3	they	-PRON-	PRP
cord-302115-r39ser2c	16	4	are	be	VBP
cord-302115-r39ser2c	16	5	insufficient	insufficient	JJ
cord-302115-r39ser2c	16	6	to	to	TO
cord-302115-r39ser2c	16	7	exactly	exactly	RB
cord-302115-r39ser2c	16	8	establish	establish	VB
cord-302115-r39ser2c	16	9	durability	durability	NN
cord-302115-r39ser2c	16	10	of	of	IN
cord-302115-r39ser2c	16	11	the	the	DT
cord-302115-r39ser2c	16	12	antibody	antibody	NN
cord-302115-r39ser2c	16	13	titers	titer	NNS
cord-302115-r39ser2c	16	14	of	of	IN
cord-302115-r39ser2c	16	15	each	each	DT
cord-302115-r39ser2c	16	16	isotype	isotype	NN
cord-302115-r39ser2c	16	17	peak	peak	NN
cord-302115-r39ser2c	16	18	when	when	WRB
cord-302115-r39ser2c	16	19	they	-PRON-	PRP
cord-302115-r39ser2c	16	20	eventually	eventually	RB
cord-302115-r39ser2c	16	21	disappear	disappear	VBP
cord-302115-r39ser2c	16	22	.	.	.
cord-302115-r39ser2c	17	1	The	the	DT
cord-302115-r39ser2c	17	2	levels	level	NNS
cord-302115-r39ser2c	17	3	of	of	IN
cord-302115-r39ser2c	17	4	serum	serum	NN
cord-302115-r39ser2c	17	5	IgG	igg	NN
cord-302115-r39ser2c	17	6	antibodies	antibody	NNS
cord-302115-r39ser2c	17	7	,	,	,
cord-302115-r39ser2c	17	8	however	however	RB
cord-302115-r39ser2c	17	9	seems	seem	VBZ
cord-302115-r39ser2c	17	10	to	to	TO
cord-302115-r39ser2c	17	11	be	be	VB
cord-302115-r39ser2c	17	12	proportional	proportional	JJ
cord-302115-r39ser2c	17	13	to	to	IN
cord-302115-r39ser2c	17	14	the	the	DT
cord-302115-r39ser2c	17	15	intensity	intensity	NN
cord-302115-r39ser2c	17	16	of	of	IN
cord-302115-r39ser2c	17	17	the	the	DT
cord-302115-r39ser2c	17	18	viral	viral	JJ
cord-302115-r39ser2c	17	19	load	load	NN
cord-302115-r39ser2c	17	20	and	and	CC
cord-302115-r39ser2c	17	21	to	to	IN
cord-302115-r39ser2c	17	22	the	the	DT
cord-302115-r39ser2c	17	23	symptom	symptom	NN
cord-302115-r39ser2c	17	24	severity	severity	NN
cord-302115-r39ser2c	17	25	.	.	.
cord-302115-r39ser2c	18	1	[	[	-LRB-
cord-302115-r39ser2c	18	2	32	32	CD
cord-302115-r39ser2c	18	3	,	,	,
cord-302115-r39ser2c	18	4	36	36	CD
cord-302115-r39ser2c	18	5	]	]	-RRB-
cord-302115-r39ser2c	18	6	 	 	_SP
cord-302115-r39ser2c	19	1	The	the	DT
cord-302115-r39ser2c	19	2	efficacy	efficacy	NN
cord-302115-r39ser2c	19	3	of	of	IN
cord-302115-r39ser2c	19	4	specific	specific	JJ
cord-302115-r39ser2c	19	5	Ig	Ig	NNP
cord-302115-r39ser2c	19	6	and	and	CC
cord-302115-r39ser2c	19	7	their	-PRON-	PRP$
cord-302115-r39ser2c	19	8	role	role	NN
cord-302115-r39ser2c	19	9	in	in	IN
cord-302115-r39ser2c	19	10	limiting	limit	VBG
cord-302115-r39ser2c	19	11	viral	viral	JJ
cord-302115-r39ser2c	19	12	spread	spread	NN
cord-302115-r39ser2c	19	13	may	may	MD
cord-302115-r39ser2c	19	14	be	be	VB
cord-302115-r39ser2c	19	15	indirectly	indirectly	RB
cord-302115-r39ser2c	19	16	assumed	assume	VBN
cord-302115-r39ser2c	19	17	by	by	IN
cord-302115-r39ser2c	19	18	observations	observation	NNS
cord-302115-r39ser2c	19	19	demonstrating	demonstrate	VBG
cord-302115-r39ser2c	19	20	that	that	IN
cord-302115-r39ser2c	19	21	plasma	plasma	NN
cord-302115-r39ser2c	19	22	from	from	IN
cord-302115-r39ser2c	19	23	subjects	subject	NNS
cord-302115-r39ser2c	19	24	recovered	recover	VBN
cord-302115-r39ser2c	19	25	from	from	IN
cord-302115-r39ser2c	19	26	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	19	27	showed	show	VBD
cord-302115-r39ser2c	19	28	a	a	DT
cord-302115-r39ser2c	19	29	therapeutic	therapeutic	JJ
cord-302115-r39ser2c	19	30	efficacy	efficacy	NN
cord-302115-r39ser2c	19	31	if	if	IN
cord-302115-r39ser2c	19	32	passively	passively	RB
cord-302115-r39ser2c	19	33	transferred	transfer	VBN
cord-302115-r39ser2c	19	34	to	to	IN
cord-302115-r39ser2c	19	35	patients.[37,38	patients.[37,38	NNP
cord-302115-r39ser2c	19	36	]	]	-RRB-
cord-302115-r39ser2c	20	1	Similar	similar	JJ
cord-302115-r39ser2c	20	2	effectiveness	effectiveness	NN
cord-302115-r39ser2c	20	3	had	have	VBD
cord-302115-r39ser2c	20	4	been	be	VBN
cord-302115-r39ser2c	20	5	This	this	DT
cord-302115-r39ser2c	20	6	article	article	NN
cord-302115-r39ser2c	20	7	is	be	VBZ
cord-302115-r39ser2c	20	8	protected	protect	VBN
cord-302115-r39ser2c	20	9	by	by	IN
cord-302115-r39ser2c	20	10	copyright	copyright	NN
cord-302115-r39ser2c	20	11	.	.	.
cord-302115-r39ser2c	21	1	All	all	DT
cord-302115-r39ser2c	21	2	rights	right	NNS
cord-302115-r39ser2c	21	3	reserved	reserve	VBN
cord-302115-r39ser2c	21	4	already	already	RB
cord-302115-r39ser2c	21	5	demonstrated	demonstrate	VBD
cord-302115-r39ser2c	21	6	for	for	IN
cord-302115-r39ser2c	21	7	plasma	plasma	NN
cord-302115-r39ser2c	21	8	from	from	IN
cord-302115-r39ser2c	21	9	patients	patient	NNS
cord-302115-r39ser2c	21	10	having	have	VBG
cord-302115-r39ser2c	21	11	recovered	recover	VBN
cord-302115-r39ser2c	21	12	from	from	IN
cord-302115-r39ser2c	21	13	SARS	SARS	NNP
cord-302115-r39ser2c	21	14	-	-	HYPH
cord-302115-r39ser2c	21	15	CoV	CoV	NNP
cord-302115-r39ser2c	21	16	and	and	CC
cord-302115-r39ser2c	21	17	MERS	MERS	NNP
cord-302115-r39ser2c	22	1	-CoV.	-cov.	ADD
cord-302115-r39ser2c	23	1	[	[	-LRB-
cord-302115-r39ser2c	23	2	39	39	CD
cord-302115-r39ser2c	23	3	,	,	,
cord-302115-r39ser2c	23	4	40	40	CD
cord-302115-r39ser2c	23	5	]	]	-RRB-
cord-302115-r39ser2c	24	1	Consequently	consequently	RB
cord-302115-r39ser2c	24	2	,	,	,
cord-302115-r39ser2c	24	3	infusion	infusion	NN
cord-302115-r39ser2c	24	4	of	of	IN
cord-302115-r39ser2c	24	5	plasma	plasma	NN
cord-302115-r39ser2c	24	6	from	from	IN
cord-302115-r39ser2c	24	7	convalescent	convalescent	JJ
cord-302115-r39ser2c	24	8	individuals	individual	NNS
cord-302115-r39ser2c	24	9	to	to	TO
cord-302115-r39ser2c	24	10	critically	critically	RB
cord-302115-r39ser2c	24	11	ill	ill	VB
cord-302115-r39ser2c	25	1	COVID-19	covid-19	JJ
cord-302115-r39ser2c	25	2	patients	patient	NNS
cord-302115-r39ser2c	25	3	is	be	VBZ
cord-302115-r39ser2c	25	4	a	a	DT
cord-302115-r39ser2c	25	5	therapeutic	therapeutic	JJ
cord-302115-r39ser2c	25	6	option	option	NN
cord-302115-r39ser2c	25	7	that	that	WDT
cord-302115-r39ser2c	25	8	is	be	VBZ
cord-302115-r39ser2c	25	9	being	be	VBG
cord-302115-r39ser2c	25	10	investigated	investigate	VBN
cord-302115-r39ser2c	25	11	.	.	.
cord-302115-r39ser2c	26	1	Although	although	IN
cord-302115-r39ser2c	26	2	controlled	control	VBN
cord-302115-r39ser2c	26	3	clinical	clinical	JJ
cord-302115-r39ser2c	26	4	trials	trial	NNS
cord-302115-r39ser2c	26	5	are	be	VBP
cord-302115-r39ser2c	26	6	not	not	RB
cord-302115-r39ser2c	26	7	yet	yet	RB
cord-302115-r39ser2c	26	8	available	available	JJ
cord-302115-r39ser2c	26	9	,	,	,
cord-302115-r39ser2c	26	10	several	several	JJ
cord-302115-r39ser2c	26	11	papers	paper	NNS
cord-302115-r39ser2c	26	12	report	report	VBP
cord-302115-r39ser2c	26	13	the	the	DT
cord-302115-r39ser2c	26	14	efficacy	efficacy	NN
cord-302115-r39ser2c	26	15	of	of	IN
cord-302115-r39ser2c	26	16	this	this	DT
cord-302115-r39ser2c	26	17	treatment	treatment	NN
cord-302115-r39ser2c	26	18	and	and	CC
cord-302115-r39ser2c	26	19	the	the	DT
cord-302115-r39ser2c	26	20	lack	lack	NN
cord-302115-r39ser2c	26	21	of	of	IN
cord-302115-r39ser2c	26	22	serious	serious	JJ
cord-302115-r39ser2c	26	23	adverse	adverse	JJ
cord-302115-r39ser2c	26	24	events	event	NNS
cord-302115-r39ser2c	26	25	.	.	.
cord-302115-r39ser2c	27	1	[	[	-LRB-
cord-302115-r39ser2c	27	2	41	41	CD
cord-302115-r39ser2c	27	3	,	,	,
cord-302115-r39ser2c	27	4	42	42	CD
cord-302115-r39ser2c	27	5	]	]	-RRB-
cord-302115-r39ser2c	27	6	Convalescent	convalescent	JJ
cord-302115-r39ser2c	27	7	plasma	plasma	NN
cord-302115-r39ser2c	27	8	was	be	VBD
cord-302115-r39ser2c	27	9	administered	administer	VBN
cord-302115-r39ser2c	27	10	in	in	IN
cord-302115-r39ser2c	27	11	patients	patient	NNS
cord-302115-r39ser2c	27	12	with	with	IN
cord-302115-r39ser2c	27	13	a	a	DT
cord-302115-r39ser2c	27	14	severe	severe	JJ
cord-302115-r39ser2c	27	15	disease	disease	NN
cord-302115-r39ser2c	27	16	,	,	,
cord-302115-r39ser2c	27	17	and	and	CC
cord-302115-r39ser2c	27	18	it	-PRON-	PRP
cord-302115-r39ser2c	27	19	is	be	VBZ
cord-302115-r39ser2c	27	20	unclear	unclear	JJ
cord-302115-r39ser2c	27	21	whether	whether	IN
cord-302115-r39ser2c	27	22	earlier	early	JJR
cord-302115-r39ser2c	27	23	administration	administration	NN
cord-302115-r39ser2c	27	24	might	may	MD
cord-302115-r39ser2c	27	25	have	have	VB
cord-302115-r39ser2c	27	26	been	be	VBN
cord-302115-r39ser2c	27	27	associated	associate	VBN
cord-302115-r39ser2c	27	28	with	with	IN
cord-302115-r39ser2c	27	29	different	different	JJ
cord-302115-r39ser2c	27	30	clinical	clinical	JJ
cord-302115-r39ser2c	27	31	outcomes	outcome	NNS
cord-302115-r39ser2c	27	32	[	[	-LRB-
cord-302115-r39ser2c	27	33	43	43	CD
cord-302115-r39ser2c	27	34	]	]	-RRB-
cord-302115-r39ser2c	27	35	and	and	CC
cord-302115-r39ser2c	27	36	with	with	IN
cord-302115-r39ser2c	27	37	the	the	DT
cord-302115-r39ser2c	27	38	prevention	prevention	NN
cord-302115-r39ser2c	27	39	of	of	IN
cord-302115-r39ser2c	27	40	respiratory	respiratory	JJ
cord-302115-r39ser2c	27	41	distress	distress	NN
cord-302115-r39ser2c	27	42	.	.	.
cord-302115-r39ser2c	28	1	Only	only	RB
cord-302115-r39ser2c	28	2	a	a	DT
cord-302115-r39ser2c	28	3	small	small	JJ
cord-302115-r39ser2c	28	4	proportion	proportion	NN
cord-302115-r39ser2c	28	5	of	of	IN
cord-302115-r39ser2c	28	6	humans	human	NNS
cord-302115-r39ser2c	28	7	younger	young	JJR
cord-302115-r39ser2c	28	8	than	than	IN
cord-302115-r39ser2c	28	9	50	50	CD
cord-302115-r39ser2c	28	10	,	,	,
cord-302115-r39ser2c	28	11	among	among	IN
cord-302115-r39ser2c	28	12	those	those	DT
cord-302115-r39ser2c	28	13	who	who	WP
cord-302115-r39ser2c	28	14	get	get	VBP
cord-302115-r39ser2c	28	15	infected	infect	VBN
cord-302115-r39ser2c	28	16	by	by	IN
cord-302115-r39ser2c	28	17	SARS	SARS	NNP
cord-302115-r39ser2c	28	18	-	-	HYPH
cord-302115-r39ser2c	28	19	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	28	20	,	,	,
cord-302115-r39ser2c	28	21	suffer	suffer	VBP
cord-302115-r39ser2c	28	22	from	from	IN
cord-302115-r39ser2c	28	23	moderate	moderate	JJ
cord-302115-r39ser2c	28	24	and	and	CC
cord-302115-r39ser2c	28	25	severe	severe	JJ
cord-302115-r39ser2c	28	26	COVID-19	covid-19	NN
cord-302115-r39ser2c	28	27	.	.	.
cord-302115-r39ser2c	29	1	[	[	-LRB-
cord-302115-r39ser2c	29	2	44	44	CD
cord-302115-r39ser2c	29	3	-	-	SYM
cord-302115-r39ser2c	29	4	46	46	CD
cord-302115-r39ser2c	29	5	]	]	-RRB-
cord-302115-r39ser2c	30	1	Among	among	IN
cord-302115-r39ser2c	30	2	them	-PRON-	PRP
cord-302115-r39ser2c	30	3	,	,	,
cord-302115-r39ser2c	30	4	hospital	hospital	NN
cord-302115-r39ser2c	30	5	doctors	doctor	NNS
cord-302115-r39ser2c	30	6	frequently	frequently	RB
cord-302115-r39ser2c	30	7	exposed	expose	VBN
cord-302115-r39ser2c	30	8	to	to	IN
cord-302115-r39ser2c	30	9	COVID-19	covid-19	JJ
cord-302115-r39ser2c	30	10	patients	patient	NNS
cord-302115-r39ser2c	30	11	are	be	VBP
cord-302115-r39ser2c	30	12	,	,	,
cord-302115-r39ser2c	30	13	unfortunately	unfortunately	RB
cord-302115-r39ser2c	30	14	,	,	,
cord-302115-r39ser2c	30	15	highly	highly	RB
cord-302115-r39ser2c	30	16	represented	represent	VBN
cord-302115-r39ser2c	30	17	.	.	.
cord-302115-r39ser2c	31	1	[	[	-LRB-
cord-302115-r39ser2c	31	2	47	47	CD
cord-302115-r39ser2c	31	3	]	]	-RRB-
cord-302115-r39ser2c	32	1	Dr.	Dr.	NNP
cord-302115-r39ser2c	32	2	Li	Li	NNP
cord-302115-r39ser2c	32	3	Wenliang	Wenliang	NNP
cord-302115-r39ser2c	32	4	,	,	,
cord-302115-r39ser2c	32	5	the	the	DT
cord-302115-r39ser2c	32	6	first	first	JJ
cord-302115-r39ser2c	32	7	man	man	NN
cord-302115-r39ser2c	32	8	alerting	alert	VBG
cord-302115-r39ser2c	32	9	China	China	NNP
cord-302115-r39ser2c	32	10	and	and	CC
cord-302115-r39ser2c	32	11	the	the	DT
cord-302115-r39ser2c	32	12	World	World	NNP
cord-302115-r39ser2c	32	13	of	of	IN
cord-302115-r39ser2c	32	14	the	the	DT
cord-302115-r39ser2c	32	15	new	new	JJ
cord-302115-r39ser2c	32	16	infection	infection	NN
cord-302115-r39ser2c	32	17	,	,	,
cord-302115-r39ser2c	32	18	died	die	VBD
cord-302115-r39ser2c	32	19	from	from	IN
cord-302115-r39ser2c	32	20	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	32	21	at	at	IN
cord-302115-r39ser2c	32	22	the	the	DT
cord-302115-r39ser2c	32	23	age	age	NN
cord-302115-r39ser2c	32	24	of	of	IN
cord-302115-r39ser2c	32	25	33	33	CD
cord-302115-r39ser2c	32	26	.	.	.
cord-302115-r39ser2c	33	1	[	[	-LRB-
cord-302115-r39ser2c	33	2	48	48	CD
cord-302115-r39ser2c	33	3	]	]	-RRB-
cord-302115-r39ser2c	34	1	Similarly	similarly	RB
cord-302115-r39ser2c	34	2	,	,	,
cord-302115-r39ser2c	34	3	Dr.	Dr.	NNP
cord-302115-r39ser2c	34	4	Carlo	Carlo	NNP
cord-302115-r39ser2c	34	5	Urbani	Urbani	NNP
cord-302115-r39ser2c	34	6	,	,	,
cord-302115-r39ser2c	34	7	i.e.	i.e.	FW
cord-302115-r39ser2c	34	8	the	the	DT
cord-302115-r39ser2c	34	9	first	first	JJ
cord-302115-r39ser2c	34	10	man	man	NN
cord-302115-r39ser2c	34	11	alerting	alert	VBG
cord-302115-r39ser2c	34	12	the	the	DT
cord-302115-r39ser2c	34	13	of	of	IN
cord-302115-r39ser2c	34	14	SARS	SARS	NNP
cord-302115-r39ser2c	34	15	-	-	HYPH
cord-302115-r39ser2c	34	16	CoV	CoV	NNP
cord-302115-r39ser2c	34	17	,	,	,
cord-302115-r39ser2c	34	18	died	die	VBD
cord-302115-r39ser2c	34	19	of	of	IN
cord-302115-r39ser2c	34	20	SARS	SARS	NNP
cord-302115-r39ser2c	34	21	at	at	IN
cord-302115-r39ser2c	34	22	the	the	DT
cord-302115-r39ser2c	34	23	age	age	NN
cord-302115-r39ser2c	34	24	of	of	IN
cord-302115-r39ser2c	34	25	46	46	CD
cord-302115-r39ser2c	34	26	.	.	.
cord-302115-r39ser2c	35	1	[	[	-LRB-
cord-302115-r39ser2c	35	2	49	49	CD
cord-302115-r39ser2c	35	3	]	]	-RRB-
cord-302115-r39ser2c	36	1	Both	both	DT
cord-302115-r39ser2c	36	2	doctors	doctor	NNS
cord-302115-r39ser2c	36	3	cared	care	VBD
cord-302115-r39ser2c	36	4	for	for	IN
cord-302115-r39ser2c	36	5	weeks	week	NNS
cord-302115-r39ser2c	36	6	patients	patient	NNS
cord-302115-r39ser2c	36	7	with	with	IN
cord-302115-r39ser2c	36	8	severe	severe	JJ
cord-302115-r39ser2c	36	9	pneumonia	pneumonia	NN
cord-302115-r39ser2c	36	10	with	with	IN
cord-302115-r39ser2c	36	11	no	no	DT
cord-302115-r39ser2c	36	12	personal	personal	JJ
cord-302115-r39ser2c	36	13	protection	protection	NN
cord-302115-r39ser2c	36	14	.	.	.
cord-302115-r39ser2c	37	1	[	[	-LRB-
cord-302115-r39ser2c	37	2	48	48	CD
cord-302115-r39ser2c	37	3	,	,	,
cord-302115-r39ser2c	37	4	49	49	CD
cord-302115-r39ser2c	37	5	]	]	-RRB-
cord-302115-r39ser2c	38	1	In	in	IN
cord-302115-r39ser2c	38	2	Italy	Italy	NNP
cord-302115-r39ser2c	38	3	,	,	,
cord-302115-r39ser2c	38	4	114	114	CD
cord-302115-r39ser2c	38	5	doctors	doctor	NNS
cord-302115-r39ser2c	38	6	exposed	expose	VBN
cord-302115-r39ser2c	38	7	to	to	IN
cord-302115-r39ser2c	38	8	SARS	SARS	NNP
cord-302115-r39ser2c	38	9	-	-	HYPH
cord-302115-r39ser2c	38	10	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	38	11	,	,	,
cord-302115-r39ser2c	38	12	have	have	VBP
cord-302115-r39ser2c	38	13	so	so	RB
cord-302115-r39ser2c	38	14	far	far	RB
cord-302115-r39ser2c	38	15	(	(	-LRB-
cord-302115-r39ser2c	38	16	14th	14th	JJ
cord-302115-r39ser2c	38	17	April	April	NNP
cord-302115-r39ser2c	38	18	,	,	,
cord-302115-r39ser2c	38	19	2020	2020	CD
cord-302115-r39ser2c	38	20	)	)	-RRB-
cord-302115-r39ser2c	38	21	died	die	VBD
cord-302115-r39ser2c	38	22	of	of	IN
cord-302115-r39ser2c	38	23	COVID	COVID	NNP
cord-302115-r39ser2c	38	24	.	.	.
cord-302115-r39ser2c	39	1	[	[	-LRB-
cord-302115-r39ser2c	39	2	50	50	CD
cord-302115-r39ser2c	39	3	]	]	-RRB-
cord-302115-r39ser2c	40	1	The	the	DT
cord-302115-r39ser2c	40	2	case	case	NN
cord-302115-r39ser2c	40	3	fatality	fatality	NN
cord-302115-r39ser2c	40	4	ratio	ratio	NN
cord-302115-r39ser2c	40	5	among	among	IN
cord-302115-r39ser2c	40	6	doctors	doctor	NNS
cord-302115-r39ser2c	40	7	working	work	VBG
cord-302115-r39ser2c	40	8	in	in	IN
cord-302115-r39ser2c	40	9	hospitals	hospital	NNS
cord-302115-r39ser2c	40	10	and	and	CC
cord-302115-r39ser2c	40	11	caring	care	VBG
cord-302115-r39ser2c	40	12	patients	patient	NNS
cord-302115-r39ser2c	40	13	developing	develop	VBG
cord-302115-r39ser2c	40	14	severe	severe	JJ
cord-302115-r39ser2c	40	15	COVID-19	covid-19	NN
cord-302115-r39ser2c	40	16	has	have	VBZ
cord-302115-r39ser2c	40	17	been	be	VBN
cord-302115-r39ser2c	40	18	therefore	therefore	RB
cord-302115-r39ser2c	40	19	much	much	RB
cord-302115-r39ser2c	40	20	higher	high	JJR
cord-302115-r39ser2c	40	21	than	than	IN
cord-302115-r39ser2c	40	22	among	among	IN
cord-302115-r39ser2c	40	23	their	-PRON-	PRP$
cord-302115-r39ser2c	40	24	age	age	NN
cord-302115-r39ser2c	40	25	and	and	CC
cord-302115-r39ser2c	40	26	gender	gender	NN
cord-302115-r39ser2c	40	27	matched	match	VBN
cord-302115-r39ser2c	40	28	peers	peer	NNS
cord-302115-r39ser2c	40	29	.	.	.
cord-302115-r39ser2c	41	1	[	[	-LRB-
cord-302115-r39ser2c	41	2	50	50	CD
cord-302115-r39ser2c	41	3	,	,	,
cord-302115-r39ser2c	41	4	51	51	CD
cord-302115-r39ser2c	41	5	]	]	-RRB-
cord-302115-r39ser2c	42	1	(	(	-LRB-
cord-302115-r39ser2c	42	2	Table-1	Table-1	NNP
cord-302115-r39ser2c	42	3	 	 	_SP
cord-302115-r39ser2c	42	4	Observations	Observations	NNP
cord-302115-r39ser2c	42	5	in	in	IN
cord-302115-r39ser2c	42	6	previous	previous	JJ
cord-302115-r39ser2c	42	7	viral	viral	JJ
cord-302115-r39ser2c	42	8	epidemics	epidemic	NNS
cord-302115-r39ser2c	42	9	,	,	,
cord-302115-r39ser2c	42	10	further	further	RB
cord-302115-r39ser2c	42	11	clarify	clarify	VB
cord-302115-r39ser2c	42	12	this	this	DT
cord-302115-r39ser2c	42	13	aspect	aspect	NN
cord-302115-r39ser2c	42	14	.	.	.
cord-302115-r39ser2c	43	1	The	the	DT
cord-302115-r39ser2c	43	2	reliability	reliability	NN
cord-302115-r39ser2c	43	3	of	of	IN
cord-302115-r39ser2c	43	4	high	high	JJ
cord-302115-r39ser2c	43	5	viral	viral	JJ
cord-302115-r39ser2c	43	6	loads	load	NNS
cord-302115-r39ser2c	43	7	in	in	IN
cord-302115-r39ser2c	43	8	nasopharyngeal	nasopharyngeal	JJ
cord-302115-r39ser2c	43	9	specimens	specimen	NNS
cord-302115-r39ser2c	43	10	as	as	IN
cord-302115-r39ser2c	43	11	a	a	DT
cord-302115-r39ser2c	43	12	prognostic	prognostic	JJ
cord-302115-r39ser2c	43	13	indicator	indicator	NN
cord-302115-r39ser2c	43	14	of	of	IN
cord-302115-r39ser2c	43	15	respiratory	respiratory	JJ
cord-302115-r39ser2c	43	16	failure	failure	NN
cord-302115-r39ser2c	43	17	or	or	CC
cord-302115-r39ser2c	43	18	mortality	mortality	NN
cord-302115-r39ser2c	43	19	,	,	,
cord-302115-r39ser2c	43	20	with	with	IN
cord-302115-r39ser2c	43	21	or	or	CC
cord-302115-r39ser2c	43	22	without	without	IN
cord-302115-r39ser2c	43	23	a	a	DT
cord-302115-r39ser2c	43	24	high	high	JJ
cord-302115-r39ser2c	43	25	viral	viral	JJ
cord-302115-r39ser2c	43	26	load	load	NN
cord-302115-r39ser2c	43	27	in	in	IN
cord-302115-r39ser2c	43	28	serum	serum	NN
cord-302115-r39ser2c	43	29	,	,	,
cord-302115-r39ser2c	43	30	has	have	VBZ
cord-302115-r39ser2c	43	31	been	be	VBN
cord-302115-r39ser2c	43	32	previously	previously	RB
cord-302115-r39ser2c	43	33	characterized	characterize	VBN
cord-302115-r39ser2c	43	34	in	in	IN
cord-302115-r39ser2c	43	35	SARS	SARS	NNP
cord-302115-r39ser2c	43	36	.	.	.
cord-302115-r39ser2c	44	1	[	[	-LRB-
cord-302115-r39ser2c	44	2	52	52	CD
cord-302115-r39ser2c	44	3	]	]	-RRB-
cord-302115-r39ser2c	45	1	A	a	DT
cord-302115-r39ser2c	45	2	link	link	NN
cord-302115-r39ser2c	45	3	has	have	VBZ
cord-302115-r39ser2c	45	4	been	be	VBN
cord-302115-r39ser2c	45	5	established	establish	VBN
cord-302115-r39ser2c	45	6	between	between	IN
cord-302115-r39ser2c	45	7	the	the	DT
cord-302115-r39ser2c	45	8	initial	initial	JJ
cord-302115-r39ser2c	45	9	dose	dose	NN
cord-302115-r39ser2c	45	10	and	and	CC
cord-302115-r39ser2c	45	11	subsequent	subsequent	JJ
cord-302115-r39ser2c	45	12	severity	severity	NN
cord-302115-r39ser2c	45	13	of	of	IN
cord-302115-r39ser2c	45	14	the	the	DT
cord-302115-r39ser2c	45	15	disease	disease	NN
cord-302115-r39ser2c	45	16	to	to	IN
cord-302115-r39ser2c	45	17	the	the	DT
cord-302115-r39ser2c	45	18	1918	1918	CD
cord-302115-r39ser2c	45	19	-	-	SYM
cord-302115-r39ser2c	45	20	19	19	CD
cord-302115-r39ser2c	45	21	Spanish	spanish	JJ
cord-302115-r39ser2c	45	22	Flu	Flu	NNP
cord-302115-r39ser2c	45	23	pandemic	pandemic	NN
cord-302115-r39ser2c	45	24	.	.	.
cord-302115-r39ser2c	46	1	It	-PRON-	PRP
cord-302115-r39ser2c	46	2	was	be	VBD
cord-302115-r39ser2c	46	3	demonstrated	demonstrate	VBN
cord-302115-r39ser2c	46	4	by	by	IN
cord-302115-r39ser2c	46	5	simulation	simulation	NN
cord-302115-r39ser2c	46	6	models	model	NNS
cord-302115-r39ser2c	46	7	that	that	IN
cord-302115-r39ser2c	46	8	the	the	DT
cord-302115-r39ser2c	46	9	number	number	NN
cord-302115-r39ser2c	46	10	of	of	IN
cord-302115-r39ser2c	46	11	This	this	DT
cord-302115-r39ser2c	46	12	article	article	NN
cord-302115-r39ser2c	46	13	is	be	VBZ
cord-302115-r39ser2c	46	14	protected	protect	VBN
cord-302115-r39ser2c	46	15	by	by	IN
cord-302115-r39ser2c	46	16	copyright	copyright	NN
cord-302115-r39ser2c	46	17	.	.	.
cord-302115-r39ser2c	47	1	All	all	DT
cord-302115-r39ser2c	47	2	rights	right	NNS
cord-302115-r39ser2c	47	3	reserved	reserve	VBD
cord-302115-r39ser2c	47	4	simultaneous	simultaneous	JJ
cord-302115-r39ser2c	47	5	contacts	contact	NNS
cord-302115-r39ser2c	47	6	a	a	DT
cord-302115-r39ser2c	47	7	susceptible	susceptible	JJ
cord-302115-r39ser2c	47	8	person	person	NN
cord-302115-r39ser2c	47	9	has	have	VBZ
cord-302115-r39ser2c	47	10	with	with	IN
cord-302115-r39ser2c	47	11	infectious	infectious	JJ
cord-302115-r39ser2c	47	12	ones	one	NNS
cord-302115-r39ser2c	47	13	are	be	VBP
cord-302115-r39ser2c	47	14	correlated	correlate	VBN
cord-302115-r39ser2c	47	15	with	with	IN
cord-302115-r39ser2c	47	16	the	the	DT
cord-302115-r39ser2c	47	17	infectious	infectious	JJ
cord-302115-r39ser2c	47	18	dose	dose	NN
cord-302115-r39ser2c	47	19	;	;	:
cord-302115-r39ser2c	47	20	that	that	IN
cord-302115-r39ser2c	47	21	severe	severe	JJ
cord-302115-r39ser2c	47	22	cases	case	NNS
cord-302115-r39ser2c	47	23	of	of	IN
cord-302115-r39ser2c	47	24	influenza	influenza	NN
cord-302115-r39ser2c	47	25	result	result	NN
cord-302115-r39ser2c	47	26	from	from	IN
cord-302115-r39ser2c	47	27	higher	high	JJR
cord-302115-r39ser2c	47	28	infectious	infectious	JJ
cord-302115-r39ser2c	47	29	doses	dose	NNS
cord-302115-r39ser2c	47	30	of	of	IN
cord-302115-r39ser2c	47	31	the	the	DT
cord-302115-r39ser2c	47	32	virus	virus	NN
cord-302115-r39ser2c	47	33	;	;	:
cord-302115-r39ser2c	47	34	and	and	CC
cord-302115-r39ser2c	47	35	that	that	IN
cord-302115-r39ser2c	47	36	a	a	DT
cord-302115-r39ser2c	47	37	susceptible	susceptible	JJ
cord-302115-r39ser2c	47	38	person	person	NN
cord-302115-r39ser2c	47	39	can	can	MD
cord-302115-r39ser2c	47	40	be	be	VB
cord-302115-r39ser2c	47	41	easily	easily	RB
cord-302115-r39ser2c	47	42	exposed	expose	VBN
cord-302115-r39ser2c	47	43	to	to	IN
cord-302115-r39ser2c	47	44	very	very	RB
cord-302115-r39ser2c	47	45	high	high	JJ
cord-302115-r39ser2c	47	46	infectious	infectious	JJ
cord-302115-r39ser2c	47	47	doses	dose	NNS
cord-302115-r39ser2c	47	48	of	of	IN
cord-302115-r39ser2c	47	49	influenza	influenza	NN
cord-302115-r39ser2c	47	50	in	in	IN
cord-302115-r39ser2c	47	51	over	over	RB
cord-302115-r39ser2c	47	52	-	-	HYPH
cord-302115-r39ser2c	47	53	crowded	crowd	VBN
cord-302115-r39ser2c	47	54	places	place	NNS
cord-302115-r39ser2c	47	55	.	.	.
cord-302115-r39ser2c	48	1	[	[	-LRB-
cord-302115-r39ser2c	48	2	53	53	CD
cord-302115-r39ser2c	48	3	]	]	-RRB-
cord-302115-r39ser2c	48	4	The	the	DT
cord-302115-r39ser2c	48	5	viral	viral	JJ
cord-302115-r39ser2c	48	6	replication	replication	NN
cord-302115-r39ser2c	48	7	is	be	VBZ
cord-302115-r39ser2c	48	8	more	more	RBR
cord-302115-r39ser2c	48	9	active	active	JJ
cord-302115-r39ser2c	48	10	and	and	CC
cord-302115-r39ser2c	48	11	prolonged	prolong	VBN
cord-302115-r39ser2c	48	12	in	in	IN
cord-302115-r39ser2c	48	13	patients	patient	NNS
cord-302115-r39ser2c	48	14	suffering	suffer	VBG
cord-302115-r39ser2c	48	15	from	from	IN
cord-302115-r39ser2c	48	16	severe	severe	JJ
cord-302115-r39ser2c	48	17	influenza	influenza	NN
cord-302115-r39ser2c	48	18	.	.	.
cord-302115-r39ser2c	49	1	Viral	viral	JJ
cord-302115-r39ser2c	49	2	clearance	clearance	NN
cord-302115-r39ser2c	49	3	is	be	VBZ
cord-302115-r39ser2c	49	4	slow	slow	JJ
cord-302115-r39ser2c	49	5	when	when	WRB
cord-302115-r39ser2c	49	6	host	host	NN
cord-302115-r39ser2c	49	7	defenses	defense	NNS
cord-302115-r39ser2c	49	8	are	be	VBP
cord-302115-r39ser2c	49	9	weakened	weaken	VBN
cord-302115-r39ser2c	49	10	,	,	,
cord-302115-r39ser2c	49	11	however	however	RB
cord-302115-r39ser2c	49	12	it	-PRON-	PRP
cord-302115-r39ser2c	49	13	is	be	VBZ
cord-302115-r39ser2c	49	14	enhanced	enhance	VBN
cord-302115-r39ser2c	49	15	when	when	WRB
cord-302115-r39ser2c	49	16	antivirals	antiviral	NNS
cord-302115-r39ser2c	49	17	start	start	VBP
cord-302115-r39ser2c	49	18	within	within	IN
cord-302115-r39ser2c	49	19	the	the	DT
cord-302115-r39ser2c	49	20	first	first	JJ
cord-302115-r39ser2c	49	21	4	4	CD
cord-302115-r39ser2c	49	22	days	day	NNS
cord-302115-r39ser2c	49	23	of	of	IN
cord-302115-r39ser2c	49	24	illness	illness	NN
cord-302115-r39ser2c	49	25	.	.	.
cord-302115-r39ser2c	50	1	[	[	-LRB-
cord-302115-r39ser2c	50	2	54	54	CD
cord-302115-r39ser2c	50	3	]	]	-RRB-
cord-302115-r39ser2c	51	1	Among	among	IN
cord-302115-r39ser2c	51	2	over	over	IN
cord-302115-r39ser2c	51	3	70	70	CD
cord-302115-r39ser2c	51	4	thousand	thousand	CD
cord-302115-r39ser2c	51	5	Chinese	Chinese	NNPS
cord-302115-r39ser2c	51	6	with	with	IN
cord-302115-r39ser2c	51	7	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	51	8	,	,	,
cord-302115-r39ser2c	51	9	most	most	JJS
cord-302115-r39ser2c	51	10	were	be	VBD
cord-302115-r39ser2c	51	11	aged	age	VBN
cord-302115-r39ser2c	51	12	over	over	IN
cord-302115-r39ser2c	51	13	30	30	CD
cord-302115-r39ser2c	51	14	years	year	NNS
cord-302115-r39ser2c	51	15	(	(	-LRB-
cord-302115-r39ser2c	51	16	90	90	CD
cord-302115-r39ser2c	51	17	%	%	NN
cord-302115-r39ser2c	51	18	)	)	-RRB-
cord-302115-r39ser2c	51	19	,	,	,
cord-302115-r39ser2c	51	20	while	while	IN
cord-302115-r39ser2c	51	21	only	only	RB
cord-302115-r39ser2c	51	22	1	1	CD
cord-302115-r39ser2c	51	23	%	%	NN
cord-302115-r39ser2c	51	24	were	be	VBD
cord-302115-r39ser2c	51	25	aged	aged	JJ
cord-302115-r39ser2c	51	26	9	9	CD
cord-302115-r39ser2c	51	27	years	year	NNS
cord-302115-r39ser2c	51	28	or	or	CC
cord-302115-r39ser2c	51	29	younger	young	JJR
cord-302115-r39ser2c	51	30	,	,	,
cord-302115-r39ser2c	51	31	1	1	CD
cord-302115-r39ser2c	51	32	%	%	NN
cord-302115-r39ser2c	51	33	were	be	VBD
cord-302115-r39ser2c	51	34	aged	age	VBN
cord-302115-r39ser2c	51	35	10	10	CD
cord-302115-r39ser2c	51	36	to	to	TO
cord-302115-r39ser2c	51	37	19	19	CD
cord-302115-r39ser2c	51	38	years	year	NNS
cord-302115-r39ser2c	51	39	an	an	DT
cord-302115-r39ser2c	51	40	8	8	CD
cord-302115-r39ser2c	51	41	%	%	NN
cord-302115-r39ser2c	51	42	aged	age	VBN
cord-302115-r39ser2c	51	43	20	20	CD
cord-302115-r39ser2c	51	44	to	to	TO
cord-302115-r39ser2c	51	45	29	29	CD
cord-302115-r39ser2c	51	46	years	year	NNS
cord-302115-r39ser2c	51	47	.	.	.
cord-302115-r39ser2c	52	1	[	[	-LRB-
cord-302115-r39ser2c	52	2	55	55	CD
cord-302115-r39ser2c	52	3	]	]	-RRB-
cord-302115-r39ser2c	53	1	Moreover	moreover	RB
cord-302115-r39ser2c	53	2	,	,	,
cord-302115-r39ser2c	53	3	most	most	JJS
cord-302115-r39ser2c	53	4	of	of	IN
cord-302115-r39ser2c	53	5	the	the	DT
cord-302115-r39ser2c	53	6	relatively	relatively	RB
cord-302115-r39ser2c	53	7	few	few	JJ
cord-302115-r39ser2c	53	8	pediatric	pediatric	JJ
cord-302115-r39ser2c	53	9	cases	case	NNS
cord-302115-r39ser2c	53	10	were	be	VBD
cord-302115-r39ser2c	53	11	classified	classify	VBN
cord-302115-r39ser2c	53	12	as	as	IN
cord-302115-r39ser2c	53	13	mild	mild	JJ
cord-302115-r39ser2c	53	14	(	(	-LRB-
cord-302115-r39ser2c	53	15	81	81	CD
cord-302115-r39ser2c	53	16	%	%	NN
cord-302115-r39ser2c	53	17	)	)	-RRB-
cord-302115-r39ser2c	53	18	,	,	,
cord-302115-r39ser2c	53	19	only	only	RB
cord-302115-r39ser2c	53	20	14	14	CD
cord-302115-r39ser2c	53	21	%	%	NN
cord-302115-r39ser2c	53	22	severe	severe	JJ
cord-302115-r39ser2c	53	23	and	and	CC
cord-302115-r39ser2c	53	24	5	5	CD
cord-302115-r39ser2c	53	25	%	%	NN
cord-302115-r39ser2c	53	26	critical	critical	JJ
cord-302115-r39ser2c	53	27	.	.	.
cord-302115-r39ser2c	54	1	[	[	-LRB-
cord-302115-r39ser2c	54	2	 	 	_SP
cord-302115-r39ser2c	54	3	This	this	DT
cord-302115-r39ser2c	54	4	article	article	NN
cord-302115-r39ser2c	54	5	is	be	VBZ
cord-302115-r39ser2c	54	6	protected	protect	VBN
cord-302115-r39ser2c	54	7	by	by	IN
cord-302115-r39ser2c	54	8	copyright	copyright	NN
cord-302115-r39ser2c	54	9	.	.	.
cord-302115-r39ser2c	55	1	All	all	DT
cord-302115-r39ser2c	55	2	rights	right	NNS
cord-302115-r39ser2c	55	3	reserved	reserve	VBN
cord-302115-r39ser2c	56	1	COVID-19	covid-19	JJ
cord-302115-r39ser2c	56	2	mortality	mortality	NN
cord-302115-r39ser2c	56	3	has	have	VBZ
cord-302115-r39ser2c	56	4	been	be	VBN
cord-302115-r39ser2c	56	5	lower	low	JJR
cord-302115-r39ser2c	56	6	among	among	IN
cord-302115-r39ser2c	56	7	Chinese	chinese	JJ
cord-302115-r39ser2c	56	8	females	female	NNS
cord-302115-r39ser2c	56	9	than	than	IN
cord-302115-r39ser2c	56	10	males	male	NNS
cord-302115-r39ser2c	56	11	.	.	.
cord-302115-r39ser2c	57	1	[	[	-LRB-
cord-302115-r39ser2c	57	2	59	59	CD
cord-302115-r39ser2c	57	3	]	]	-RRB-
cord-302115-r39ser2c	58	1	In	in	IN
cord-302115-r39ser2c	58	2	Italy	Italy	NNP
cord-302115-r39ser2c	58	3	,	,	,
cord-302115-r39ser2c	58	4	mortality	mortality	NN
cord-302115-r39ser2c	58	5	and	and	CC
cord-302115-r39ser2c	58	6	hospitalization	hospitalization	NN
cord-302115-r39ser2c	58	7	rates	rate	NNS
cord-302115-r39ser2c	58	8	have	have	VBP
cord-302115-r39ser2c	58	9	been	be	VBN
cord-302115-r39ser2c	58	10	also	also	RB
cord-302115-r39ser2c	58	11	more	more	RBR
cord-302115-r39ser2c	58	12	frequent	frequent	JJ
cord-302115-r39ser2c	58	13	among	among	IN
cord-302115-r39ser2c	58	14	males	male	NNS
cord-302115-r39ser2c	58	15	than	than	IN
cord-302115-r39ser2c	58	16	among	among	IN
cord-302115-r39ser2c	58	17	females	female	NNS
cord-302115-r39ser2c	58	18	.	.	.
cord-302115-r39ser2c	59	1	[	[	-LRB-
cord-302115-r39ser2c	59	2	60	60	CD
cord-302115-r39ser2c	59	3	]	]	-RRB-
cord-302115-r39ser2c	60	1	Moreover	moreover	RB
cord-302115-r39ser2c	60	2	,	,	,
cord-302115-r39ser2c	60	3	patients	patient	NNS
cord-302115-r39ser2c	60	4	with	with	IN
cord-302115-r39ser2c	60	5	blood	blood	NN
cord-302115-r39ser2c	60	6	group	group	NN
cord-302115-r39ser2c	60	7	0	0	NFP
cord-302115-r39ser2c	60	8	and	and	CC
cord-302115-r39ser2c	60	9	A	a	DT
cord-302115-r39ser2c	60	10	have	have	VBP
cord-302115-r39ser2c	60	11	slightly	slightly	RB
cord-302115-r39ser2c	60	12	lower	low	JJR
cord-302115-r39ser2c	60	13	and	and	CC
cord-302115-r39ser2c	60	14	a	a	DT
cord-302115-r39ser2c	60	15	slightly	slightly	RB
cord-302115-r39ser2c	60	16	higher	high	JJR
cord-302115-r39ser2c	60	17	risk	risk	NN
cord-302115-r39ser2c	60	18	,	,	,
cord-302115-r39ser2c	60	19	 	 	_SP
cord-302115-r39ser2c	61	1	The	the	DT
cord-302115-r39ser2c	61	2	first	first	JJ
cord-302115-r39ser2c	61	3	diagnosis	diagnosis	NN
cord-302115-r39ser2c	61	4	of	of	IN
cord-302115-r39ser2c	61	5	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	61	6	in	in	IN
cord-302115-r39ser2c	61	7	Europe	Europe	NNP
cord-302115-r39ser2c	61	8	has	have	VBZ
cord-302115-r39ser2c	61	9	been	be	VBN
cord-302115-r39ser2c	61	10	confirmed	confirm	VBN
cord-302115-r39ser2c	61	11	in	in	IN
cord-302115-r39ser2c	61	12	a	a	DT
cord-302115-r39ser2c	61	13	38	38	CD
cord-302115-r39ser2c	61	14	year	year	NN
cord-302115-r39ser2c	61	15	-	-	HYPH
cord-302115-r39ser2c	61	16	old	old	JJ
cord-302115-r39ser2c	61	17	Italian	italian	JJ
cord-302115-r39ser2c	61	18	healthy	healthy	JJ
cord-302115-r39ser2c	61	19	male	male	NN
cord-302115-r39ser2c	61	20	who	who	WP
cord-302115-r39ser2c	61	21	regularly	regularly	RB
cord-302115-r39ser2c	61	22	participated	participate	VBD
cord-302115-r39ser2c	61	23	in	in	IN
cord-302115-r39ser2c	61	24	running	run	VBG
cord-302115-r39ser2c	61	25	events	event	NNS
cord-302115-r39ser2c	61	26	and	and	CC
cord-302115-r39ser2c	61	27	soccer	soccer	NN
cord-302115-r39ser2c	61	28	games	game	NNS
cord-302115-r39ser2c	61	29	.	.	.
cord-302115-r39ser2c	62	1	One	one	CD
cord-302115-r39ser2c	62	2	day	day	NN
cord-302115-r39ser2c	62	3	before	before	IN
cord-302115-r39ser2c	62	4	starting	start	VBG
cord-302115-r39ser2c	62	5	COVID-19	covid-19	JJ
cord-302115-r39ser2c	62	6	symptoms	symptom	NNS
cord-302115-r39ser2c	62	7	,	,	,
cord-302115-r39ser2c	62	8	he	-PRON-	PRP
cord-302115-r39ser2c	62	9	had	have	VBD
cord-302115-r39ser2c	62	10	been	be	VBN
cord-302115-r39ser2c	62	11	training	train	VBG
cord-302115-r39ser2c	62	12	sport	sport	NN
cord-302115-r39ser2c	62	13	.	.	.
cord-302115-r39ser2c	63	1	The	the	DT
cord-302115-r39ser2c	63	2	time	time	NN
cord-302115-r39ser2c	63	3	-	-	HYPH
cord-302115-r39ser2c	63	4	lapse	lapse	NN
cord-302115-r39ser2c	63	5	between	between	IN
cord-302115-r39ser2c	63	6	the	the	DT
cord-302115-r39ser2c	63	7	onset	onset	NN
cord-302115-r39ser2c	63	8	of	of	IN
cord-302115-r39ser2c	63	9	upper	upper	JJ
cord-302115-r39ser2c	63	10	airways	airway	NNS
cord-302115-r39ser2c	63	11	symptoms	symptom	NNS
cord-302115-r39ser2c	63	12	and	and	CC
cord-302115-r39ser2c	63	13	pneumonia	pneumonia	NN
cord-302115-r39ser2c	63	14	was	be	VBD
cord-302115-r39ser2c	63	15	2	2	CD
cord-302115-r39ser2c	63	16	days	day	NNS
cord-302115-r39ser2c	63	17	only	only	RB
cord-302115-r39ser2c	63	18	.	.	.
cord-302115-r39ser2c	64	1	Only	only	RB
cord-302115-r39ser2c	64	2	4	4	CD
cord-302115-r39ser2c	64	3	days	day	NNS
cord-302115-r39ser2c	64	4	after	after	IN
cord-302115-r39ser2c	64	5	the	the	DT
cord-302115-r39ser2c	64	6	onset	onset	NN
cord-302115-r39ser2c	64	7	of	of	IN
cord-302115-r39ser2c	64	8	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	64	9	,	,	,
cord-302115-r39ser2c	64	10	the	the	DT
cord-302115-r39ser2c	64	11	patient	patient	NN
cord-302115-r39ser2c	64	12	was	be	VBD
cord-302115-r39ser2c	64	13	admitted	admit	VBN
cord-302115-r39ser2c	64	14	to	to	IN
cord-302115-r39ser2c	64	15	the	the	DT
cord-302115-r39ser2c	64	16	intensive	intensive	JJ
cord-302115-r39ser2c	64	17	care	care	NN
cord-302115-r39ser2c	64	18	unit	unit	NN
cord-302115-r39ser2c	64	19	of	of	IN
cord-302115-r39ser2c	64	20	the	the	DT
cord-302115-r39ser2c	64	21	Policlinico	Policlinico	NNP
cord-302115-r39ser2c	64	22	San	San	NNP
cord-302115-r39ser2c	64	23	Matteo	Matteo	NNP
cord-302115-r39ser2c	64	24	in	in	IN
cord-302115-r39ser2c	64	25	Pavia	Pavia	NNP
cord-302115-r39ser2c	64	26	because	because	IN
cord-302115-r39ser2c	64	27	of	of	IN
cord-302115-r39ser2c	64	28	respiratory	respiratory	JJ
cord-302115-r39ser2c	64	29	failure	failure	NN
cord-302115-r39ser2c	64	30	.	.	.
cord-302115-r39ser2c	65	1	After	after	IN
cord-302115-r39ser2c	65	2	weeks	week	NNS
cord-302115-r39ser2c	65	3	of	of	IN
cord-302115-r39ser2c	65	4	intubation	intubation	NN
cord-302115-r39ser2c	65	5	and	and	CC
cord-302115-r39ser2c	65	6	supportive	supportive	JJ
cord-302115-r39ser2c	65	7	treatment	treatment	NN
cord-302115-r39ser2c	65	8	,	,	,
cord-302115-r39ser2c	65	9	the	the	DT
cord-302115-r39ser2c	65	10	patient	patient	NN
cord-302115-r39ser2c	65	11	luckily	luckily	RB
cord-302115-r39ser2c	65	12	recovered	recover	VBD
cord-302115-r39ser2c	65	13	and	and	CC
cord-302115-r39ser2c	65	14	could	could	MD
cord-302115-r39ser2c	65	15	be	be	VB
cord-302115-r39ser2c	65	16	discharged	discharge	VBN
cord-302115-r39ser2c	65	17	in	in	IN
cord-302115-r39ser2c	65	18	good	good	JJ
cord-302115-r39ser2c	65	19	conditions	condition	NNS
cord-302115-r39ser2c	65	20	.	.	.
cord-302115-r39ser2c	66	1	The	the	DT
cord-302115-r39ser2c	66	2	Italian	italian	JJ
cord-302115-r39ser2c	66	3	first	first	JJ
cord-302115-r39ser2c	66	4	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	66	5	case	case	NN
cord-302115-r39ser2c	66	6	is	be	VBZ
cord-302115-r39ser2c	66	7	worldwide	worldwide	RB
cord-302115-r39ser2c	66	8	famous	famous	JJ
cord-302115-r39ser2c	66	9	but	but	CC
cord-302115-r39ser2c	66	10	,	,	,
cord-302115-r39ser2c	66	11	surprisingly	surprisingly	RB
cord-302115-r39ser2c	66	12	,	,	,
cord-302115-r39ser2c	66	13	no	no	DT
cord-302115-r39ser2c	66	14	official	official	JJ
cord-302115-r39ser2c	66	15	study	study	NN
cord-302115-r39ser2c	66	16	on	on	IN
cord-302115-r39ser2c	66	17	it	-PRON-	PRP
cord-302115-r39ser2c	66	18	has	have	VBZ
cord-302115-r39ser2c	66	19	been	be	VBN
cord-302115-r39ser2c	66	20	so	so	RB
cord-302115-r39ser2c	66	21	far	far	RB
cord-302115-r39ser2c	66	22	published	publish	VBN
cord-302115-r39ser2c	66	23	.	.	.
cord-302115-r39ser2c	67	1	The	the	DT
cord-302115-r39ser2c	67	2	example	example	NN
cord-302115-r39ser2c	67	3	of	of	IN
cord-302115-r39ser2c	67	4	this	this	DT
cord-302115-r39ser2c	67	5	physically	physically	RB
cord-302115-r39ser2c	67	6	active	active	JJ
cord-302115-r39ser2c	67	7	,	,	,
cord-302115-r39ser2c	67	8	young	young	JJ
cord-302115-r39ser2c	67	9	patient	patient	NN
cord-302115-r39ser2c	67	10	offers	offer	VBZ
cord-302115-r39ser2c	67	11	room	room	NN
cord-302115-r39ser2c	67	12	for	for	IN
cord-302115-r39ser2c	67	13	reasoning	reason	VBG
cord-302115-r39ser2c	67	14	with	with	IN
cord-302115-r39ser2c	67	15	regard	regard	NN
cord-302115-r39ser2c	67	16	to	to	IN
cord-302115-r39ser2c	67	17	the	the	DT
cord-302115-r39ser2c	67	18	importance	importance	NN
cord-302115-r39ser2c	67	19	of	of	IN
cord-302115-r39ser2c	67	20	sport	sport	NN
cord-302115-r39ser2c	67	21	for	for	IN
cord-302115-r39ser2c	67	22	virus	virus	NN
cord-302115-r39ser2c	67	23	transmission	transmission	NN
cord-302115-r39ser2c	67	24	and	and	CC
cord-302115-r39ser2c	67	25	course	course	NN
cord-302115-r39ser2c	67	26	of	of	IN
cord-302115-r39ser2c	67	27	disease	disease	NN
cord-302115-r39ser2c	67	28	.	.	.
cord-302115-r39ser2c	68	1	Indeed	indeed	RB
cord-302115-r39ser2c	68	2	,	,	,
cord-302115-r39ser2c	68	3	other	other	JJ
cord-302115-r39ser2c	68	4	cases	case	NNS
cord-302115-r39ser2c	68	5	of	of	IN
cord-302115-r39ser2c	68	6	COVID-19	covid-19	CD
cord-302115-r39ser2c	68	7	in	in	IN
cord-302115-r39ser2c	68	8	(	(	-LRB-
cord-302115-r39ser2c	68	9	semi-	semi-	NN
cord-302115-r39ser2c	68	10	)	)	-RRB-
cord-302115-r39ser2c	68	11	professional	professional	JJ
cord-302115-r39ser2c	68	12	athletes	athlete	NNS
cord-302115-r39ser2c	68	13	have	have	VBP
cord-302115-r39ser2c	68	14	been	be	VBN
cord-302115-r39ser2c	68	15	described	describe	VBN
cord-302115-r39ser2c	68	16	.	.	.
cord-302115-r39ser2c	69	1	The	the	DT
cord-302115-r39ser2c	69	2	pattern	pattern	NN
cord-302115-r39ser2c	69	3	of	of	IN
cord-302115-r39ser2c	69	4	breathing	breathing	NN
cord-302115-r39ser2c	69	5	during	during	IN
cord-302115-r39ser2c	69	6	strenuous	strenuous	JJ
cord-302115-r39ser2c	69	7	exercise	exercise	NN
cord-302115-r39ser2c	69	8	changes	change	NNS
cord-302115-r39ser2c	69	9	dramatically	dramatically	RB
cord-302115-r39ser2c	69	10	by	by	IN
cord-302115-r39ser2c	69	11	a	a	DT
cord-302115-r39ser2c	69	12	tremendous	tremendous	JJ
cord-302115-r39ser2c	69	13	increase	increase	NN
cord-302115-r39ser2c	69	14	of	of	IN
cord-302115-r39ser2c	69	15	ventilation	ventilation	NN
cord-302115-r39ser2c	69	16	(	(	-LRB-
cord-302115-r39ser2c	69	17	i.e.	i.e.	FW
cord-302115-r39ser2c	69	18	:	:	:
cord-302115-r39ser2c	69	19	inspiratory	inspiratory	JJ
cord-302115-r39ser2c	69	20	and	and	CC
cord-302115-r39ser2c	69	21	expiratory	expiratory	JJ
cord-302115-r39ser2c	69	22	volumes	volume	NNS
cord-302115-r39ser2c	69	23	of	of	IN
cord-302115-r39ser2c	69	24	air	air	NN
cord-302115-r39ser2c	69	25	)	)	-RRB-
cord-302115-r39ser2c	69	26	,	,	,
cord-302115-r39ser2c	69	27	and	and	CC
cord-302115-r39ser2c	69	28	of	of	IN
cord-302115-r39ser2c	69	29	alveolar	alveolar	JJ
cord-302115-r39ser2c	69	30	ventilation	ventilation	NN
cord-302115-r39ser2c	69	31	in	in	IN
cord-302115-r39ser2c	69	32	particular	particular	JJ
cord-302115-r39ser2c	69	33	.	.	.
cord-302115-r39ser2c	70	1	Obviously	obviously	RB
cord-302115-r39ser2c	70	2	,	,	,
cord-302115-r39ser2c	70	3	these	these	DT
cord-302115-r39ser2c	70	4	changes	change	NNS
cord-302115-r39ser2c	70	5	mostly	mostly	RB
cord-302115-r39ser2c	70	6	attain	attain	JJ
cord-302115-r39ser2c	70	7	to	to	IN
cord-302115-r39ser2c	70	8	whatever	whatever	WDT
cord-302115-r39ser2c	70	9	kind	kind	NN
cord-302115-r39ser2c	70	10	of	of	IN
cord-302115-r39ser2c	70	11	runners	runner	NNS
cord-302115-r39ser2c	70	12	belonging	belong	VBG
cord-302115-r39ser2c	70	13	to	to	IN
cord-302115-r39ser2c	70	14	all	all	DT
cord-302115-r39ser2c	70	15	sport	sport	NN
cord-302115-r39ser2c	70	16	disciplines	discipline	NNS
cord-302115-r39ser2c	70	17	,	,	,
cord-302115-r39ser2c	70	18	being	be	VBG
cord-302115-r39ser2c	70	19	semi	semi	JJ
cord-302115-r39ser2c	70	20	-	-	JJ
cord-302115-r39ser2c	70	21	professional	professional	JJ
cord-302115-r39ser2c	70	22	and	and	CC
cord-302115-r39ser2c	70	23	professional	professional	JJ
cord-302115-r39ser2c	70	24	athletes	athlete	NNS
cord-302115-r39ser2c	70	25	particularly	particularly	RB
cord-302115-r39ser2c	70	26	exposed	expose	VBN
cord-302115-r39ser2c	70	27	(	(	-LRB-
cord-302115-r39ser2c	70	28	such	such	JJ
cord-302115-r39ser2c	70	29	as	as	RB
cord-302115-r39ser2c	70	30	much	much	RB
cord-302115-r39ser2c	70	31	more	more	JJR
cord-302115-r39ser2c	70	32	than	than	IN
cord-302115-r39ser2c	70	33	individuals	individual	NNS
cord-302115-r39ser2c	70	34	of	of	IN
cord-302115-r39ser2c	70	35	common	common	JJ
cord-302115-r39ser2c	70	36	population	population	NN
cord-302115-r39ser2c	70	37	)	)	-RRB-
cord-302115-r39ser2c	70	38	due	due	IN
cord-302115-r39ser2c	70	39	to	to	IN
cord-302115-r39ser2c	70	40	their	-PRON-	PRP$
cord-302115-r39ser2c	70	41	frequent	frequent	JJ
cord-302115-r39ser2c	70	42	practice	practice	NN
cord-302115-r39ser2c	70	43	of	of	IN
cord-302115-r39ser2c	70	44	extreme	extreme	JJ
cord-302115-r39ser2c	70	45	and	and	CC
cord-302115-r39ser2c	70	46	long	long	RB
cord-302115-r39ser2c	70	47	-	-	HYPH
cord-302115-r39ser2c	70	48	lasting	last	VBG
cord-302115-r39ser2c	70	49	exercise	exercise	NN
cord-302115-r39ser2c	70	50	.	.	.
cord-302115-r39ser2c	71	1	Furthermore	furthermore	RB
cord-302115-r39ser2c	71	2	,	,	,
cord-302115-r39ser2c	71	3	the	the	DT
cord-302115-r39ser2c	71	4	majority	majority	NN
cord-302115-r39ser2c	71	5	of	of	IN
cord-302115-r39ser2c	71	6	these	these	DT
cord-302115-r39ser2c	71	7	athletes	athlete	NNS
cord-302115-r39ser2c	71	8	have	have	VBP
cord-302115-r39ser2c	71	9	their	-PRON-	PRP$
cord-302115-r39ser2c	71	10	lungs	lung	NNS
cord-302115-r39ser2c	71	11	that	that	WDT
cord-302115-r39ser2c	71	12	usually	usually	RB
cord-302115-r39ser2c	71	13	work	work	VBP
cord-302115-r39ser2c	71	14	in	in	IN
cord-302115-r39ser2c	71	15	perfect	perfect	JJ
cord-302115-r39ser2c	71	16	physiological	physiological	JJ
cord-302115-r39ser2c	71	17	conditions	condition	NNS
cord-302115-r39ser2c	71	18	,	,	,
cord-302115-r39ser2c	71	19	such	such	JJ
cord-302115-r39ser2c	71	20	as	as	IN
cord-302115-r39ser2c	71	21	very	very	RB
cord-302115-r39ser2c	71	22	close	close	JJ
cord-302115-r39ser2c	71	23	to	to	IN
cord-302115-r39ser2c	71	24	those	those	DT
cord-302115-r39ser2c	71	25	of	of	IN
cord-302115-r39ser2c	71	26	the	the	DT
cord-302115-r39ser2c	71	27	"	"	``
cord-302115-r39ser2c	71	28	ideal	ideal	JJ
cord-302115-r39ser2c	71	29	lung	lung	NN
cord-302115-r39ser2c	71	30	"	"	''
cord-302115-r39ser2c	71	31	.	.	.
cord-302115-r39ser2c	72	1	In	in	IN
cord-302115-r39ser2c	72	2	other	other	JJ
cord-302115-r39ser2c	72	3	words	word	NNS
cord-302115-r39ser2c	72	4	,	,	,
cord-302115-r39ser2c	72	5	in	in	IN
cord-302115-r39ser2c	72	6	the	the	DT
cord-302115-r39ser2c	72	7	absence	absence	NN
cord-302115-r39ser2c	72	8	of	of	IN
cord-302115-r39ser2c	72	9	any	any	DT
cord-302115-r39ser2c	72	10	anatomical	anatomical	JJ
cord-302115-r39ser2c	72	11	or	or	CC
cord-302115-r39ser2c	72	12	physiological	physiological	JJ
cord-302115-r39ser2c	72	13	factor	factor	NN
cord-302115-r39ser2c	72	14	causing	cause	VBG
cord-302115-r39ser2c	72	15	a	a	DT
cord-302115-r39ser2c	72	16	significant	significant	JJ
cord-302115-r39ser2c	72	17	unevenness	unevenness	NN
cord-302115-r39ser2c	72	18	in	in	IN
cord-302115-r39ser2c	72	19	distribution	distribution	NN
cord-302115-r39ser2c	72	20	of	of	IN
cord-302115-r39ser2c	72	21	their	-PRON-	PRP$
cord-302115-r39ser2c	72	22	alveolar	alveolar	NN
cord-302115-r39ser2c	72	23	ventilation	ventilation	NN
cord-302115-r39ser2c	72	24	.	.	.
cord-302115-r39ser2c	73	1	Paradoxically	paradoxically	RB
cord-302115-r39ser2c	73	2	,	,	,
cord-302115-r39ser2c	73	3	these	these	DT
cord-302115-r39ser2c	73	4	pre	pre	JJ
cord-302115-r39ser2c	73	5	-	-	JJ
cord-302115-r39ser2c	73	6	existing	exist	VBG
cord-302115-r39ser2c	73	7	ideal	ideal	NN
cord-302115-r39ser2c	73	8	This	this	DT
cord-302115-r39ser2c	73	9	article	article	NN
cord-302115-r39ser2c	73	10	is	be	VBZ
cord-302115-r39ser2c	73	11	protected	protect	VBN
cord-302115-r39ser2c	73	12	by	by	IN
cord-302115-r39ser2c	73	13	copyright	copyright	NN
cord-302115-r39ser2c	73	14	.	.	.
cord-302115-r39ser2c	74	1	All	all	DT
cord-302115-r39ser2c	74	2	rights	right	NNS
cord-302115-r39ser2c	74	3	reserved	reserve	VBN
cord-302115-r39ser2c	74	4	conditions	condition	NNS
cord-302115-r39ser2c	74	5	significantly	significantly	RB
cord-302115-r39ser2c	74	6	favor	favor	VBP
cord-302115-r39ser2c	74	7	the	the	DT
cord-302115-r39ser2c	74	8	deep	deep	JJ
cord-302115-r39ser2c	74	9	inhalation	inhalation	NN
cord-302115-r39ser2c	74	10	of	of	IN
cord-302115-r39ser2c	74	11	several	several	JJ
cord-302115-r39ser2c	74	12	irritants	irritant	NNS
cord-302115-r39ser2c	74	13	,	,	,
cord-302115-r39ser2c	74	14	allergens	allergen	NNS
cord-302115-r39ser2c	74	15	,	,	,
cord-302115-r39ser2c	74	16	infectious	infectious	JJ
cord-302115-r39ser2c	74	17	agents	agent	NNS
cord-302115-r39ser2c	74	18	.	.	.
cord-302115-r39ser2c	75	1	Even	even	RB
cord-302115-r39ser2c	75	2	the	the	DT
cord-302115-r39ser2c	75	3	SARS	SARS	NNP
cord-302115-r39ser2c	75	4	-	-	HYPH
cord-302115-r39ser2c	75	5	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	75	6	can	can	MD
cord-302115-r39ser2c	75	7	then	then	RB
cord-302115-r39ser2c	75	8	spread	spread	VB
cord-302115-r39ser2c	75	9	more	more	RBR
cord-302115-r39ser2c	75	10	easily	easily	RB
cord-302115-r39ser2c	75	11	to	to	IN
cord-302115-r39ser2c	75	12	the	the	DT
cord-302115-r39ser2c	75	13	deepest	deep	JJS
cord-302115-r39ser2c	75	14	areas	area	NNS
cord-302115-r39ser2c	75	15	of	of	IN
cord-302115-r39ser2c	75	16	the	the	DT
cord-302115-r39ser2c	75	17	lungs	lung	NNS
cord-302115-r39ser2c	75	18	(	(	-LRB-
cord-302115-r39ser2c	75	19	alveolar	alveolar	JJ
cord-302115-r39ser2c	75	20	bronchioles	bronchiole	NNS
cord-302115-r39ser2c	75	21	and	and	CC
cord-302115-r39ser2c	75	22	alveoli	alveolus	NNS
cord-302115-r39ser2c	75	23	)	)	-RRB-
cord-302115-r39ser2c	75	24	during	during	IN
cord-302115-r39ser2c	75	25	strenuous	strenuous	JJ
cord-302115-r39ser2c	75	26	exercise	exercise	NN
cord-302115-r39ser2c	75	27	,	,	,
cord-302115-r39ser2c	75	28	and	and	CC
cord-302115-r39ser2c	75	29	there	there	EX
cord-302115-r39ser2c	75	30	starts	start	VBZ
cord-302115-r39ser2c	75	31	its	-PRON-	PRP$
cord-302115-r39ser2c	75	32	aggressive	aggressive	JJ
cord-302115-r39ser2c	75	33	action	action	NN
cord-302115-r39ser2c	75	34	.	.	.
cord-302115-r39ser2c	76	1	Not	not	RB
cord-302115-r39ser2c	76	2	by	by	IN
cord-302115-r39ser2c	76	3	chance	chance	NN
cord-302115-r39ser2c	76	4	,	,	,
cord-302115-r39ser2c	76	5	a	a	DT
cord-302115-r39ser2c	76	6	great	great	JJ
cord-302115-r39ser2c	76	7	proportion	proportion	NN
cord-302115-r39ser2c	76	8	of	of	IN
cord-302115-r39ser2c	76	9	professional	professional	JJ
cord-302115-r39ser2c	76	10	football	football	NN
cord-302115-r39ser2c	76	11	players	player	NNS
cord-302115-r39ser2c	76	12	claimed	claim	VBD
cord-302115-r39ser2c	76	13	the	the	DT
cord-302115-r39ser2c	76	14	occurrence	occurrence	NN
cord-302115-r39ser2c	76	15	of	of	IN
cord-302115-r39ser2c	76	16	fever	fever	NN
cord-302115-r39ser2c	76	17	,	,	,
cord-302115-r39ser2c	76	18	dry	dry	JJ
cord-302115-r39ser2c	76	19	cough	cough	NN
cord-302115-r39ser2c	76	20	and	and	CC
cord-302115-r39ser2c	76	21	malaise	malaise	NN
cord-302115-r39ser2c	76	22	(	(	-LRB-
cord-302115-r39ser2c	76	23	and	and	CC
cord-302115-r39ser2c	76	24	dyspnea	dyspnea	NN
cord-302115-r39ser2c	76	25	in	in	IN
cord-302115-r39ser2c	76	26	some	some	DT
cord-302115-r39ser2c	76	27	cases	case	NNS
cord-302115-r39ser2c	76	28	)	)	-RRB-
cord-302115-r39ser2c	76	29	immediately	immediately	RB
cord-302115-r39ser2c	76	30	after	after	RB
cord-302115-r39ser2c	76	31	,	,	,
cord-302115-r39ser2c	76	32	or	or	CC
cord-302115-r39ser2c	76	33	a	a	DT
cord-302115-r39ser2c	76	34	few	few	JJ
cord-302115-r39ser2c	76	35	hours	hour	NNS
cord-302115-r39ser2c	76	36	following	follow	VBG
cord-302115-r39ser2c	76	37	their	-PRON-	PRP$
cord-302115-r39ser2c	76	38	last	last	JJ
cord-302115-r39ser2c	76	39	official	official	JJ
cord-302115-r39ser2c	76	40	match	match	NN
cord-302115-r39ser2c	76	41	.	.	.
cord-302115-r39ser2c	77	1	In	in	IN
cord-302115-r39ser2c	77	2	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	77	3	,	,	,
cord-302115-r39ser2c	77	4	the	the	DT
cord-302115-r39ser2c	77	5	occurrence	occurrence	NN
cord-302115-r39ser2c	77	6	of	of	IN
cord-302115-r39ser2c	77	7	pneumonia	pneumonia	NN
cord-302115-r39ser2c	77	8	requiring	require	VBG
cord-302115-r39ser2c	77	9	oxygen	oxygen	NN
cord-302115-r39ser2c	77	10	therapy	therapy	NN
cord-302115-r39ser2c	77	11	is	be	VBZ
cord-302115-r39ser2c	77	12	a	a	DT
cord-302115-r39ser2c	77	13	critical	critical	JJ
cord-302115-r39ser2c	77	14	event	event	NN
cord-302115-r39ser2c	77	15	discriminating	discriminate	VBG
cord-302115-r39ser2c	77	16	asymptomatic	asymptomatic	JJ
cord-302115-r39ser2c	77	17	or	or	CC
cord-302115-r39ser2c	77	18	mild	mild	JJ
cord-302115-r39ser2c	77	19	cases	case	NNS
cord-302115-r39ser2c	77	20	,	,	,
cord-302115-r39ser2c	77	21	whose	whose	WP$
cord-302115-r39ser2c	77	22	infection	infection	NN
cord-302115-r39ser2c	77	23	remains	remain	VBZ
cord-302115-r39ser2c	77	24	mostly	mostly	RB
cord-302115-r39ser2c	77	25	confined	confine	VBN
cord-302115-r39ser2c	77	26	to	to	IN
cord-302115-r39ser2c	77	27	the	the	DT
cord-302115-r39ser2c	77	28	upper	upper	NNP
cord-302115-r39ser2c	77	29	airways	airway	NNS
cord-302115-r39ser2c	77	30	,	,	,
cord-302115-r39ser2c	77	31	from	from	IN
cord-302115-r39ser2c	77	32	those	those	DT
cord-302115-r39ser2c	77	33	with	with	IN
cord-302115-r39ser2c	77	34	severe	severe	JJ
cord-302115-r39ser2c	77	35	disease	disease	NN
cord-302115-r39ser2c	77	36	,	,	,
cord-302115-r39ser2c	77	37	who	who	WP
cord-302115-r39ser2c	77	38	experience	experience	VBP
cord-302115-r39ser2c	77	39	massive	massive	JJ
cord-302115-r39ser2c	77	40	viral	viral	JJ
cord-302115-r39ser2c	77	41	invasion	invasion	NN
cord-302115-r39ser2c	77	42	of	of	IN
cord-302115-r39ser2c	77	43	their	-PRON-	PRP$
cord-302115-r39ser2c	77	44	lower	low	JJR
cord-302115-r39ser2c	77	45	airways	airway	NNS
cord-302115-r39ser2c	77	46	.	.	.
cord-302115-r39ser2c	78	1	[	[	-LRB-
cord-302115-r39ser2c	78	2	19	19	CD
cord-302115-r39ser2c	78	3	]	]	-RRB-
cord-302115-r39ser2c	79	1	What	what	WP
cord-302115-r39ser2c	79	2	makes	make	VBZ
cord-302115-r39ser2c	79	3	the	the	DT
cord-302115-r39ser2c	79	4	difference	difference	NN
cord-302115-r39ser2c	79	5	?	?	.
cord-302115-r39ser2c	80	1	What	what	WP
cord-302115-r39ser2c	80	2	prevents	prevent	VBZ
cord-302115-r39ser2c	80	3	the	the	DT
cord-302115-r39ser2c	80	4	virus	virus	NN
cord-302115-r39ser2c	80	5	from	from	IN
cord-302115-r39ser2c	80	6	rapidly	rapidly	RB
cord-302115-r39ser2c	80	7	reaching	reach	VBG
cord-302115-r39ser2c	80	8	the	the	DT
cord-302115-r39ser2c	80	9	lungs	lung	NNS
cord-302115-r39ser2c	80	10	and	and	CC
cord-302115-r39ser2c	80	11	then	then	RB
cord-302115-r39ser2c	80	12	causing	cause	VBG
cord-302115-r39ser2c	80	13	severe	severe	JJ
cord-302115-r39ser2c	80	14	pneumonia	pneumonia	NN
cord-302115-r39ser2c	80	15	?	?	.
cord-302115-r39ser2c	81	1	What	what	WP
cord-302115-r39ser2c	81	2	makes	make	VBZ
cord-302115-r39ser2c	81	3	COVID-19	covid-19	VB
cord-302115-r39ser2c	81	4	pneumonia	pneumonia	NN
cord-302115-r39ser2c	81	5	a	a	DT
cord-302115-r39ser2c	81	6	life	life	NN
cord-302115-r39ser2c	81	7	-	-	HYPH
cord-302115-r39ser2c	81	8	threatening	threaten	VBG
cord-302115-r39ser2c	81	9	disease	disease	NN
cord-302115-r39ser2c	81	10	?	?	.
cord-302115-r39ser2c	82	1	2	2	LS
cord-302115-r39ser2c	82	2	)	)	-RRB-
cord-302115-r39ser2c	82	3	Pneumonia	Pneumonia	NNP
cord-302115-r39ser2c	82	4	may	may	MD
cord-302115-r39ser2c	82	5	start	start	VB
cord-302115-r39ser2c	82	6	before	before	IN
cord-302115-r39ser2c	82	7	adaptive	adaptive	JJ
cord-302115-r39ser2c	82	8	immune	immune	JJ
cord-302115-r39ser2c	82	9	response	response	NN
cord-302115-r39ser2c	82	10	develops	develop	VBZ
cord-302115-r39ser2c	82	11	;	;	:
cord-302115-r39ser2c	82	12	[	[	-LRB-
cord-302115-r39ser2c	82	13	20	20	CD
cord-302115-r39ser2c	82	14	]	]	-RRB-
cord-302115-r39ser2c	82	15	3	3	CD
cord-302115-r39ser2c	82	16	)	)	-RRB-
cord-302115-r39ser2c	83	1	Serious	serious	JJ
cord-302115-r39ser2c	83	2	complications	complication	NNS
cord-302115-r39ser2c	83	3	begin	begin	VBP
cord-302115-r39ser2c	83	4	together	together	RB
cord-302115-r39ser2c	83	5	with	with	IN
cord-302115-r39ser2c	83	6	the	the	DT
cord-302115-r39ser2c	83	7	adaptive	adaptive	JJ
cord-302115-r39ser2c	83	8	immune	immune	JJ
cord-302115-r39ser2c	83	9	response	response	NN
cord-302115-r39ser2c	83	10	.	.	.
cord-302115-r39ser2c	84	1	The	the	DT
cord-302115-r39ser2c	84	2	first	first	JJ
cord-302115-r39ser2c	84	3	two	two	CD
cord-302115-r39ser2c	84	4	weeks	week	NNS
cord-302115-r39ser2c	84	5	after	after	IN
cord-302115-r39ser2c	84	6	infection	infection	NN
cord-302115-r39ser2c	84	7	are	be	VBP
cord-302115-r39ser2c	84	8	crucial	crucial	JJ
cord-302115-r39ser2c	84	9	.	.	.
cord-302115-r39ser2c	85	1	[	[	-LRB-
cord-302115-r39ser2c	85	2	18,20	18,20	CD
cord-302115-r39ser2c	85	3	]	]	-RRB-
cord-302115-r39ser2c	85	4	Innate	innate	JJ
cord-302115-r39ser2c	85	5	immunity	immunity	NN
cord-302115-r39ser2c	85	6	is	be	VBZ
cord-302115-r39ser2c	85	7	the	the	DT
cord-302115-r39ser2c	85	8	only	only	JJ
cord-302115-r39ser2c	85	9	first	first	JJ
cord-302115-r39ser2c	85	10	-	-	HYPH
cord-302115-r39ser2c	85	11	line	line	NN
cord-302115-r39ser2c	85	12	,	,	,
cord-302115-r39ser2c	85	13	early	early	JJ
cord-302115-r39ser2c	85	14	defense	defense	NN
cord-302115-r39ser2c	85	15	against	against	IN
cord-302115-r39ser2c	85	16	the	the	DT
cord-302115-r39ser2c	85	17	new	new	JJ
cord-302115-r39ser2c	85	18	SARS	SARS	NNP
cord-302115-r39ser2c	85	19	-	-	HYPH
cord-302115-r39ser2c	85	20	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	85	21	virus	virus	NN
cord-302115-r39ser2c	85	22	.	.	.
cord-302115-r39ser2c	86	1	Consequently	consequently	RB
cord-302115-r39ser2c	86	2	,	,	,
cord-302115-r39ser2c	86	3	the	the	DT
cord-302115-r39ser2c	86	4	early	early	JJ
cord-302115-r39ser2c	86	5	confrontation	confrontation	NN
cord-302115-r39ser2c	86	6	between	between	IN
cord-302115-r39ser2c	86	7	host	host	NN
cord-302115-r39ser2c	86	8	's	's	POS
cord-302115-r39ser2c	86	9	innate	innate	JJ
cord-302115-r39ser2c	86	10	immunity	immunity	NN
cord-302115-r39ser2c	86	11	and	and	CC
cord-302115-r39ser2c	86	12	SARS	SARS	NNP
cord-302115-r39ser2c	86	13	-	-	HYPH
cord-302115-r39ser2c	86	14	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	86	15	,	,	,
cord-302115-r39ser2c	86	16	at	at	IN
cord-302115-r39ser2c	86	17	exposure	exposure	NN
cord-302115-r39ser2c	86	18	and	and	CC
cord-302115-r39ser2c	86	19	during	during	IN
cord-302115-r39ser2c	86	20	the	the	DT
cord-302115-r39ser2c	86	21	following	following	JJ
cord-302115-r39ser2c	86	22	two	two	CD
cord-302115-r39ser2c	86	23	weeks	week	NNS
cord-302115-r39ser2c	86	24	,	,	,
cord-302115-r39ser2c	86	25	decides	decide	VBZ
cord-302115-r39ser2c	86	26	the	the	DT
cord-302115-r39ser2c	86	27	natural	natural	JJ
cord-302115-r39ser2c	86	28	history	history	NN
cord-302115-r39ser2c	86	29	of	of	IN
cord-302115-r39ser2c	86	30	the	the	DT
cord-302115-r39ser2c	86	31	disease	disease	NN
cord-302115-r39ser2c	86	32	.	.	.
cord-302115-r39ser2c	87	1	This	this	DT
cord-302115-r39ser2c	87	2	confrontation	confrontation	NN
cord-302115-r39ser2c	87	3	also	also	RB
cord-302115-r39ser2c	87	4	decides	decide	VBZ
cord-302115-r39ser2c	87	5	whether	whether	IN
cord-302115-r39ser2c	87	6	the	the	DT
cord-302115-r39ser2c	87	7	infection	infection	NN
cord-302115-r39ser2c	87	8	will	will	MD
cord-302115-r39ser2c	87	9	be	be	VB
cord-302115-r39ser2c	87	10	efficiently	efficiently	RB
cord-302115-r39ser2c	87	11	blocked	block	VBN
cord-302115-r39ser2c	87	12	in	in	IN
cord-302115-r39ser2c	87	13	upper	upper	JJ
cord-302115-r39ser2c	87	14	airways	airway	NNS
cord-302115-r39ser2c	87	15	,	,	,
cord-302115-r39ser2c	87	16	or	or	CC
cord-302115-r39ser2c	87	17	how	how	WRB
cord-302115-r39ser2c	87	18	many	many	JJ
cord-302115-r39ser2c	87	19	virus	virus	NN
cord-302115-r39ser2c	87	20	particles	particle	NNS
cord-302115-r39ser2c	87	21	reach	reach	VBP
cord-302115-r39ser2c	87	22	the	the	DT
cord-302115-r39ser2c	87	23	lungs	lung	NNS
cord-302115-r39ser2c	87	24	,	,	,
cord-302115-r39ser2c	87	25	and	and	CC
cord-302115-r39ser2c	87	26	when	when	WRB
cord-302115-r39ser2c	87	27	.	.	.
cord-302115-r39ser2c	88	1	To	to	TO
cord-302115-r39ser2c	88	2	understand	understand	VB
cord-302115-r39ser2c	88	3	which	which	WDT
cord-302115-r39ser2c	88	4	part	part	NN
cord-302115-r39ser2c	88	5	of	of	IN
cord-302115-r39ser2c	88	6	the	the	DT
cord-302115-r39ser2c	88	7	innate	innate	JJ
cord-302115-r39ser2c	88	8	immunity	immunity	NN
cord-302115-r39ser2c	88	9	involved	involve	VBN
cord-302115-r39ser2c	88	10	in	in	IN
cord-302115-r39ser2c	88	11	early	early	JJ
cord-302115-r39ser2c	88	12	protection	protection	NN
cord-302115-r39ser2c	88	13	from	from	IN
cord-302115-r39ser2c	88	14	SARS	SARS	NNP
cord-302115-r39ser2c	88	15	-	-	HYPH
cord-302115-r39ser2c	88	16	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	88	17	,	,	,
cord-302115-r39ser2c	88	18	we	-PRON-	PRP
cord-302115-r39ser2c	88	19	have	have	VBP
cord-302115-r39ser2c	88	20	:	:	:
cord-302115-r39ser2c	88	21	1	1	LS
cord-302115-r39ser2c	88	22	)	)	-RRB-
cord-302115-r39ser2c	88	23	Examined	examine	VBN
cord-302115-r39ser2c	88	24	which	which	WDT
cord-302115-r39ser2c	88	25	Primary	Primary	NNP
cord-302115-r39ser2c	88	26	Immune	Immune	NNP
cord-302115-r39ser2c	88	27	Deficiencies	Deficiencies	NNPS
cord-302115-r39ser2c	88	28	are	be	VBP
cord-302115-r39ser2c	88	29	associated	associate	VBN
cord-302115-r39ser2c	88	30	with	with	IN
cord-302115-r39ser2c	88	31	pneumonia	pneumonia	NN
cord-302115-r39ser2c	88	32	.	.	.
cord-302115-r39ser2c	89	1	2	2	LS
cord-302115-r39ser2c	89	2	)	)	-RRB-
cord-302115-r39ser2c	89	3	Examined	examine	VBD
cord-302115-r39ser2c	89	4	the	the	DT
cord-302115-r39ser2c	89	5	patterns	pattern	NNS
cord-302115-r39ser2c	89	6	of	of	IN
cord-302115-r39ser2c	89	7	risk	risk	NN
cord-302115-r39ser2c	89	8	factors	factor	NNS
cord-302115-r39ser2c	89	9	for	for	IN
cord-302115-r39ser2c	89	10	COVID-19	covid-19	JJ
cord-302115-r39ser2c	89	11	severity	severity	NN
cord-302115-r39ser2c	89	12	:	:	:
cord-302115-r39ser2c	89	13	dose	dose	NN
cord-302115-r39ser2c	89	14	of	of	IN
cord-302115-r39ser2c	89	15	exposure	exposure	NN
cord-302115-r39ser2c	89	16	to	to	IN
cord-302115-r39ser2c	89	17	SARS	SARS	NNP
cord-302115-r39ser2c	89	18	-	-	HYPH
cord-302115-r39ser2c	89	19	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	89	20	;	;	:
cord-302115-r39ser2c	89	21	age	age	NN
cord-302115-r39ser2c	89	22	,	,	,
cord-302115-r39ser2c	89	23	gender	gender	NN
cord-302115-r39ser2c	89	24	,	,	,
cord-302115-r39ser2c	89	25	ABO	ABO	NNP
cord-302115-r39ser2c	89	26	group	group	NN
cord-302115-r39ser2c	89	27	;	;	:
cord-302115-r39ser2c	89	28	3	3	LS
cord-302115-r39ser2c	89	29	)	)	-RRB-
cord-302115-r39ser2c	89	30	Identified	identify	VBD
cord-302115-r39ser2c	89	31	the	the	DT
cord-302115-r39ser2c	89	32	innate	innate	JJ
cord-302115-r39ser2c	89	33	immunity	immunity	NN
cord-302115-r39ser2c	89	34	components	component	NNS
cord-302115-r39ser2c	89	35	fitting	fit	VBG
cord-302115-r39ser2c	89	36	the	the	DT
cord-302115-r39ser2c	89	37	same	same	JJ
cord-302115-r39ser2c	89	38	patterns	pattern	NNS
cord-302115-r39ser2c	89	39	of	of	IN
cord-302115-r39ser2c	89	40	risk	risk	NN
cord-302115-r39ser2c	89	41	factors	factor	NNS
cord-302115-r39ser2c	89	42	;	;	:
cord-302115-r39ser2c	89	43	This	this	DT
cord-302115-r39ser2c	89	44	article	article	NN
cord-302115-r39ser2c	89	45	is	be	VBZ
cord-302115-r39ser2c	89	46	protected	protect	VBN
cord-302115-r39ser2c	89	47	by	by	IN
cord-302115-r39ser2c	89	48	copyright	copyright	NN
cord-302115-r39ser2c	89	49	.	.	.
cord-302115-r39ser2c	90	1	All	all	DT
cord-302115-r39ser2c	90	2	rights	right	NNS
cord-302115-r39ser2c	90	3	reserved	reserve	VBN
cord-302115-r39ser2c	90	4	4	4	CD
cord-302115-r39ser2c	90	5	)	)	-RRB-
cord-302115-r39ser2c	90	6	Examined	examine	VBD
cord-302115-r39ser2c	90	7	the	the	DT
cord-302115-r39ser2c	90	8	biological	biological	JJ
cord-302115-r39ser2c	90	9	plausibility	plausibility	NN
cord-302115-r39ser2c	90	10	that	that	IN
cord-302115-r39ser2c	90	11	the	the	DT
cord-302115-r39ser2c	90	12	candidate	candidate	NN
cord-302115-r39ser2c	90	13	molecules	molecule	NNS
cord-302115-r39ser2c	90	14	,	,	,
cord-302115-r39ser2c	90	15	emerging	emerge	VBG
cord-302115-r39ser2c	90	16	from	from	IN
cord-302115-r39ser2c	90	17	the	the	DT
cord-302115-r39ser2c	90	18	previous	previous	JJ
cord-302115-r39ser2c	90	19	reasoning	reasoning	NN
cord-302115-r39ser2c	90	20	,	,	,
cord-302115-r39ser2c	90	21	are	be	VBP
cord-302115-r39ser2c	90	22	really	really	RB
cord-302115-r39ser2c	90	23	essential	essential	JJ
cord-302115-r39ser2c	90	24	in	in	IN
cord-302115-r39ser2c	90	25	limiting	limit	VBG
cord-302115-r39ser2c	90	26	the	the	DT
cord-302115-r39ser2c	90	27	consequences	consequence	NNS
cord-302115-r39ser2c	90	28	of	of	IN
cord-302115-r39ser2c	90	29	SARS	SARS	NNP
cord-302115-r39ser2c	90	30	-	-	HYPH
cord-302115-r39ser2c	90	31	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	90	32	infection	infection	NN
cord-302115-r39ser2c	90	33	to	to	IN
cord-302115-r39ser2c	90	34	upper	upper	JJ
cord-302115-r39ser2c	90	35	airways	airway	NNS
cord-302115-r39ser2c	90	36	or	or	CC
cord-302115-r39ser2c	90	37	to	to	TO
cord-302115-r39ser2c	90	38	mitigate	mitigate	VB
cord-302115-r39ser2c	90	39	the	the	DT
cord-302115-r39ser2c	90	40	course	course	NN
cord-302115-r39ser2c	90	41	of	of	IN
cord-302115-r39ser2c	90	42	pneumonia	pneumonia	NN
cord-302115-r39ser2c	90	43	.	.	.
cord-302115-r39ser2c	91	1	These	these	DT
cord-302115-r39ser2c	91	2	data	datum	NNS
cord-302115-r39ser2c	91	3	suggest	suggest	VBP
cord-302115-r39ser2c	91	4	that	that	IN
cord-302115-r39ser2c	91	5	the	the	DT
cord-302115-r39ser2c	91	6	lack	lack	NN
cord-302115-r39ser2c	91	7	of	of	IN
cord-302115-r39ser2c	91	8	natural	natural	JJ
cord-302115-r39ser2c	91	9	IgM	IgM	NNP
cord-302115-r39ser2c	91	10	and	and	CC
cord-302115-r39ser2c	91	11	IgA	IgA	NNP
cord-302115-r39ser2c	91	12	in	in	IN
cord-302115-r39ser2c	91	13	the	the	DT
cord-302115-r39ser2c	91	14	upper	upper	JJ
cord-302115-r39ser2c	91	15	respiratory	respiratory	JJ
cord-302115-r39ser2c	91	16	airways	airway	NNS
cord-302115-r39ser2c	91	17	may	may	MD
cord-302115-r39ser2c	91	18	have	have	VB
cord-302115-r39ser2c	91	19	contributed	contribute	VBN
cord-302115-r39ser2c	91	20	to	to	IN
cord-302115-r39ser2c	91	21	the	the	DT
cord-302115-r39ser2c	91	22	rapid	rapid	JJ
cord-302115-r39ser2c	91	23	viral	viral	JJ
cord-302115-r39ser2c	91	24	spread	spread	NN
cord-302115-r39ser2c	91	25	to	to	IN
cord-302115-r39ser2c	91	26	lungs	lung	NNS
cord-302115-r39ser2c	91	27	,	,	,
cord-302115-r39ser2c	91	28	causing	cause	VBG
cord-302115-r39ser2c	91	29	pneumonia	pneumonia	NN
cord-302115-r39ser2c	91	30	.	.	.
cord-302115-r39ser2c	92	1	Unexpectedly	unexpectedly	RB
cord-302115-r39ser2c	92	2	in	in	IN
cord-302115-r39ser2c	92	3	immunodeficient	immunodeficient	JJ
cord-302115-r39ser2c	92	4	individuals	individual	NNS
cord-302115-r39ser2c	92	5	,	,	,
cord-302115-r39ser2c	92	6	agammaglobulinemic	agammaglobulinemic	JJ
cord-302115-r39ser2c	92	7	patients	patient	NNS
cord-302115-r39ser2c	92	8	,	,	,
cord-302115-r39ser2c	92	9	who	who	WP
cord-302115-r39ser2c	92	10	are	be	VBP
cord-302115-r39ser2c	92	11	unable	unable	JJ
cord-302115-r39ser2c	92	12	to	to	TO
cord-302115-r39ser2c	92	13	develop	develop	VB
cord-302115-r39ser2c	92	14	specific	specific	JJ
cord-302115-r39ser2c	92	15	SARS	SARS	NNP
cord-302115-r39ser2c	92	16	-	-	HYPH
cord-302115-r39ser2c	92	17	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	92	18	Igs	Igs	NNP
cord-302115-r39ser2c	92	19	,	,	,
cord-302115-r39ser2c	92	20	did	do	VBD
cord-302115-r39ser2c	92	21	not	not	RB
cord-302115-r39ser2c	92	22	develop	develop	VB
cord-302115-r39ser2c	92	23	severe	severe	JJ
cord-302115-r39ser2c	92	24	pneumonia	pneumonia	NN
cord-302115-r39ser2c	92	25	,	,	,
cord-302115-r39ser2c	92	26	suggesting	suggest	VBG
cord-302115-r39ser2c	92	27	that	that	IN
cord-302115-r39ser2c	92	28	the	the	DT
cord-302115-r39ser2c	92	29	serious	serious	JJ
cord-302115-r39ser2c	92	30	complications	complication	NNS
cord-302115-r39ser2c	92	31	observed	observe	VBN
cord-302115-r39ser2c	92	32	in	in	IN
cord-302115-r39ser2c	92	33	other	other	JJ
cord-302115-r39ser2c	92	34	patients	patient	NNS
cord-302115-r39ser2c	92	35	may	may	MD
cord-302115-r39ser2c	92	36	be	be	VB
cord-302115-r39ser2c	92	37	related	relate	VBN
cord-302115-r39ser2c	92	38	to	to	IN
cord-302115-r39ser2c	92	39	the	the	DT
cord-302115-r39ser2c	92	40	development	development	NN
cord-302115-r39ser2c	92	41	of	of	IN
cord-302115-r39ser2c	92	42	acquired	acquire	VBN
cord-302115-r39ser2c	92	43	immunity	immunity	NN
cord-302115-r39ser2c	92	44	.	.	.
cord-302115-r39ser2c	93	1	Under	under	IN
cord-302115-r39ser2c	93	2	the	the	DT
cord-302115-r39ser2c	93	3	circumstances	circumstance	NNS
cord-302115-r39ser2c	93	4	described	describe	VBN
cord-302115-r39ser2c	93	5	above	above	RB
cord-302115-r39ser2c	93	6	,	,	,
cord-302115-r39ser2c	93	7	innate	innate	JJ
cord-302115-r39ser2c	93	8	immunity	immunity	NN
cord-302115-r39ser2c	93	9	become	become	VBP
cord-302115-r39ser2c	93	10	an	an	DT
cord-302115-r39ser2c	93	11	obvious	obvious	JJ
cord-302115-r39ser2c	93	12	candidate	candidate	NN
cord-302115-r39ser2c	93	13	to	to	TO
cord-302115-r39ser2c	93	14	act	act	VB
cord-302115-r39ser2c	93	15	as	as	RB
cord-302115-r39ser2c	93	16	very	very	RB
cord-302115-r39ser2c	93	17	first	first	JJ
cord-302115-r39ser2c	93	18	barrier	barrier	NN
cord-302115-r39ser2c	93	19	protecting	protect	VBG
cord-302115-r39ser2c	93	20	of	of	IN
cord-302115-r39ser2c	93	21	children	child	NNS
cord-302115-r39ser2c	93	22	,	,	,
cord-302115-r39ser2c	93	23	almost	almost	RB
cord-302115-r39ser2c	93	24	all	all	DT
cord-302115-r39ser2c	93	25	adults	adult	NNS
cord-302115-r39ser2c	93	26	and	and	CC
cord-302115-r39ser2c	93	27	most	most	JJS
cord-302115-r39ser2c	93	28	elders	elder	NNS
cord-302115-r39ser2c	93	29	from	from	IN
cord-302115-r39ser2c	93	30	SARS	SARS	NNP
cord-302115-r39ser2c	93	31	-	-	HYPH
cord-302115-r39ser2c	93	32	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	93	33	.	.	.
cord-302115-r39ser2c	94	1	Innate	innate	JJ
cord-302115-r39ser2c	94	2	immunity	immunity	NN
cord-302115-r39ser2c	94	3	is	be	VBZ
cord-302115-r39ser2c	94	4	essential	essential	JJ
cord-302115-r39ser2c	94	5	to	to	TO
cord-302115-r39ser2c	94	6	control	control	VB
cord-302115-r39ser2c	94	7	virus	virus	NN
cord-302115-r39ser2c	94	8	replication	replication	NN
cord-302115-r39ser2c	94	9	early	early	RB
cord-302115-r39ser2c	94	10	enough	enough	RB
cord-302115-r39ser2c	94	11	,	,	,
cord-302115-r39ser2c	94	12	before	before	IN
cord-302115-r39ser2c	94	13	a	a	DT
cord-302115-r39ser2c	94	14	very	very	RB
cord-302115-r39ser2c	94	15	effective	effective	JJ
cord-302115-r39ser2c	94	16	adaptive	adaptive	JJ
cord-302115-r39ser2c	94	17	immune	immune	JJ
cord-302115-r39ser2c	94	18	response	response	NN
cord-302115-r39ser2c	94	19	is	be	VBZ
cord-302115-r39ser2c	94	20	generated	generate	VBN
cord-302115-r39ser2c	94	21	.	.	.
cord-302115-r39ser2c	95	1	[	[	-LRB-
cord-302115-r39ser2c	95	2	77	77	CD
cord-302115-r39ser2c	95	3	]	]	-RRB-
cord-302115-r39ser2c	95	4	Accepted	accepted	JJ
cord-302115-r39ser2c	95	5	Article	Article	NNP
cord-302115-r39ser2c	95	6	This	this	DT
cord-302115-r39ser2c	95	7	article	article	NN
cord-302115-r39ser2c	95	8	is	be	VBZ
cord-302115-r39ser2c	95	9	protected	protect	VBN
cord-302115-r39ser2c	95	10	by	by	IN
cord-302115-r39ser2c	95	11	copyright	copyright	NN
cord-302115-r39ser2c	95	12	.	.	.
cord-302115-r39ser2c	96	1	All	all	DT
cord-302115-r39ser2c	96	2	rights	right	NNS
cord-302115-r39ser2c	96	3	reserved	reserve	VBN
cord-302115-r39ser2c	96	4	We	-PRON-	PRP
cord-302115-r39ser2c	96	5	focused	focus	VBD
cord-302115-r39ser2c	96	6	on	on	IN
cord-302115-r39ser2c	96	7	humoral	humoral	JJ
cord-302115-r39ser2c	96	8	components	component	NNS
cord-302115-r39ser2c	96	9	and	and	CC
cord-302115-r39ser2c	96	10	,	,	,
cord-302115-r39ser2c	96	11	in	in	IN
cord-302115-r39ser2c	96	12	particular	particular	JJ
cord-302115-r39ser2c	96	13	on	on	IN
cord-302115-r39ser2c	96	14	natural	natural	JJ
cord-302115-r39ser2c	96	15	antibodies	antibody	NNS
cord-302115-r39ser2c	96	16	and	and	CC
cord-302115-r39ser2c	96	17	MBL	MBL	NNP
cord-302115-r39ser2c	96	18	,	,	,
cord-302115-r39ser2c	96	19	to	to	TO
cord-302115-r39ser2c	96	20	ascertain	ascertain	VB
cord-302115-r39ser2c	96	21	whether	whether	IN
cord-302115-r39ser2c	96	22	these	these	DT
cord-302115-r39ser2c	96	23	players	player	NNS
cord-302115-r39ser2c	96	24	of	of	IN
cord-302115-r39ser2c	96	25	the	the	DT
cord-302115-r39ser2c	96	26	innate	innate	JJ
cord-302115-r39ser2c	96	27	immunity	immunity	NN
cord-302115-r39ser2c	96	28	fit	fit	VBD
cord-302115-r39ser2c	96	29	all	all	PDT
cord-302115-r39ser2c	96	30	the	the	DT
cord-302115-r39ser2c	96	31	epidemiological	epidemiological	JJ
cord-302115-r39ser2c	96	32	and	and	CC
cord-302115-r39ser2c	96	33	clinical	clinical	JJ
cord-302115-r39ser2c	96	34	pre	pre	NNS
cord-302115-r39ser2c	96	35	-	-	NNS
cord-302115-r39ser2c	96	36	conditions	condition	NNS
cord-302115-r39ser2c	96	37	presented	present	VBN
cord-302115-r39ser2c	96	38	in	in	IN
cord-302115-r39ser2c	96	39	the	the	DT
cord-302115-r39ser2c	96	40	last	last	JJ
cord-302115-r39ser2c	96	41	three	three	CD
cord-302115-r39ser2c	96	42	months	month	NNS
cord-302115-r39ser2c	96	43	by	by	IN
cord-302115-r39ser2c	96	44	SARS	SARS	NNP
cord-302115-r39ser2c	96	45	-	-	HYPH
cord-302115-r39ser2c	96	46	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	96	47	.	.	.
cord-302115-r39ser2c	97	1	Finally	finally	RB
cord-302115-r39ser2c	97	2	,	,	,
cord-302115-r39ser2c	97	3	we	-PRON-	PRP
cord-302115-r39ser2c	97	4	tentatively	tentatively	RB
cord-302115-r39ser2c	97	5	describe	describe	VBP
cord-302115-r39ser2c	97	6	mechanisms	mechanism	NNS
cord-302115-r39ser2c	97	7	beyond	beyond	IN
cord-302115-r39ser2c	97	8	the	the	DT
cord-302115-r39ser2c	97	9	most	most	RBS
cord-302115-r39ser2c	97	10	severe	severe	JJ
cord-302115-r39ser2c	97	11	cases	case	NNS
cord-302115-r39ser2c	97	12	of	of	IN
cord-302115-r39ser2c	97	13	pneumonia	pneumonia	NN
cord-302115-r39ser2c	97	14	as	as	IN
cord-302115-r39ser2c	97	15	a	a	DT
cord-302115-r39ser2c	97	16	possible	possible	JJ
cord-302115-r39ser2c	97	17	consequence	consequence	NN
cord-302115-r39ser2c	97	18	of	of	IN
cord-302115-r39ser2c	97	19	the	the	DT
cord-302115-r39ser2c	97	20	development	development	NN
cord-302115-r39ser2c	97	21	of	of	IN
cord-302115-r39ser2c	97	22	adaptive	adaptive	JJ
cord-302115-r39ser2c	97	23	immunity	immunity	NN
cord-302115-r39ser2c	97	24	in	in	IN
cord-302115-r39ser2c	97	25	individuals	individual	NNS
cord-302115-r39ser2c	97	26	with	with	IN
cord-302115-r39ser2c	97	27	an	an	DT
cord-302115-r39ser2c	97	28	early	early	JJ
cord-302115-r39ser2c	97	29	high	high	JJ
cord-302115-r39ser2c	97	30	viral	viral	JJ
cord-302115-r39ser2c	97	31	spread	spread	NN
cord-302115-r39ser2c	97	32	in	in	IN
cord-302115-r39ser2c	97	33	lungs	lung	NNS
cord-302115-r39ser2c	97	34	.	.	.
cord-302115-r39ser2c	98	1	Anti	anti	JJ
cord-302115-r39ser2c	98	2	-	-	JJ
cord-302115-r39ser2c	98	3	glycan	glycan	JJ
cord-302115-r39ser2c	98	4	natural	natural	JJ
cord-302115-r39ser2c	98	5	antibodies	antibody	NNS
cord-302115-r39ser2c	98	6	are	be	VBP
cord-302115-r39ser2c	98	7	detected	detect	VBN
cord-302115-r39ser2c	98	8	in	in	IN
cord-302115-r39ser2c	98	9	serum	serum	NN
cord-302115-r39ser2c	98	10	in	in	IN
cord-302115-r39ser2c	98	11	the	the	DT
cord-302115-r39ser2c	98	12	absence	absence	NN
cord-302115-r39ser2c	98	13	of	of	IN
cord-302115-r39ser2c	98	14	previous	previous	JJ
cord-302115-r39ser2c	98	15	immunization	immunization	NN
cord-302115-r39ser2c	98	16	,	,	,
cord-302115-r39ser2c	98	17	are	be	VBP
cord-302115-r39ser2c	98	18	observed	observe	VBN
cord-302115-r39ser2c	98	19	also	also	RB
cord-302115-r39ser2c	98	20	in	in	IN
cord-302115-r39ser2c	98	21	gnotobiotic	gnotobiotic	JJ
cord-302115-r39ser2c	98	22	animals	animal	NNS
cord-302115-r39ser2c	98	23	,	,	,
cord-302115-r39ser2c	98	24	and	and	CC
cord-302115-r39ser2c	98	25	belong	belong	VBP
cord-302115-r39ser2c	98	26	mostly	mostly	RB
cord-302115-r39ser2c	98	27	to	to	IN
cord-302115-r39ser2c	98	28	the	the	DT
cord-302115-r39ser2c	98	29	IgM	IgM	NNP
cord-302115-r39ser2c	98	30	isotype	isotype	NN
cord-302115-r39ser2c	98	31	[	[	-LRB-
cord-302115-r39ser2c	98	32	79	79	CD
cord-302115-r39ser2c	98	33	]	]	-RRB-
cord-302115-r39ser2c	98	34	but	but	CC
cord-302115-r39ser2c	98	35	also	also	RB
cord-302115-r39ser2c	98	36	to	to	IN
cord-302115-r39ser2c	98	37	the	the	DT
cord-302115-r39ser2c	98	38	IgA	IgA	NNP
cord-302115-r39ser2c	98	39	and	and	CC
cord-302115-r39ser2c	98	40	IgG	IgG	NNP
cord-302115-r39ser2c	98	41	isotype	isotype	NN
cord-302115-r39ser2c	98	42	.	.	.
cord-302115-r39ser2c	99	1	(	(	-LRB-
cord-302115-r39ser2c	99	2	B	b	NN
cord-302115-r39ser2c	99	3	)	)	-RRB-
cord-302115-r39ser2c	99	4	old	old	JJ
cord-302115-r39ser2c	99	5	patients	patient	NNS
cord-302115-r39ser2c	99	6	-viral	-viral	JJ
cord-302115-r39ser2c	99	7	exposure	exposure	NN
cord-302115-r39ser2c	99	8	is	be	VBZ
cord-302115-r39ser2c	99	9	probably	probably	RB
cord-302115-r39ser2c	99	10	higher	high	JJR
cord-302115-r39ser2c	99	11	(	(	-LRB-
cord-302115-r39ser2c	99	12	the	the	DT
cord-302115-r39ser2c	99	13	source	source	NN
cord-302115-r39ser2c	99	14	of	of	IN
cord-302115-r39ser2c	99	15	contagion	contagion	NN
cord-302115-r39ser2c	99	16	is	be	VBZ
cord-302115-r39ser2c	99	17	also	also	RB
cord-302115-r39ser2c	99	18	an	an	DT
cord-302115-r39ser2c	99	19	old	old	JJ
cord-302115-r39ser2c	99	20	person	person	NN
cord-302115-r39ser2c	99	21	)	)	-RRB-
cord-302115-r39ser2c	99	22	but	but	CC
cord-302115-r39ser2c	99	23	the	the	DT
cord-302115-r39ser2c	99	24	innate	innate	JJ
cord-302115-r39ser2c	99	25	immunity	immunity	NN
cord-302115-r39ser2c	99	26	is	be	VBZ
cord-302115-r39ser2c	99	27	much	much	RB
cord-302115-r39ser2c	99	28	weaker	weak	JJR
cord-302115-r39ser2c	99	29	;	;	:
cord-302115-r39ser2c	99	30	a	a	DT
cord-302115-r39ser2c	99	31	high	high	JJ
cord-302115-r39ser2c	99	32	number	number	NN
cord-302115-r39ser2c	99	33	of	of	IN
cord-302115-r39ser2c	99	34	viral	viral	JJ
cord-302115-r39ser2c	99	35	particles	particle	NNS
cord-302115-r39ser2c	99	36	can	can	MD
cord-302115-r39ser2c	99	37	reach	reach	VB
cord-302115-r39ser2c	99	38	the	the	DT
cord-302115-r39ser2c	99	39	alveoli	alveolus	NNS
cord-302115-r39ser2c	99	40	and	and	CC
cord-302115-r39ser2c	99	41	replicate	replicate	VB
cord-302115-r39ser2c	99	42	in	in	IN
cord-302115-r39ser2c	99	43	type	type	NN
cord-302115-r39ser2c	99	44	II	II	NNP
cord-302115-r39ser2c	99	45	pneumocytes	pneumocyte	NNS
cord-302115-r39ser2c	99	46	in	in	IN
cord-302115-r39ser2c	99	47	coincidence	coincidence	NN
cord-302115-r39ser2c	99	48	or	or	CC
cord-302115-r39ser2c	99	49	even	even	RB
cord-302115-r39ser2c	99	50	much	much	RB
cord-302115-r39ser2c	99	51	before	before	IN
cord-302115-r39ser2c	99	52	the	the	DT
cord-302115-r39ser2c	99	53	This	this	DT
cord-302115-r39ser2c	99	54	article	article	NN
cord-302115-r39ser2c	99	55	is	be	VBZ
cord-302115-r39ser2c	99	56	protected	protect	VBN
cord-302115-r39ser2c	99	57	by	by	IN
cord-302115-r39ser2c	99	58	copyright	copyright	NN
cord-302115-r39ser2c	99	59	.	.	.
cord-302115-r39ser2c	100	1	All	all	DT
cord-302115-r39ser2c	100	2	rights	right	NNS
cord-302115-r39ser2c	100	3	reserved	reserve	VBN
cord-302115-r39ser2c	100	4	expansion	expansion	NN
cord-302115-r39ser2c	100	5	of	of	IN
cord-302115-r39ser2c	100	6	the	the	DT
cord-302115-r39ser2c	100	7	specific	specific	JJ
cord-302115-r39ser2c	100	8	immune	immune	JJ
cord-302115-r39ser2c	100	9	response	response	NN
cord-302115-r39ser2c	100	10	leading	lead	VBG
cord-302115-r39ser2c	100	11	to	to	IN
cord-302115-r39ser2c	100	12	a	a	DT
cord-302115-r39ser2c	100	13	more	more	RBR
cord-302115-r39ser2c	100	14	severe	severe	JJ
cord-302115-r39ser2c	100	15	and	and	CC
cord-302115-r39ser2c	100	16	symptomatic	symptomatic	JJ
cord-302115-r39ser2c	100	17	pneumonia	pneumonia	NN
cord-302115-r39ser2c	100	18	;	;	.
cord-302115-r39ser2c	101	1	(	(	-LRB-
cord-302115-r39ser2c	101	2	C	C	NNP
cord-302115-r39ser2c	101	3	)	)	-RRB-
cord-302115-r39ser2c	101	4	young	young	JJ
cord-302115-r39ser2c	101	5	but	but	CC
cord-302115-r39ser2c	101	6	highly	highly	RB
cord-302115-r39ser2c	101	7	exposed	expose	VBN
cord-302115-r39ser2c	101	8	patients	patient	NNS
cord-302115-r39ser2c	102	1	-the	-the	NFP
cord-302115-r39ser2c	102	2	exposure	exposure	NN
cord-302115-r39ser2c	102	3	to	to	IN
cord-302115-r39ser2c	102	4	an	an	DT
cord-302115-r39ser2c	102	5	excessive	excessive	JJ
cord-302115-r39ser2c	102	6	cumulative	cumulative	JJ
cord-302115-r39ser2c	102	7	viral	viral	JJ
cord-302115-r39ser2c	102	8	dose	dose	NN
cord-302115-r39ser2c	102	9	(	(	-LRB-
cord-302115-r39ser2c	102	10	i.e.	i.e.	FW
cord-302115-r39ser2c	102	11	unprotected	unprotected	JJ
cord-302115-r39ser2c	102	12	health	health	NN
cord-302115-r39ser2c	102	13	care	care	NN
cord-302115-r39ser2c	102	14	personnel	personnel	NNS
cord-302115-r39ser2c	102	15	)	)	-RRB-
cord-302115-r39ser2c	102	16	will	will	MD
cord-302115-r39ser2c	102	17	overcome	overcome	VB
cord-302115-r39ser2c	102	18	their	-PRON-	PRP$
cord-302115-r39ser2c	102	19	efficient	efficient	JJ
cord-302115-r39ser2c	102	20	innate	innate	JJ
cord-302115-r39ser2c	102	21	immunity	immunity	NN
cord-302115-r39ser2c	102	22	.	.	.
cord-302115-r39ser2c	103	1	Viral	viral	JJ
cord-302115-r39ser2c	103	2	particles	particle	NNS
cord-302115-r39ser2c	103	3	will	will	MD
cord-302115-r39ser2c	103	4	reach	reach	VB
cord-302115-r39ser2c	103	5	the	the	DT
cord-302115-r39ser2c	103	6	alveoli	alveolus	NNS
cord-302115-r39ser2c	103	7	in	in	IN
cord-302115-r39ser2c	103	8	early	early	JJ
cord-302115-r39ser2c	103	9	stages	stage	NNS
cord-302115-r39ser2c	103	10	and	and	CC
cord-302115-r39ser2c	103	11	cause	cause	VB
cord-302115-r39ser2c	103	12	symptomatic	symptomatic	JJ
cord-302115-r39ser2c	103	13	pneumonia	pneumonia	NN
cord-302115-r39ser2c	103	14	;	;	:
cord-302115-r39ser2c	103	15	 	 	_SP
cord-302115-r39ser2c	103	16	This	this	DT
cord-302115-r39ser2c	103	17	article	article	NN
cord-302115-r39ser2c	103	18	is	be	VBZ
cord-302115-r39ser2c	103	19	protected	protect	VBN
cord-302115-r39ser2c	103	20	by	by	IN
cord-302115-r39ser2c	103	21	copyright	copyright	NN
cord-302115-r39ser2c	103	22	.	.	.
cord-302115-r39ser2c	104	1	All	all	DT
cord-302115-r39ser2c	104	2	rights	right	NNS
cord-302115-r39ser2c	104	3	reserved	reserve	VBN
cord-302115-r39ser2c	104	4	macrophages	macrophage	NNS
cord-302115-r39ser2c	104	5	via	via	IN
cord-302115-r39ser2c	104	6	Fc	Fc	NNP
cord-302115-r39ser2c	104	7	-	-	HYPH
cord-302115-r39ser2c	104	8	receptors	receptor	NNS
cord-302115-r39ser2c	104	9	.	.	.
cord-302115-r39ser2c	105	1	In	in	IN
cord-302115-r39ser2c	105	2	addition	addition	NN
cord-302115-r39ser2c	105	3	,	,	,
cord-302115-r39ser2c	105	4	Ig	Ig	NNP
cord-302115-r39ser2c	105	5	binding	bind	VBG
cord-302115-r39ser2c	105	6	to	to	IN
cord-302115-r39ser2c	105	7	the	the	DT
cord-302115-r39ser2c	105	8	S	S	NNP
cord-302115-r39ser2c	105	9	protein	protein	NN
cord-302115-r39ser2c	105	10	of	of	IN
cord-302115-r39ser2c	105	11	SARS	SARS	NNP
cord-302115-r39ser2c	105	12	-	-	HYPH
cord-302115-r39ser2c	105	13	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	105	14	may	may	MD
cord-302115-r39ser2c	105	15	cause	cause	VB
cord-302115-r39ser2c	105	16	its	-PRON-	PRP$
cord-302115-r39ser2c	105	17	conformational	conformational	JJ
cord-302115-r39ser2c	105	18	changes	change	NNS
cord-302115-r39ser2c	105	19	that	that	WDT
cord-302115-r39ser2c	105	20	make	make	VBP
cord-302115-r39ser2c	105	21	the	the	DT
cord-302115-r39ser2c	105	22	binding	binding	NN
cord-302115-r39ser2c	105	23	to	to	IN
cord-302115-r39ser2c	105	24	the	the	DT
cord-302115-r39ser2c	105	25	ACE-2	ACE-2	NNP
cord-302115-r39ser2c	105	26	receptor	receptor	NN
cord-302115-r39ser2c	105	27	more	more	RBR
cord-302115-r39ser2c	105	28	effective	effective	JJ
cord-302115-r39ser2c	105	29	for	for	IN
cord-302115-r39ser2c	105	30	the	the	DT
cord-302115-r39ser2c	105	31	viral	viral	JJ
cord-302115-r39ser2c	105	32	fusion	fusion	NN
cord-302115-r39ser2c	105	33	with	with	IN
cord-302115-r39ser2c	105	34	the	the	DT
cord-302115-r39ser2c	105	35	cell	cell	NN
cord-302115-r39ser2c	105	36	membrane	membrane	NN
cord-302115-r39ser2c	105	37	.	.	.
cord-302115-r39ser2c	106	1	The	the	DT
cord-302115-r39ser2c	106	2	local	local	JJ
cord-302115-r39ser2c	106	3	high	high	JJ
cord-302115-r39ser2c	106	4	concentration	concentration	NN
cord-302115-r39ser2c	106	5	of	of	IN
cord-302115-r39ser2c	106	6	cytokines	cytokine	NNS
cord-302115-r39ser2c	106	7	and	and	CC
cord-302115-r39ser2c	106	8	chemokines	chemokine	NNS
cord-302115-r39ser2c	106	9	that	that	WDT
cord-302115-r39ser2c	106	10	contribute	contribute	VBP
cord-302115-r39ser2c	106	11	to	to	IN
cord-302115-r39ser2c	106	12	recruitment	recruitment	NN
cord-302115-r39ser2c	106	13	of	of	IN
cord-302115-r39ser2c	106	14	inflammatory	inflammatory	JJ
cord-302115-r39ser2c	106	15	cells	cell	NNS
cord-302115-r39ser2c	106	16	and	and	CC
cord-302115-r39ser2c	106	17	vasodilatation	vasodilatation	NN
cord-302115-r39ser2c	106	18	,	,	,
cord-302115-r39ser2c	106	19	permits	permit	VBZ
cord-302115-r39ser2c	106	20	to	to	TO
cord-302115-r39ser2c	106	21	serum	serum	VB
cord-302115-r39ser2c	106	22	natural	natural	JJ
cord-302115-r39ser2c	106	23	Igs	Igs	NNP
cord-302115-r39ser2c	106	24	and	and	CC
cord-302115-r39ser2c	106	25	MBL	MBL	NNP
cord-302115-r39ser2c	106	26	to	to	TO
cord-302115-r39ser2c	106	27	maintain	maintain	VB
cord-302115-r39ser2c	106	28	a	a	DT
cord-302115-r39ser2c	106	29	vicious	vicious	JJ
cord-302115-r39ser2c	106	30	circle	circle	NN
cord-302115-r39ser2c	106	31	of	of	IN
cord-302115-r39ser2c	106	32	inflammation	inflammation	NN
cord-302115-r39ser2c	106	33	with	with	IN
cord-302115-r39ser2c	106	34	complement	complement	JJ
cord-302115-r39ser2c	106	35	activation	activation	NN
cord-302115-r39ser2c	106	36	and	and	CC
cord-302115-r39ser2c	106	37	immunocomplexes	immunocomplexes	JJ
cord-302115-r39ser2c	106	38	deposition	deposition	NN
cord-302115-r39ser2c	106	39	.	.	.
cord-302115-r39ser2c	107	1	In	in	IN
cord-302115-r39ser2c	107	2	this	this	DT
cord-302115-r39ser2c	107	3	light	light	NN
cord-302115-r39ser2c	107	4	,	,	,
cord-302115-r39ser2c	107	5	it	-PRON-	PRP
cord-302115-r39ser2c	107	6	can	can	MD
cord-302115-r39ser2c	107	7	not	not	RB
cord-302115-r39ser2c	107	8	be	be	VB
cord-302115-r39ser2c	107	9	excluded	exclude	VBN
cord-302115-r39ser2c	107	10	that	that	IN
cord-302115-r39ser2c	107	11	MBL	MBL	NNP
cord-302115-r39ser2c	107	12	or	or	CC
cord-302115-r39ser2c	107	13	IgM	IgM	NNP
cord-302115-r39ser2c	107	14	mediated	mediate	VBD
cord-302115-r39ser2c	107	15	immunocomplexes	immunocomplexes	NNP
cord-302115-r39ser2c	107	16	contribute	contribute	VBP
cord-302115-r39ser2c	107	17	to	to	IN
cord-302115-r39ser2c	107	18	activation	activation	NN
cord-302115-r39ser2c	107	19	of	of	IN
cord-302115-r39ser2c	107	20	platelets	platelet	NNS
cord-302115-r39ser2c	107	21	or	or	CC
cord-302115-r39ser2c	107	22	tissue	tissue	NN
cord-302115-r39ser2c	107	23	factor	factor	NN
cord-302115-r39ser2c	107	24	leading	lead	VBG
cord-302115-r39ser2c	107	25	to	to	IN
cord-302115-r39ser2c	107	26	coagulation	coagulation	NN
cord-302115-r39ser2c	107	27	and	and	CC
cord-302115-r39ser2c	107	28	microthrombosis	microthrombosis	NN
cord-302115-r39ser2c	107	29	that	that	WDT
cord-302115-r39ser2c	107	30	have	have	VBP
cord-302115-r39ser2c	107	31	been	be	VBN
cord-302115-r39ser2c	107	32	described	describe	VBN
cord-302115-r39ser2c	107	33	in	in	IN
cord-302115-r39ser2c	107	34	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	107	35	patients	patient	NNS
cord-302115-r39ser2c	107	36	with	with	IN
cord-302115-r39ser2c	107	37	acute	acute	JJ
cord-302115-r39ser2c	107	38	respiratory	respiratory	JJ
cord-302115-r39ser2c	107	39	failure	failure	NN
cord-302115-r39ser2c	107	40	.	.	.
cord-302115-r39ser2c	108	1	In	in	IN
cord-302115-r39ser2c	108	2	this	this	DT
cord-302115-r39ser2c	108	3	phase	phase	NN
cord-302115-r39ser2c	108	4	of	of	IN
cord-302115-r39ser2c	108	5	the	the	DT
cord-302115-r39ser2c	108	6	disease	disease	NN
cord-302115-r39ser2c	108	7	,	,	,
cord-302115-r39ser2c	108	8	natural	natural	JJ
cord-302115-r39ser2c	108	9	IgM	IgM	NNP
cord-302115-r39ser2c	108	10	and	and	CC
cord-302115-r39ser2c	108	11	MBL	MBL	NNP
cord-302115-r39ser2c	108	12	that	that	WDT
cord-302115-r39ser2c	108	13	circulate	circulate	VBP
cord-302115-r39ser2c	108	14	in	in	IN
cord-302115-r39ser2c	108	15	serum	serum	NN
cord-302115-r39ser2c	108	16	may	may	MD
cord-302115-r39ser2c	108	17	have	have	VB
cord-302115-r39ser2c	108	18	no	no	DT
cord-302115-r39ser2c	108	19	protective	protective	JJ
cord-302115-r39ser2c	108	20	role	role	NN
cord-302115-r39ser2c	108	21	,	,	,
cord-302115-r39ser2c	108	22	but	but	CC
cord-302115-r39ser2c	108	23	,	,	,
cord-302115-r39ser2c	108	24	rather	rather	RB
cord-302115-r39ser2c	108	25	may	may	MD
cord-302115-r39ser2c	108	26	contribute	contribute	VB
cord-302115-r39ser2c	108	27	to	to	IN
cord-302115-r39ser2c	108	28	tissue	tissue	NN
cord-302115-r39ser2c	108	29	damage	damage	NN
cord-302115-r39ser2c	108	30	.	.	.
cord-302115-r39ser2c	109	1	Moreover	moreover	RB
cord-302115-r39ser2c	109	2	,	,	,
cord-302115-r39ser2c	109	3	during	during	IN
cord-302115-r39ser2c	109	4	this	this	DT
cord-302115-r39ser2c	109	5	second	second	JJ
cord-302115-r39ser2c	109	6	phase	phase	NN
cord-302115-r39ser2c	109	7	of	of	IN
cord-302115-r39ser2c	109	8	the	the	DT
cord-302115-r39ser2c	109	9	disease	disease	NN
cord-302115-r39ser2c	109	10	,	,	,
cord-302115-r39ser2c	109	11	the	the	DT
cord-302115-r39ser2c	109	12	adaptive	adaptive	JJ
cord-302115-r39ser2c	109	13	response	response	NN
cord-302115-r39ser2c	109	14	is	be	VBZ
cord-302115-r39ser2c	109	15	also	also	RB
cord-302115-r39ser2c	109	16	progressively	progressively	RB
cord-302115-r39ser2c	109	17	on	on	IN
cord-302115-r39ser2c	109	18	the	the	DT
cord-302115-r39ser2c	109	19	increase	increase	NN
cord-302115-r39ser2c	109	20	.	.	.
cord-302115-r39ser2c	110	1	This	this	DT
cord-302115-r39ser2c	110	2	may	may	MD
cord-302115-r39ser2c	110	3	be	be	VB
cord-302115-r39ser2c	110	4	one	one	CD
cord-302115-r39ser2c	110	5	side	side	NN
cord-302115-r39ser2c	110	6	protective	protective	JJ
cord-302115-r39ser2c	110	7	against	against	IN
cord-302115-r39ser2c	110	8	further	further	JJ
cord-302115-r39ser2c	110	9	virus	virus	NN
cord-302115-r39ser2c	110	10	spread	spread	VBN
cord-302115-r39ser2c	110	11	in	in	IN
cord-302115-r39ser2c	110	12	the	the	DT
cord-302115-r39ser2c	110	13	lungs	lung	NNS
cord-302115-r39ser2c	110	14	,	,	,
cord-302115-r39ser2c	110	15	but	but	CC
cord-302115-r39ser2c	110	16	may	may	MD
cord-302115-r39ser2c	110	17	also	also	RB
cord-302115-r39ser2c	110	18	reinforce	reinforce	VB
cord-302115-r39ser2c	110	19	the	the	DT
cord-302115-r39ser2c	110	20	immunological	immunological	JJ
cord-302115-r39ser2c	110	21	and	and	CC
cord-302115-r39ser2c	110	22	coagulation	coagulation	NN
cord-302115-r39ser2c	110	23	cascades	cascade	NNS
cord-302115-r39ser2c	110	24	provoking	provoke	VBG
cord-302115-r39ser2c	110	25	complications	complication	NNS
cord-302115-r39ser2c	110	26	.	.	.
cord-302115-r39ser2c	111	1	MBL	MBL	NNP
cord-302115-r39ser2c	111	2	binds	bind	VBZ
cord-302115-r39ser2c	111	3	to	to	IN
cord-302115-r39ser2c	111	4	polymeric	polymeric	JJ
cord-302115-r39ser2c	111	5	IgA	IgA	NNP
cord-302115-r39ser2c	111	6	and	and	CC
cord-302115-r39ser2c	111	7	initiates	initiate	VBZ
cord-302115-r39ser2c	111	8	complement	complement	JJ
cord-302115-r39ser2c	111	9	cascade	cascade	NN
cord-302115-r39ser2c	111	10	,	,	,
cord-302115-r39ser2c	111	11	a	a	DT
cord-302115-r39ser2c	111	12	defense	defense	NN
cord-302115-r39ser2c	111	13	against	against	IN
cord-302115-r39ser2c	111	14	invading	invade	VBG
cord-302115-r39ser2c	111	15	pathogens	pathogen	NNS
cord-302115-r39ser2c	111	16	in	in	IN
cord-302115-r39ser2c	111	17	mucosal	mucosal	JJ
cord-302115-r39ser2c	111	18	immunity	immunity	NN
cord-302115-r39ser2c	111	19	.	.	.
cord-302115-r39ser2c	112	1	Polymeric	polymeric	JJ
cord-302115-r39ser2c	112	2	IgA	IgA	NNP
cord-302115-r39ser2c	112	3	also	also	RB
cord-302115-r39ser2c	112	4	has	have	VBZ
cord-302115-r39ser2c	112	5	a	a	DT
cord-302115-r39ser2c	112	6	role	role	NN
cord-302115-r39ser2c	112	7	in	in	IN
cord-302115-r39ser2c	112	8	activating	activate	VBG
cord-302115-r39ser2c	112	9	lectin	lectin	NN
cord-302115-r39ser2c	112	10	-	-	HYPH
cord-302115-r39ser2c	112	11	mediated	mediate	VBN
cord-302115-r39ser2c	112	12	complement	complement	NN
cord-302115-r39ser2c	112	13	signaling	signaling	NN
cord-302115-r39ser2c	112	14	.	.	.
cord-302115-r39ser2c	113	1	The	the	DT
cord-302115-r39ser2c	113	2	complement	complement	NN
cord-302115-r39ser2c	113	3	cascade	cascade	NN
cord-302115-r39ser2c	113	4	links	link	VBZ
cord-302115-r39ser2c	113	5	the	the	DT
cord-302115-r39ser2c	113	6	innate	innate	JJ
cord-302115-r39ser2c	113	7	and	and	CC
cord-302115-r39ser2c	113	8	the	the	DT
cord-302115-r39ser2c	113	9	adaptive	adaptive	JJ
cord-302115-r39ser2c	113	10	immune	immune	JJ
cord-302115-r39ser2c	113	11	system	system	NN
cord-302115-r39ser2c	113	12	,	,	,
cord-302115-r39ser2c	113	13	protecting	protect	VBG
cord-302115-r39ser2c	113	14	against	against	IN
cord-302115-r39ser2c	113	15	invading	invade	VBG
cord-302115-r39ser2c	113	16	pathogens	pathogen	NNS
cord-302115-r39ser2c	113	17	during	during	IN
cord-302115-r39ser2c	113	18	the	the	DT
cord-302115-r39ser2c	113	19	first	first	JJ
cord-302115-r39ser2c	113	20	phase	phase	NN
cord-302115-r39ser2c	113	21	of	of	IN
cord-302115-r39ser2c	113	22	the	the	DT
cord-302115-r39ser2c	113	23	diseases	disease	NNS
cord-302115-r39ser2c	113	24	.	.	.
cord-302115-r39ser2c	114	1	In	in	IN
cord-302115-r39ser2c	114	2	this	this	DT
cord-302115-r39ser2c	114	3	sense	sense	NN
cord-302115-r39ser2c	114	4	,	,	,
cord-302115-r39ser2c	114	5	Ab	ab	NN
cord-302115-r39ser2c	114	6	-	-	HYPH
cord-302115-r39ser2c	114	7	mediated	mediate	VBN
cord-302115-r39ser2c	114	8	complement	complement	NN
cord-302115-r39ser2c	114	9	activation	activation	NN
cord-302115-r39ser2c	114	10	flows	flow	NNS
cord-302115-r39ser2c	114	11	in	in	IN
cord-302115-r39ser2c	114	12	parallel	parallel	NN
cord-302115-r39ser2c	114	13	between	between	IN
cord-302115-r39ser2c	114	14	MBL	MBL	NNP
cord-302115-r39ser2c	114	15	and	and	CC
cord-302115-r39ser2c	114	16	C1q	C1q	NNP
cord-302115-r39ser2c	114	17	.	.	.
cord-302115-r39ser2c	115	1	Additionally	additionally	RB
cord-302115-r39ser2c	115	2	,	,	,
cord-302115-r39ser2c	115	3	it	-PRON-	PRP
cord-302115-r39ser2c	115	4	can	can	MD
cord-302115-r39ser2c	115	5	boost	boost	VB
cord-302115-r39ser2c	115	6	proinflammatory	proinflammatory	JJ
cord-302115-r39ser2c	115	7	effects	effect	NNS
cord-302115-r39ser2c	115	8	of	of	IN
cord-302115-r39ser2c	115	9	IgA	IgA	NNP
cord-302115-r39ser2c	115	10	deposition	deposition	NN
cord-302115-r39ser2c	115	11	with	with	IN
cord-302115-r39ser2c	115	12	the	the	DT
cord-302115-r39ser2c	115	13	same	same	JJ
cord-302115-r39ser2c	115	14	mechanism	mechanism	NN
cord-302115-r39ser2c	115	15	that	that	WDT
cord-302115-r39ser2c	115	16	is	be	VBZ
cord-302115-r39ser2c	115	17	supposed	suppose	VBN
cord-302115-r39ser2c	115	18	to	to	TO
cord-302115-r39ser2c	115	19	occur	occur	VB
cord-302115-r39ser2c	115	20	in	in	IN
cord-302115-r39ser2c	115	21	the	the	DT
cord-302115-r39ser2c	115	22	glomerulus	glomerulus	NN
cord-302115-r39ser2c	115	23	,	,	,
cord-302115-r39ser2c	115	24	and	and	CC
cord-302115-r39ser2c	115	25	results	result	NNS
cord-302115-r39ser2c	115	26	in	in	IN
cord-302115-r39ser2c	115	27	renal	renal	JJ
cord-302115-r39ser2c	115	28	injury	injury	NN
cord-302115-r39ser2c	115	29	.	.	.
cord-302115-r39ser2c	116	1	This	this	DT
cord-302115-r39ser2c	116	2	article	article	NN
cord-302115-r39ser2c	116	3	is	be	VBZ
cord-302115-r39ser2c	116	4	protected	protect	VBN
cord-302115-r39ser2c	116	5	by	by	IN
cord-302115-r39ser2c	116	6	copyright	copyright	NN
cord-302115-r39ser2c	116	7	.	.	.
cord-302115-r39ser2c	117	1	All	all	DT
cord-302115-r39ser2c	117	2	rights	right	NNS
cord-302115-r39ser2c	117	3	reserved	reserve	VBN
cord-302115-r39ser2c	117	4	Evidence	evidence	NN
cord-302115-r39ser2c	117	5	-	-	HYPH
cord-302115-r39ser2c	117	6	based	base	VBN
cord-302115-r39ser2c	117	7	medicine	medicine	NN
cord-302115-r39ser2c	117	8	should	should	MD
cord-302115-r39ser2c	117	9	also	also	RB
cord-302115-r39ser2c	117	10	apply	apply	VB
cord-302115-r39ser2c	117	11	for	for	IN
cord-302115-r39ser2c	117	12	Covid-19	covid-19	NN
cord-302115-r39ser2c	117	13	patients	patient	NNS
cord-302115-r39ser2c	117	14	,	,	,
cord-302115-r39ser2c	117	15	so	so	IN
cord-302115-r39ser2c	117	16	that	that	IN
cord-302115-r39ser2c	117	17	"	"	``
cord-302115-r39ser2c	117	18	new	new	JJ
cord-302115-r39ser2c	117	19	"	"	''
cord-302115-r39ser2c	117	20	or	or	CC
cord-302115-r39ser2c	117	21	off	off	IN
cord-302115-r39ser2c	117	22	-	-	HYPH
cord-302115-r39ser2c	117	23	label	label	NN
cord-302115-r39ser2c	117	24	drugs	drug	NNS
cord-302115-r39ser2c	117	25	or	or	CC
cord-302115-r39ser2c	117	26	treatment	treatment	NN
cord-302115-r39ser2c	117	27	regimens	regimen	NNS
cord-302115-r39ser2c	117	28	should	should	MD
cord-302115-r39ser2c	117	29	only	only	RB
cord-302115-r39ser2c	117	30	be	be	VB
cord-302115-r39ser2c	117	31	given	give	VBN
cord-302115-r39ser2c	117	32	in	in	IN
cord-302115-r39ser2c	117	33	a	a	DT
cord-302115-r39ser2c	117	34	clinical	clinical	JJ
cord-302115-r39ser2c	117	35	study	study	NN
cord-302115-r39ser2c	117	36	context	context	NN
cord-302115-r39ser2c	117	37	,	,	,
cord-302115-r39ser2c	117	38	following	follow	VBG
cord-302115-r39ser2c	117	39	approval	approval	NN
cord-302115-r39ser2c	117	40	by	by	IN
cord-302115-r39ser2c	117	41	relevant	relevant	JJ
cord-302115-r39ser2c	117	42	national	national	JJ
cord-302115-r39ser2c	117	43	or	or	CC
cord-302115-r39ser2c	117	44	international	international	JJ
cord-302115-r39ser2c	117	45	agencies	agency	NNS
cord-302115-r39ser2c	117	46	.	.	.
cord-302115-r39ser2c	118	1	However	however	RB
cord-302115-r39ser2c	118	2	,	,	,
cord-302115-r39ser2c	118	3	we	-PRON-	PRP
cord-302115-r39ser2c	118	4	believe	believe	VBP
cord-302115-r39ser2c	118	5	that	that	IN
cord-302115-r39ser2c	118	6	these	these	DT
cord-302115-r39ser2c	118	7	points	point	NNS
cord-302115-r39ser2c	118	8	are	be	VBP
cord-302115-r39ser2c	118	9	first	first	JJ
cord-302115-r39ser2c	118	10	priorities	priority	NNS
cord-302115-r39ser2c	118	11	for	for	IN
cord-302115-r39ser2c	118	12	intensively	intensively	RB
cord-302115-r39ser2c	118	13	and	and	CC
cord-302115-r39ser2c	118	14	focused	focus	VBD
cord-302115-r39ser2c	118	15	clinically	clinically	RB
cord-302115-r39ser2c	118	16	oriented	orient	VBN
cord-302115-r39ser2c	118	17	research	research	NN
cord-302115-r39ser2c	118	18	.	.	.
cord-302115-r39ser2c	118	19	 	 	_SP
cord-302115-r39ser2c	119	1	microarras	microarras	NNP
cord-302115-r39ser2c	119	2	and	and	CC
cord-302115-r39ser2c	119	3	other	other	JJ
cord-302115-r39ser2c	119	4	tests	test	NNS
cord-302115-r39ser2c	119	5	aimed	aim	VBN
cord-302115-r39ser2c	119	6	at	at	IN
cord-302115-r39ser2c	119	7	measuring	measure	VBG
cord-302115-r39ser2c	119	8	natural	natural	JJ
cord-302115-r39ser2c	119	9	antibodies	antibody	NNS
cord-302115-r39ser2c	119	10	,	,	,
cord-302115-r39ser2c	119	11	that	that	WDT
cord-302115-r39ser2c	119	12	might	may	MD
cord-302115-r39ser2c	119	13	be	be	VB
cord-302115-r39ser2c	119	14	protective	protective	JJ
cord-302115-r39ser2c	119	15	against	against	IN
cord-302115-r39ser2c	119	16	SARS	SARS	NNP
cord-302115-r39ser2c	119	17	-	-	HYPH
cord-302115-r39ser2c	119	18	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	119	19	and	and	CC
cord-302115-r39ser2c	119	20	other	other	JJ
cord-302115-r39ser2c	119	21	viruses	virus	NNS
cord-302115-r39ser2c	119	22	,	,	,
cord-302115-r39ser2c	119	23	should	should	MD
cord-302115-r39ser2c	119	24	be	be	VB
cord-302115-r39ser2c	119	25	developed	develop	VBN
cord-302115-r39ser2c	119	26	.	.	.
cord-302115-r39ser2c	120	1	Individuals	individual	NNS
cord-302115-r39ser2c	120	2	with	with	IN
cord-302115-r39ser2c	120	3	low	low	JJ
cord-302115-r39ser2c	120	4	natural	natural	JJ
cord-302115-r39ser2c	120	5	antibody	antibody	NN
cord-302115-r39ser2c	120	6	and	and	CC
cord-302115-r39ser2c	120	7	MBL	MBL	NNP
cord-302115-r39ser2c	120	8	levels	level	NNS
cord-302115-r39ser2c	120	9	should	should	MD
cord-302115-r39ser2c	120	10	be	be	VB
cord-302115-r39ser2c	120	11	identified	identify	VBN
cord-302115-r39ser2c	120	12	and	and	CC
cord-302115-r39ser2c	120	13	specifically	specifically	RB
cord-302115-r39ser2c	120	14	protected	protect	VBN
cord-302115-r39ser2c	120	15	.	.	.
cord-302115-r39ser2c	121	1	Moreover	moreover	RB
cord-302115-r39ser2c	121	2	,	,	,
cord-302115-r39ser2c	121	3	governments	government	NNS
cord-302115-r39ser2c	121	4	promoting	promote	VBG
cord-302115-r39ser2c	121	5	herd	herd	NN
cord-302115-r39ser2c	121	6	immunity	immunity	NN
cord-302115-r39ser2c	121	7	must	must	MD
cord-302115-r39ser2c	121	8	protect	protect	VB
cord-302115-r39ser2c	121	9	individuals	individual	NNS
cord-302115-r39ser2c	121	10	,	,	,
cord-302115-r39ser2c	121	11	even	even	RB
cord-302115-r39ser2c	121	12	if	if	IN
cord-302115-r39ser2c	121	13	young	young	JJ
cord-302115-r39ser2c	121	14	,	,	,
cord-302115-r39ser2c	121	15	who	who	WP
cord-302115-r39ser2c	121	16	may	may	MD
cord-302115-r39ser2c	121	17	have	have	VB
cord-302115-r39ser2c	121	18	low	low	JJ
cord-302115-r39ser2c	121	19	levels	level	NNS
cord-302115-r39ser2c	121	20	of	of	IN
cord-302115-r39ser2c	121	21	natural	natural	JJ
cord-302115-r39ser2c	121	22	antibodies	antibody	NNS
cord-302115-r39ser2c	121	23	.	.	.
cord-302115-r39ser2c	122	1	These	these	DT
cord-302115-r39ser2c	122	2	individuals	individual	NNS
cord-302115-r39ser2c	122	3	should	should	MD
cord-302115-r39ser2c	122	4	be	be	VB
cord-302115-r39ser2c	122	5	not	not	RB
cord-302115-r39ser2c	122	6	exposed	expose	VBN
cord-302115-r39ser2c	122	7	to	to	IN
cord-302115-r39ser2c	122	8	the	the	DT
cord-302115-r39ser2c	122	9	virus	virus	NN
cord-302115-r39ser2c	122	10	,	,	,
cord-302115-r39ser2c	122	11	especially	especially	RB
cord-302115-r39ser2c	122	12	if	if	IN
cord-302115-r39ser2c	122	13	shed	shed	VBN
cord-302115-r39ser2c	122	14	at	at	IN
cord-302115-r39ser2c	122	15	high	high	JJ
cord-302115-r39ser2c	122	16	doses	dose	NNS
cord-302115-r39ser2c	122	17	.	.	.
cord-302115-r39ser2c	123	1	including	include	VBG
cord-302115-r39ser2c	123	2	strenuous	strenuous	JJ
cord-302115-r39ser2c	123	3	sport	sport	NN
cord-302115-r39ser2c	123	4	activities	activity	NNS
cord-302115-r39ser2c	123	5	requiring	require	VBG
cord-302115-r39ser2c	123	6	high	high	JJ
cord-302115-r39ser2c	123	7	respiratory	respiratory	JJ
cord-302115-r39ser2c	123	8	volumes	volume	NNS
cord-302115-r39ser2c	123	9	and	and	CC
cord-302115-r39ser2c	123	10	flows	flow	NNS
cord-302115-r39ser2c	123	11	,	,	,
cord-302115-r39ser2c	123	12	should	should	MD
cord-302115-r39ser2c	123	13	be	be	VB
cord-302115-r39ser2c	123	14	avoided	avoid	VBN
cord-302115-r39ser2c	123	15	during	during	IN
cord-302115-r39ser2c	123	16	the	the	DT
cord-302115-r39ser2c	123	17	early	early	JJ
cord-302115-r39ser2c	123	18	stage	stage	NN
cord-302115-r39ser2c	123	19	of	of	IN
cord-302115-r39ser2c	123	20	infection	infection	NN
cord-302115-r39ser2c	123	21	.	.	.
cord-302115-r39ser2c	124	1	when	when	WRB
cord-302115-r39ser2c	124	2	the	the	DT
cord-302115-r39ser2c	124	3	adaptive	adaptive	JJ
cord-302115-r39ser2c	124	4	immune	immune	JJ
cord-302115-r39ser2c	124	5	response	response	NN
cord-302115-r39ser2c	124	6	is	be	VBZ
cord-302115-r39ser2c	124	7	This	this	DT
cord-302115-r39ser2c	124	8	article	article	NN
cord-302115-r39ser2c	124	9	is	be	VBZ
cord-302115-r39ser2c	124	10	protected	protect	VBN
cord-302115-r39ser2c	124	11	by	by	IN
cord-302115-r39ser2c	124	12	copyright	copyright	NN
cord-302115-r39ser2c	124	13	.	.	.
cord-302115-r39ser2c	125	1	All	all	DT
cord-302115-r39ser2c	125	2	rights	right	NNS
cord-302115-r39ser2c	125	3	reserved	reserve	VBN
cord-302115-r39ser2c	125	4	still	still	RB
cord-302115-r39ser2c	125	5	not	not	RB
cord-302115-r39ser2c	125	6	initiated	initiate	VBN
cord-302115-r39ser2c	125	7	.	.	.
cord-302115-r39ser2c	126	1	Particular	particular	JJ
cord-302115-r39ser2c	126	2	precautions	precaution	NNS
cord-302115-r39ser2c	126	3	should	should	MD
cord-302115-r39ser2c	126	4	be	be	VB
cord-302115-r39ser2c	126	5	given	give	VBN
cord-302115-r39ser2c	126	6	to	to	IN
cord-302115-r39ser2c	126	7	athletes	athlete	NNS
cord-302115-r39ser2c	126	8	performing	perform	VBG
cord-302115-r39ser2c	126	9	fatiguing	fatiguing	JJ
cord-302115-r39ser2c	126	10	sports	sport	NNS
cord-302115-r39ser2c	126	11	,	,	,
cord-302115-r39ser2c	126	12	since	since	IN
cord-302115-r39ser2c	126	13	a	a	DT
cord-302115-r39ser2c	126	14	portion	portion	NN
cord-302115-r39ser2c	126	15	of	of	IN
cord-302115-r39ser2c	126	16	sub	sub	JJ
cord-302115-r39ser2c	126	17	-	-	HYPH
cord-302115-r39ser2c	126	18	micrometer	micrometer	NN
cord-302115-r39ser2c	126	19	-	-	HYPH
cord-302115-r39ser2c	126	20	size	size	NN
cord-302115-r39ser2c	126	21	,	,	,
cord-302115-r39ser2c	126	22	aerosolized	aerosolize	VBN
cord-302115-r39ser2c	126	23	particles	particle	NNS
cord-302115-r39ser2c	126	24	,	,	,
cord-302115-r39ser2c	126	25	are	be	VBP
cord-302115-r39ser2c	126	26	expired	expire	VBN
cord-302115-r39ser2c	126	27	by	by	IN
cord-302115-r39ser2c	126	28	the	the	DT
cord-302115-r39ser2c	126	29	runner	runner	NN
cord-302115-r39ser2c	126	30	or	or	CC
cord-302115-r39ser2c	126	31	eliminated	eliminate	VBN
cord-302115-r39ser2c	126	32	by	by	IN
cord-302115-r39ser2c	126	33	cough	cough	NN
cord-302115-r39ser2c	126	34	or	or	CC
cord-302115-r39ser2c	126	35	nasal	nasal	NN
cord-302115-r39ser2c	126	36	secretions	secretion	NNS
cord-302115-r39ser2c	126	37	and	and	CC
cord-302115-r39ser2c	126	38	may	may	MD
cord-302115-r39ser2c	126	39	contain	contain	VB
cord-302115-r39ser2c	126	40	viruses	virus	NNS
cord-302115-r39ser2c	126	41	if	if	IN
cord-302115-r39ser2c	126	42	the	the	DT
cord-302115-r39ser2c	126	43	athlete	athlete	NN
cord-302115-r39ser2c	126	44	is	be	VBZ
cord-302115-r39ser2c	126	45	an	an	DT
cord-302115-r39ser2c	126	46	asymptomatic	asymptomatic	JJ
cord-302115-r39ser2c	126	47	but	but	CC
cord-302115-r39ser2c	126	48	SARS	SARS	NNP
cord-302115-r39ser2c	126	49	-	-	HYPH
cord-302115-r39ser2c	126	50	CoV2	CoV2	NNP
cord-302115-r39ser2c	126	51	infected	infect	VBN
cord-302115-r39ser2c	126	52	individual	individual	NN
cord-302115-r39ser2c	126	53	.	.	.
cord-302115-r39ser2c	127	1	These	these	DT
cord-302115-r39ser2c	127	2	droplets	droplet	NNS
cord-302115-r39ser2c	127	3	or	or	CC
cord-302115-r39ser2c	127	4	aerosol	aerosol	NN
cord-302115-r39ser2c	127	5	might	may	MD
cord-302115-r39ser2c	127	6	be	be	VB
cord-302115-r39ser2c	127	7	re	re	VBN
cord-302115-r39ser2c	127	8	-	-	VBN
cord-302115-r39ser2c	127	9	inhaled	inhale	VBN
cord-302115-r39ser2c	127	10	and	and	CC
cord-302115-r39ser2c	127	11	facilitate	facilitate	VB
cord-302115-r39ser2c	127	12	the	the	DT
cord-302115-r39ser2c	127	13	spread	spread	NN
cord-302115-r39ser2c	127	14	of	of	IN
cord-302115-r39ser2c	127	15	the	the	DT
cord-302115-r39ser2c	127	16	virus	virus	NN
cord-302115-r39ser2c	127	17	from	from	IN
cord-302115-r39ser2c	127	18	the	the	DT
cord-302115-r39ser2c	127	19	upper	upper	NN
cord-302115-r39ser2c	127	20	to	to	IN
cord-302115-r39ser2c	127	21	the	the	DT
cord-302115-r39ser2c	127	22	lower	low	JJR
cord-302115-r39ser2c	127	23	airways	airway	NNS
cord-302115-r39ser2c	127	24	.	.	.
cord-302115-r39ser2c	127	25	 	 	_SP
cord-302115-r39ser2c	128	1	This	this	DT
cord-302115-r39ser2c	128	2	article	article	NN
cord-302115-r39ser2c	128	3	is	be	VBZ
cord-302115-r39ser2c	128	4	protected	protect	VBN
cord-302115-r39ser2c	128	5	by	by	IN
cord-302115-r39ser2c	128	6	copyright	copyright	NN
cord-302115-r39ser2c	128	7	.	.	.
cord-302115-r39ser2c	129	1	All	all	DT
cord-302115-r39ser2c	129	2	rights	right	NNS
cord-302115-r39ser2c	129	3	reserved	reserve	VBN
cord-302115-r39ser2c	129	4	moieties	moiety	NNS
cord-302115-r39ser2c	129	5	flanking	flank	VBG
cord-302115-r39ser2c	129	6	SARS	SARS	NNP
cord-302115-r39ser2c	129	7	-	-	HYPH
cord-302115-r39ser2c	129	8	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	129	9	S1-RBS	S1-RBS	NNP
cord-302115-r39ser2c	129	10	may	may	MD
cord-302115-r39ser2c	129	11	be	be	VB
cord-302115-r39ser2c	129	12	useful	useful	JJ
cord-302115-r39ser2c	129	13	,	,	,
cord-302115-r39ser2c	129	14	among	among	IN
cord-302115-r39ser2c	129	15	elders	elder	NNS
cord-302115-r39ser2c	129	16	,	,	,
cord-302115-r39ser2c	129	17	to	to	TO
cord-302115-r39ser2c	129	18	identify	identify	VB
cord-302115-r39ser2c	129	19	those	those	DT
cord-302115-r39ser2c	129	20	at	at	IN
cord-302115-r39ser2c	129	21	higher	high	JJR
cord-302115-r39ser2c	129	22	risk	risk	NN
cord-302115-r39ser2c	129	23	of	of	IN
cord-302115-r39ser2c	129	24	severe	severe	JJ
cord-302115-r39ser2c	129	25	disease	disease	NN
cord-302115-r39ser2c	129	26	.	.	.
cord-302115-r39ser2c	130	1	Glycan	glycan	JJ
cord-302115-r39ser2c	130	2	microarrays	microarray	NNS
cord-302115-r39ser2c	130	3	will	will	MD
cord-302115-r39ser2c	130	4	be	be	VB
cord-302115-r39ser2c	130	5	instrumental	instrumental	JJ
cord-302115-r39ser2c	130	6	for	for	IN
cord-302115-r39ser2c	130	7	this	this	DT
cord-302115-r39ser2c	130	8	target	target	NN
cord-302115-r39ser2c	130	9	.	.	.
cord-302115-r39ser2c	131	1	paucisymptomatic	paucisymptomatic	JJ
cord-302115-r39ser2c	131	2	individuals	individual	NNS
cord-302115-r39ser2c	131	3	could	could	MD
cord-302115-r39ser2c	131	4	be	be	VB
cord-302115-r39ser2c	131	5	pursued	pursue	VBN
cord-302115-r39ser2c	131	6	by	by	IN
cord-302115-r39ser2c	131	7	measuring	measure	VBG
cord-302115-r39ser2c	131	8	SARS	SARS	NNP
cord-302115-r39ser2c	131	9	-	-	HYPH
cord-302115-r39ser2c	131	10	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	131	11	specific	specific	JJ
cord-302115-r39ser2c	131	12	serum	serum	NN
cord-302115-r39ser2c	131	13	IgG	igg	NN
cord-302115-r39ser2c	131	14	and	and	CC
cord-302115-r39ser2c	131	15	IgA	IgA	NNP
cord-302115-r39ser2c	131	16	that	that	WDT
cord-302115-r39ser2c	131	17	are	be	VBP
cord-302115-r39ser2c	131	18	expected	expect	VBN
cord-302115-r39ser2c	131	19	to	to	TO
cord-302115-r39ser2c	131	20	persist	persist	VB
cord-302115-r39ser2c	131	21	as	as	IN
cord-302115-r39ser2c	131	22	a	a	DT
cord-302115-r39ser2c	131	23	memory	memory	NN
cord-302115-r39ser2c	131	24	response	response	NN
cord-302115-r39ser2c	131	25	to	to	IN
cord-302115-r39ser2c	131	26	infection	infection	NN
cord-302115-r39ser2c	131	27	.	.	.
cord-302115-r39ser2c	132	1	Appropriate	appropriate	JJ
cord-302115-r39ser2c	132	2	and	and	CC
cord-302115-r39ser2c	132	3	high	high	JJ
cord-302115-r39ser2c	132	4	performing	perform	VBG
cord-302115-r39ser2c	132	5	validated	validate	VBN
cord-302115-r39ser2c	132	6	tests	test	NNS
cord-302115-r39ser2c	132	7	should	should	MD
cord-302115-r39ser2c	132	8	be	be	VB
cord-302115-r39ser2c	132	9	used	use	VBN
cord-302115-r39ser2c	132	10	to	to	TO
cord-302115-r39ser2c	132	11	retrospectively	retrospectively	RB
cord-302115-r39ser2c	132	12	evaluate	evaluate	VB
cord-302115-r39ser2c	132	13	the	the	DT
cord-302115-r39ser2c	132	14	seroconversion	seroconversion	NN
cord-302115-r39ser2c	132	15	status	status	NN
cord-302115-r39ser2c	132	16	to	to	TO
cord-302115-r39ser2c	132	17	estimate	estimate	VB
cord-302115-r39ser2c	132	18	the	the	DT
cord-302115-r39ser2c	132	19	herd	herd	NN
cord-302115-r39ser2c	132	20	immunity	immunity	NN
cord-302115-r39ser2c	132	21	of	of	IN
cord-302115-r39ser2c	132	22	a	a	DT
cord-302115-r39ser2c	132	23	given	give	VBN
cord-302115-r39ser2c	132	24	population	population	NN
cord-302115-r39ser2c	132	25	.	.	.
cord-302115-r39ser2c	133	1	Immunization	immunization	NN
cord-302115-r39ser2c	133	2	strategy	strategy	NN
cord-302115-r39ser2c	133	3	:	:	:
cord-302115-r39ser2c	133	4	innate	innate	JJ
cord-302115-r39ser2c	133	5	and	and	CC
cord-302115-r39ser2c	133	6	adaptive	adaptive	JJ
cord-302115-r39ser2c	133	7	immunity	immunity	NN
cord-302115-r39ser2c	133	8	10.5.1	10.5.1	CD
cord-302115-r39ser2c	134	1	While	while	IN
cord-302115-r39ser2c	134	2	effective	effective	JJ
cord-302115-r39ser2c	134	3	vaccines	vaccine	NNS
cord-302115-r39ser2c	134	4	are	be	VBP
cord-302115-r39ser2c	134	5	being	be	VBG
cord-302115-r39ser2c	134	6	developed	develop	VBN
cord-302115-r39ser2c	134	7	,	,	,
cord-302115-r39ser2c	134	8	produced	produce	VBN
cord-302115-r39ser2c	134	9	,	,	,
cord-302115-r39ser2c	134	10	tested	test	VBN
cord-302115-r39ser2c	134	11	,	,	,
cord-302115-r39ser2c	134	12	and	and	CC
cord-302115-r39ser2c	134	13	validated	validate	VBD
cord-302115-r39ser2c	134	14	,	,	,
cord-302115-r39ser2c	134	15	a	a	DT
cord-302115-r39ser2c	134	16	strategy	strategy	NN
cord-302115-r39ser2c	134	17	to	to	TO
cord-302115-r39ser2c	134	18	stimulate	stimulate	VB
cord-302115-r39ser2c	134	19	innate	innate	JJ
cord-302115-r39ser2c	134	20	immunity	immunity	NN
cord-302115-r39ser2c	134	21	and	and	CC
cord-302115-r39ser2c	134	22	natural	natural	JJ
cord-302115-r39ser2c	134	23	IgM	IgM	NNP
cord-302115-r39ser2c	134	24	antibody	antibody	NNP
cord-302115-r39ser2c	134	25	production	production	NN
cord-302115-r39ser2c	134	26	in	in	IN
cord-302115-r39ser2c	134	27	particular	particular	JJ
cord-302115-r39ser2c	134	28	,	,	,
cord-302115-r39ser2c	134	29	would	would	MD
cord-302115-r39ser2c	134	30	empower	empower	VB
cord-302115-r39ser2c	134	31	the	the	DT
cord-302115-r39ser2c	134	32	defences	defence	NNS
cord-302115-r39ser2c	134	33	of	of	IN
cord-302115-r39ser2c	134	34	at	at	IN
cord-302115-r39ser2c	134	35	-	-	HYPH
cord-302115-r39ser2c	134	36	risk	risk	NN
cord-302115-r39ser2c	134	37	elderly	elderly	JJ
cord-302115-r39ser2c	134	38	population	population	NN
cord-302115-r39ser2c	134	39	.	.	.
cord-302115-r39ser2c	135	1	These	these	DT
cord-302115-r39ser2c	135	2	measures	measure	NNS
cord-302115-r39ser2c	135	3	may	may	MD
cord-302115-r39ser2c	135	4	include	include	VB
cord-302115-r39ser2c	135	5	influenza	influenza	NN
cord-302115-r39ser2c	135	6	,	,	,
cord-302115-r39ser2c	135	7	pneumococcal	pneumococcal	JJ
cord-302115-r39ser2c	135	8	,	,	,
cord-302115-r39ser2c	135	9	BCG	BCG	NNP
cord-302115-r39ser2c	135	10	and	and	CC
cord-302115-r39ser2c	135	11	other	other	JJ
cord-302115-r39ser2c	135	12	immunizations	immunization	NNS
cord-302115-r39ser2c	135	13	that	that	WDT
cord-302115-r39ser2c	135	14	have	have	VBP
cord-302115-r39ser2c	135	15	been	be	VBN
cord-302115-r39ser2c	135	16	proved	prove	VBN
cord-302115-r39ser2c	135	17	to	to	TO
cord-302115-r39ser2c	135	18	reinforce	reinforce	VB
cord-302115-r39ser2c	135	19	natural	natural	JJ
cord-302115-r39ser2c	135	20	immunity	immunity	NN
cord-302115-r39ser2c	135	21	in	in	IN
cord-302115-r39ser2c	135	22	general	general	NN
cord-302115-r39ser2c	135	23	.	.	.
cord-302115-r39ser2c	136	1	This	this	DT
cord-302115-r39ser2c	136	2	can	can	MD
cord-302115-r39ser2c	136	3	be	be	VB
cord-302115-r39ser2c	136	4	valid	valid	JJ
cord-302115-r39ser2c	136	5	especially	especially	RB
cord-302115-r39ser2c	136	6	considering	consider	VBG
cord-302115-r39ser2c	136	7	that	that	IN
cord-302115-r39ser2c	136	8	pneumococcus	pneumococcus	NNP
cord-302115-r39ser2c	136	9	is	be	VBZ
cord-302115-r39ser2c	136	10	also	also	RB
cord-302115-r39ser2c	136	11	a	a	DT
cord-302115-r39ser2c	136	12	frequent	frequent	JJ
cord-302115-r39ser2c	136	13	cause	cause	NN
cord-302115-r39ser2c	136	14	of	of	IN
cord-302115-r39ser2c	136	15	co	co	NN
cord-302115-r39ser2c	136	16	-	-	NN
cord-302115-r39ser2c	136	17	infection	infection	NN
cord-302115-r39ser2c	136	18	causing	cause	VBG
cord-302115-r39ser2c	136	19	severe	severe	JJ
cord-302115-r39ser2c	136	20	pneumonia	pneumonia	NN
cord-302115-r39ser2c	136	21	and	and	CC
cord-302115-r39ser2c	136	22	complications	complication	NNS
cord-302115-r39ser2c	136	23	.	.	.
cord-302115-r39ser2c	137	1	Given	give	VBN
cord-302115-r39ser2c	137	2	the	the	DT
cord-302115-r39ser2c	137	3	relevance	relevance	NN
cord-302115-r39ser2c	137	4	of	of	IN
cord-302115-r39ser2c	137	5	the	the	DT
cord-302115-r39ser2c	137	6	local	local	JJ
cord-302115-r39ser2c	137	7	immune	immune	JJ
cord-302115-r39ser2c	137	8	response	response	NN
cord-302115-r39ser2c	137	9	to	to	IN
cord-302115-r39ser2c	137	10	SARS	SARS	NNP
cord-302115-r39ser2c	137	11	-	-	HYPH
cord-302115-r39ser2c	137	12	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	137	13	,	,	,
cord-302115-r39ser2c	137	14	an	an	DT
cord-302115-r39ser2c	137	15	immunization	immunization	NN
cord-302115-r39ser2c	137	16	strategy	strategy	NN
cord-302115-r39ser2c	137	17	based	base	VBN
cord-302115-r39ser2c	137	18	on	on	IN
cord-302115-r39ser2c	137	19	a	a	DT
cord-302115-r39ser2c	137	20	mucosal	mucosal	JJ
cord-302115-r39ser2c	137	21	vaccination	vaccination	NN
cord-302115-r39ser2c	137	22	would	would	MD
cord-302115-r39ser2c	137	23	assure	assure	VB
cord-302115-r39ser2c	137	24	a	a	DT
cord-302115-r39ser2c	137	25	higher	high	JJR
cord-302115-r39ser2c	137	26	protection	protection	NN
cord-302115-r39ser2c	137	27	.	.	.
cord-302115-r39ser2c	138	1	This	this	DT
cord-302115-r39ser2c	138	2	article	article	NN
cord-302115-r39ser2c	138	3	is	be	VBZ
cord-302115-r39ser2c	138	4	protected	protect	VBN
cord-302115-r39ser2c	138	5	by	by	IN
cord-302115-r39ser2c	138	6	copyright	copyright	NN
cord-302115-r39ser2c	138	7	.	.	.
cord-302115-r39ser2c	139	1	All	all	DT
cord-302115-r39ser2c	139	2	rights	right	NNS
cord-302115-r39ser2c	139	3	reserved	reserve	VBN
cord-302115-r39ser2c	139	4	 	 	_SP
cord-302115-r39ser2c	139	5	This	this	DT
cord-302115-r39ser2c	139	6	article	article	NN
cord-302115-r39ser2c	139	7	is	be	VBZ
cord-302115-r39ser2c	139	8	protected	protect	VBN
cord-302115-r39ser2c	139	9	by	by	IN
cord-302115-r39ser2c	139	10	copyright	copyright	NN
cord-302115-r39ser2c	139	11	.	.	.
cord-302115-r39ser2c	140	1	All	all	DT
cord-302115-r39ser2c	140	2	rights	right	NNS
cord-302115-r39ser2c	140	3	reserved	reserve	VBD
cord-302115-r39ser2c	140	4	 	 	_SP
cord-302115-r39ser2c	140	5	A	a	DT
cord-302115-r39ser2c	140	6	Novel	Novel	NNP
cord-302115-r39ser2c	140	7	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	140	8	from	from	IN
cord-302115-r39ser2c	140	9	Patients	patient	NNS
cord-302115-r39ser2c	140	10	with	with	IN
cord-302115-r39ser2c	140	11	Pneumonia	Pneumonia	NNP
cord-302115-r39ser2c	140	12	in	in	IN
cord-302115-r39ser2c	140	13	China	China	NNP
cord-302115-r39ser2c	140	14	Detection	Detection	NNP
cord-302115-r39ser2c	140	15	of	of	IN
cord-302115-r39ser2c	140	16	2019	2019	CD
cord-302115-r39ser2c	140	17	novel	novel	JJ
cord-302115-r39ser2c	140	18	coronavirus	coronavirus	NN
cord-302115-r39ser2c	140	19	(	(	-LRB-
cord-302115-r39ser2c	140	20	2019-nCoV	2019-ncov	CD
cord-302115-r39ser2c	140	21	)	)	-RRB-
cord-302115-r39ser2c	140	22	by	by	IN
cord-302115-r39ser2c	140	23	real	real	JJ
cord-302115-r39ser2c	140	24	-	-	HYPH
cord-302115-r39ser2c	140	25	time	time	NN
cord-302115-r39ser2c	140	26	RT	RT	NNP
cord-302115-r39ser2c	140	27	-	-	HYPH
cord-302115-r39ser2c	140	28	PCR	PCR	NNP
cord-302115-r39ser2c	140	29	Identification	Identification	NNP
cord-302115-r39ser2c	140	30	of	of	IN
cord-302115-r39ser2c	140	31	a	a	DT
cord-302115-r39ser2c	140	32	Novel	Novel	NNP
cord-302115-r39ser2c	140	33	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	140	34	in	in	IN
cord-302115-r39ser2c	140	35	Patients	patient	NNS
cord-302115-r39ser2c	140	36	with	with	IN
cord-302115-r39ser2c	140	37	Severe	severe	JJ
cord-302115-r39ser2c	140	38	Acute	acute	JJ
cord-302115-r39ser2c	140	39	Respiratory	Respiratory	NNP
cord-302115-r39ser2c	140	40	Syndrome	Syndrome	NNP
cord-302115-r39ser2c	140	41	Severe	severe	JJ
cord-302115-r39ser2c	140	42	acute	acute	JJ
cord-302115-r39ser2c	140	43	respiratory	respiratory	JJ
cord-302115-r39ser2c	140	44	syndrome	syndrome	NN
cord-302115-r39ser2c	140	45	-	-	HYPH
cord-302115-r39ser2c	140	46	related	relate	VBN
cord-302115-r39ser2c	140	47	coronavirus	coronavirus	NN
cord-302115-r39ser2c	140	48	:	:	:
cord-302115-r39ser2c	141	1	The	the	DT
cord-302115-r39ser2c	141	2	species	specie	NNS
cord-302115-r39ser2c	141	3	and	and	CC
cord-302115-r39ser2c	141	4	its	-PRON-	PRP$
cord-302115-r39ser2c	141	5	viruses	virus	NNS
cord-302115-r39ser2c	141	6	-	-	:
cord-302115-r39ser2c	141	7	A	a	DT
cord-302115-r39ser2c	141	8	statement	statement	NN
cord-302115-r39ser2c	141	9	of	of	IN
cord-302115-r39ser2c	141	10	the	the	DT
cord-302115-r39ser2c	141	11	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	141	12	Study	Study	NNP
cord-302115-r39ser2c	141	13	Group	Group	NNP
cord-302115-r39ser2c	141	14	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	141	15	:	:	:
cord-302115-r39ser2c	141	16	what	what	WP
cord-302115-r39ser2c	141	17	is	be	VBZ
cord-302115-r39ser2c	141	18	next	next	JJ
cord-302115-r39ser2c	141	19	for	for	IN
cord-302115-r39ser2c	141	20	public	public	JJ
cord-302115-r39ser2c	141	21	health	health	NN
cord-302115-r39ser2c	141	22	?	?	.
cord-302115-r39ser2c	142	1	All	all	DT
cord-302115-r39ser2c	142	2	rights	right	NNS
cord-302115-r39ser2c	142	3	reserved	reserve	VBD
cord-302115-r39ser2c	142	4	6	6	CD
cord-302115-r39ser2c	142	5	-WHO	-WHO	-LRB-
cord-302115-r39ser2c	142	6	pandemic	pandemic	JJ
cord-302115-r39ser2c	142	7	statement	statement	NN
cord-302115-r39ser2c	143	1	Evolving	evolve	VBG
cord-302115-r39ser2c	143	2	epidemiology	epidemiology	NN
cord-302115-r39ser2c	143	3	and	and	CC
cord-302115-r39ser2c	143	4	transmission	transmission	NN
cord-302115-r39ser2c	143	5	dynamics	dynamic	NNS
cord-302115-r39ser2c	143	6	of	of	IN
cord-302115-r39ser2c	143	7	coronavirus	coronavirus	NN
cord-302115-r39ser2c	143	8	disease	disease	NN
cord-302115-r39ser2c	143	9	2019	2019	CD
cord-302115-r39ser2c	143	10	outside	outside	IN
cord-302115-r39ser2c	143	11	Hubei	Hubei	NNP
cord-302115-r39ser2c	143	12	province	province	NN
cord-302115-r39ser2c	143	13	,	,	,
cord-302115-r39ser2c	143	14	China	China	NNP
cord-302115-r39ser2c	143	15	:	:	:
cord-302115-r39ser2c	143	16	a	a	DT
cord-302115-r39ser2c	143	17	descriptive	descriptive	JJ
cord-302115-r39ser2c	143	18	and	and	CC
cord-302115-r39ser2c	143	19	modelling	modelling	NN
cord-302115-r39ser2c	143	20	study	study	NN
cord-302115-r39ser2c	143	21	.	.	.
cord-302115-r39ser2c	144	1	The	the	DT
cord-302115-r39ser2c	144	2	Lancet	Lancet	NNP
cord-302115-r39ser2c	144	3	,	,	,
cord-302115-r39ser2c	144	4	Infectious	Infectious	NNP
cord-302115-r39ser2c	144	5	Diseases	Diseases	NNPS
cord-302115-r39ser2c	144	6	Clinical	Clinical	NNP
cord-302115-r39ser2c	144	7	presentation	presentation	NN
cord-302115-r39ser2c	144	8	and	and	CC
cord-302115-r39ser2c	144	9	virological	virological	JJ
cord-302115-r39ser2c	144	10	assessment	assessment	NN
cord-302115-r39ser2c	144	11	of	of	IN
cord-302115-r39ser2c	144	12	hospitalized	hospitalize	VBN
cord-302115-r39ser2c	144	13	cases	case	NNS
cord-302115-r39ser2c	144	14	of	of	IN
cord-302115-r39ser2c	144	15	coronavirus	coronavirus	NN
cord-302115-r39ser2c	144	16	disease	disease	NN
cord-302115-r39ser2c	144	17	2019	2019	CD
cord-302115-r39ser2c	144	18	in	in	IN
cord-302115-r39ser2c	144	19	a	a	DT
cord-302115-r39ser2c	144	20	travel	travel	NN
cord-302115-r39ser2c	144	21	-	-	HYPH
cord-302115-r39ser2c	144	22	associated	associate	VBN
cord-302115-r39ser2c	144	23	transmission	transmission	NN
cord-302115-r39ser2c	144	24	cluster	cluster	NN
cord-302115-r39ser2c	144	25	.	.	.
cord-302115-r39ser2c	145	1	medRxiv	medRxiv	NNP
cord-302115-r39ser2c	145	2	preprint	preprint	NN
cord-302115-r39ser2c	145	3	2020	2020	CD
cord-302115-r39ser2c	146	1	Minimum	minimum	JJ
cord-302115-r39ser2c	146	2	infective	infective	JJ
cord-302115-r39ser2c	146	3	dose	dose	NN
cord-302115-r39ser2c	146	4	of	of	IN
cord-302115-r39ser2c	146	5	the	the	DT
cord-302115-r39ser2c	146	6	major	major	JJ
cord-302115-r39ser2c	146	7	human	human	JJ
cord-302115-r39ser2c	146	8	respiratory	respiratory	NN
cord-302115-r39ser2c	146	9	and	and	CC
cord-302115-r39ser2c	146	10	enteric	enteric	JJ
cord-302115-r39ser2c	146	11	viruses	virus	NNS
cord-302115-r39ser2c	146	12	transmitted	transmit	VBN
cord-302115-r39ser2c	146	13	through	through	IN
cord-302115-r39ser2c	146	14	food	food	NN
cord-302115-r39ser2c	146	15	and	and	CC
cord-302115-r39ser2c	146	16	the	the	DT
cord-302115-r39ser2c	146	17	environment	environment	NN
cord-302115-r39ser2c	146	18	SARS	SARS	NNP
cord-302115-r39ser2c	146	19	-	-	HYPH
cord-302115-r39ser2c	146	20	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	146	21	viral	viral	JJ
cord-302115-r39ser2c	146	22	load	load	NN
cord-302115-r39ser2c	146	23	and	and	CC
cord-302115-r39ser2c	146	24	the	the	DT
cord-302115-r39ser2c	146	25	severity	severity	NN
cord-302115-r39ser2c	146	26	of	of	IN
cord-302115-r39ser2c	146	27	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	146	28	Clinical	Clinical	NNP
cord-302115-r39ser2c	146	29	Characteristics	Characteristics	NNPS
cord-302115-r39ser2c	146	30	of	of	IN
cord-302115-r39ser2c	146	31	138	138	CD
cord-302115-r39ser2c	146	32	Hospitalized	hospitalize	VBN
cord-302115-r39ser2c	146	33	Patients	patient	NNS
cord-302115-r39ser2c	146	34	With	with	IN
cord-302115-r39ser2c	146	35	2019	2019	CD
cord-302115-r39ser2c	146	36	Novel	Novel	NNP
cord-302115-r39ser2c	146	37	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	146	38	-	-	HYPH
cord-302115-r39ser2c	146	39	Infected	infect	VBN
cord-302115-r39ser2c	146	40	Pneumonia	Pneumonia	NNP
cord-302115-r39ser2c	146	41	in	in	IN
cord-302115-r39ser2c	146	42	Wuhan	Wuhan	NNP
cord-302115-r39ser2c	146	43	Incubation	Incubation	NNP
cord-302115-r39ser2c	146	44	Period	Period	NNP
cord-302115-r39ser2c	146	45	and	and	CC
cord-302115-r39ser2c	146	46	Other	other	JJ
cord-302115-r39ser2c	146	47	Epidemiological	epidemiological	JJ
cord-302115-r39ser2c	146	48	Characteristics	characteristic	NNS
cord-302115-r39ser2c	146	49	of	of	IN
cord-302115-r39ser2c	146	50	2019	2019	CD
cord-302115-r39ser2c	146	51	Novel	Novel	NNP
cord-302115-r39ser2c	146	52	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	146	53	Infections	Infections	NNPS
cord-302115-r39ser2c	146	54	with	with	IN
cord-302115-r39ser2c	146	55	Right	Right	NNP
cord-302115-r39ser2c	146	56	Truncation	truncation	NN
cord-302115-r39ser2c	146	57	:	:	:
cord-302115-r39ser2c	146	58	A	a	DT
cord-302115-r39ser2c	146	59	Statistical	Statistical	NNP
cord-302115-r39ser2c	146	60	Analysis	Analysis	NNP
cord-302115-r39ser2c	146	61	of	of	IN
cord-302115-r39ser2c	146	62	Publicly	publicly	RB
cord-302115-r39ser2c	146	63	Available	Available	NNP
cord-302115-r39ser2c	146	64	Case	Case	NNP
cord-302115-r39ser2c	146	65	Data	Data	NNP
cord-302115-r39ser2c	146	66	SARS	SARS	NNP
cord-302115-r39ser2c	146	67	-	-	HYPH
cord-302115-r39ser2c	146	68	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	146	69	viral	viral	JJ
cord-302115-r39ser2c	146	70	load	load	NN
cord-302115-r39ser2c	146	71	in	in	IN
cord-302115-r39ser2c	146	72	upper	upper	JJ
cord-302115-r39ser2c	146	73	respiratory	respiratory	JJ
cord-302115-r39ser2c	146	74	specimens	specimen	NNS
cord-302115-r39ser2c	146	75	of	of	IN
cord-302115-r39ser2c	146	76	infected	infected	JJ
cord-302115-r39ser2c	146	77	patients	patient	NNS
cord-302115-r39ser2c	146	78	Chest	Chest	NNP
cord-302115-r39ser2c	146	79	CT	CT	NNP
cord-302115-r39ser2c	146	80	Findings	Findings	NNPS
cord-302115-r39ser2c	146	81	in	in	IN
cord-302115-r39ser2c	146	82	Cases	case	NNS
cord-302115-r39ser2c	146	83	from	from	IN
cord-302115-r39ser2c	146	84	the	the	DT
cord-302115-r39ser2c	146	85	Cruise	Cruise	NNP
cord-302115-r39ser2c	146	86	Ship	Ship	NNP
cord-302115-r39ser2c	146	87	"	"	''
cord-302115-r39ser2c	146	88	Diamond	Diamond	NNP
cord-302115-r39ser2c	146	89	Princess	Princess	NNP
cord-302115-r39ser2c	146	90	Clinical	clinical	JJ
cord-302115-r39ser2c	146	91	course	course	NN
cord-302115-r39ser2c	146	92	and	and	CC
cord-302115-r39ser2c	146	93	risk	risk	NN
cord-302115-r39ser2c	146	94	factors	factor	NNS
cord-302115-r39ser2c	146	95	for	for	IN
cord-302115-r39ser2c	146	96	mortality	mortality	NN
cord-302115-r39ser2c	146	97	of	of	IN
cord-302115-r39ser2c	146	98	adult	adult	NN
cord-302115-r39ser2c	146	99	inpatients	inpatient	NNS
cord-302115-r39ser2c	146	100	with	with	IN
cord-302115-r39ser2c	146	101	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	146	102	in	in	IN
cord-302115-r39ser2c	146	103	Wuhan	Wuhan	NNP
cord-302115-r39ser2c	146	104	,	,	,
cord-302115-r39ser2c	146	105	China	China	NNP
cord-302115-r39ser2c	146	106	:	:	:
cord-302115-r39ser2c	146	107	a	a	DT
cord-302115-r39ser2c	146	108	retrospective	retrospective	JJ
cord-302115-r39ser2c	146	109	cohort	cohort	NN
cord-302115-r39ser2c	146	110	study	study	NN
cord-302115-r39ser2c	146	111	Organ	Organ	NNP
cord-302115-r39ser2c	146	112	distribution	distribution	NN
cord-302115-r39ser2c	146	113	of	of	IN
cord-302115-r39ser2c	146	114	severe	severe	JJ
cord-302115-r39ser2c	146	115	acute	acute	JJ
cord-302115-r39ser2c	146	116	respiratory	respiratory	JJ
cord-302115-r39ser2c	146	117	syndrome	syndrome	NN
cord-302115-r39ser2c	146	118	(	(	-LRB-
cord-302115-r39ser2c	146	119	SARS	SARS	NNP
cord-302115-r39ser2c	146	120	)	)	-RRB-
cord-302115-r39ser2c	146	121	associated	associate	VBD
cord-302115-r39ser2c	146	122	coronavirus	coronavirus	NN
cord-302115-r39ser2c	146	123	(	(	-LRB-
cord-302115-r39ser2c	146	124	SARS	SARS	NNP
cord-302115-r39ser2c	146	125	-	-	HYPH
cord-302115-r39ser2c	146	126	CoV	CoV	NNP
cord-302115-r39ser2c	146	127	)	)	-RRB-
cord-302115-r39ser2c	146	128	in	in	IN
cord-302115-r39ser2c	146	129	SARS	SARS	NNP
cord-302115-r39ser2c	146	130	patients	patient	NNS
cord-302115-r39ser2c	146	131	:	:	:
cord-302115-r39ser2c	146	132	implications	implication	NNS
cord-302115-r39ser2c	146	133	for	for	IN
cord-302115-r39ser2c	146	134	Accepted	Accepted	NNP
cord-302115-r39ser2c	146	135	Article	Article	NNP
cord-302115-r39ser2c	147	1	This	this	DT
cord-302115-r39ser2c	147	2	article	article	NN
cord-302115-r39ser2c	147	3	is	be	VBZ
cord-302115-r39ser2c	147	4	protected	protect	VBN
cord-302115-r39ser2c	147	5	by	by	IN
cord-302115-r39ser2c	147	6	copyright	copyright	NN
cord-302115-r39ser2c	147	7	.	.	.
cord-302115-r39ser2c	148	1	All	all	DT
cord-302115-r39ser2c	148	2	rights	right	NNS
cord-302115-r39ser2c	148	3	reserved	reserve	VBN
cord-302115-r39ser2c	148	4	pathogenesis	pathogenesis	NN
cord-302115-r39ser2c	148	5	and	and	CC
cord-302115-r39ser2c	148	6	virus	virus	NN
cord-302115-r39ser2c	148	7	transmission	transmission	NN
cord-302115-r39ser2c	148	8	pathways	pathway	NNS
cord-302115-r39ser2c	148	9	Exploring	explore	VBG
cord-302115-r39ser2c	148	10	the	the	DT
cord-302115-r39ser2c	148	11	pathogenesis	pathogenesis	NN
cord-302115-r39ser2c	148	12	of	of	IN
cord-302115-r39ser2c	148	13	severe	severe	JJ
cord-302115-r39ser2c	148	14	acute	acute	JJ
cord-302115-r39ser2c	148	15	respiratory	respiratory	JJ
cord-302115-r39ser2c	148	16	syndrome	syndrome	NN
cord-302115-r39ser2c	148	17	(	(	-LRB-
cord-302115-r39ser2c	148	18	SARS	SARS	NNP
cord-302115-r39ser2c	148	19	)	)	-RRB-
cord-302115-r39ser2c	148	20	:	:	:
cord-302115-r39ser2c	148	21	the	the	DT
cord-302115-r39ser2c	148	22	tissue	tissue	NN
cord-302115-r39ser2c	148	23	distribution	distribution	NN
cord-302115-r39ser2c	148	24	of	of	IN
cord-302115-r39ser2c	148	25	the	the	DT
cord-302115-r39ser2c	148	26	coronavirus	coronavirus	NN
cord-302115-r39ser2c	148	27	(	(	-LRB-
cord-302115-r39ser2c	148	28	SARS	SARS	NNP
cord-302115-r39ser2c	148	29	-	-	HYPH
cord-302115-r39ser2c	148	30	CoV	CoV	NNP
cord-302115-r39ser2c	148	31	)	)	-RRB-
cord-302115-r39ser2c	148	32	and	and	CC
cord-302115-r39ser2c	148	33	its	-PRON-	PRP$
cord-302115-r39ser2c	148	34	putative	putative	JJ
cord-302115-r39ser2c	148	35	receptor	receptor	NN
cord-302115-r39ser2c	148	36	,	,	,
cord-302115-r39ser2c	148	37	angiotensin	angiotensin	NN
cord-302115-r39ser2c	148	38	-	-	HYPH
cord-302115-r39ser2c	148	39	converting	convert	VBG
cord-302115-r39ser2c	148	40	enzyme	enzyme	NN
cord-302115-r39ser2c	148	41	2	2	CD
cord-302115-r39ser2c	148	42	(	(	-LRB-
cord-302115-r39ser2c	148	43	ACE2	ACE2	NNP
cord-302115-r39ser2c	148	44	)	)	-RRB-
cord-302115-r39ser2c	149	1	Accessible	accessible	JJ
cord-302115-r39ser2c	149	2	surface	surface	NN
cord-302115-r39ser2c	149	3	glycopeptide	glycopeptide	NN
cord-302115-r39ser2c	149	4	motifs	motif	NNS
cord-302115-r39ser2c	149	5	on	on	IN
cord-302115-r39ser2c	149	6	Spike	Spike	NNP
cord-302115-r39ser2c	149	7	glycoprotein	glycoprotein	NN
cord-302115-r39ser2c	149	8	of	of	IN
cord-302115-r39ser2c	149	9	2019-nCoV	2019-ncov	CD
cord-302115-r39ser2c	149	10	:	:	:
cord-302115-r39ser2c	150	1	implications	implication	NNS
cord-302115-r39ser2c	150	2	on	on	IN
cord-302115-r39ser2c	150	3	vaccination	vaccination	NN
cord-302115-r39ser2c	150	4	and	and	CC
cord-302115-r39ser2c	150	5	antibody	antibody	NN
cord-302115-r39ser2c	150	6	therapeutics	therapeutic	NNS
cord-302115-r39ser2c	150	7	.	.	.
cord-302115-r39ser2c	151	1	Preprints	preprint	NNS
cord-302115-r39ser2c	151	2	.	.	.
cord-302115-r39ser2c	152	1	2020	2020	CD
cord-302115-r39ser2c	153	1	Profiling	profile	VBG
cord-302115-r39ser2c	153	2	Early	early	JJ
cord-302115-r39ser2c	153	3	Humoral	Humoral	NNP
cord-302115-r39ser2c	153	4	Response	response	NN
cord-302115-r39ser2c	153	5	to	to	TO
cord-302115-r39ser2c	153	6	Diagnose	diagnose	VB
cord-302115-r39ser2c	153	7	Novel	Novel	NNP
cord-302115-r39ser2c	153	8	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	153	9	Disease	Disease	NNP
cord-302115-r39ser2c	153	10	(	(	-LRB-
cord-302115-r39ser2c	153	11	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	153	12	)	)	-RRB-
cord-302115-r39ser2c	154	1	The	the	DT
cord-302115-r39ser2c	154	2	effectiveness	effectiveness	NN
cord-302115-r39ser2c	154	3	of	of	IN
cord-302115-r39ser2c	154	4	convalescent	convalescent	JJ
cord-302115-r39ser2c	154	5	plasma	plasma	NN
cord-302115-r39ser2c	154	6	and	and	CC
cord-302115-r39ser2c	154	7	hyperimmune	hyperimmune	NNP
cord-302115-r39ser2c	154	8	immunoglobulin	immunoglobulin	NN
cord-302115-r39ser2c	154	9	for	for	IN
cord-302115-r39ser2c	154	10	the	the	DT
cord-302115-r39ser2c	154	11	treatment	treatment	NN
cord-302115-r39ser2c	154	12	of	of	IN
cord-302115-r39ser2c	154	13	severe	severe	JJ
cord-302115-r39ser2c	154	14	acute	acute	JJ
cord-302115-r39ser2c	154	15	respiratory	respiratory	JJ
cord-302115-r39ser2c	154	16	infections	infection	NNS
cord-302115-r39ser2c	154	17	of	of	IN
cord-302115-r39ser2c	154	18	viral	viral	JJ
cord-302115-r39ser2c	154	19	etiology	etiology	NN
cord-302115-r39ser2c	154	20	:	:	:
cord-302115-r39ser2c	154	21	a	a	DT
cord-302115-r39ser2c	154	22	systematic	systematic	JJ
cord-302115-r39ser2c	154	23	review	review	NN
cord-302115-r39ser2c	154	24	and	and	CC
cord-302115-r39ser2c	154	25	exploratory	exploratory	JJ
cord-302115-r39ser2c	154	26	metaanalysis	metaanalysis	NN
cord-302115-r39ser2c	154	27	38	38	CD
cord-302115-r39ser2c	154	28	-Casadevall	-Casadevall	.
cord-302115-r39ser2c	155	1	A	a	LS
cord-302115-r39ser2c	155	2	,	,	,
cord-302115-r39ser2c	155	3	Pirofski	Pirofski	NNP
cord-302115-r39ser2c	155	4	L.	L.	NNP
cord-302115-r39ser2c	156	1	The	the	DT
cord-302115-r39ser2c	156	2	convalescent	convalescent	JJ
cord-302115-r39ser2c	156	3	sera	sera	NN
cord-302115-r39ser2c	156	4	option	option	NN
cord-302115-r39ser2c	156	5	for	for	IN
cord-302115-r39ser2c	156	6	containing	contain	VBG
cord-302115-r39ser2c	156	7	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	156	8	Identify	identify	VB
cord-302115-r39ser2c	156	9	-	-	HYPH
cord-302115-r39ser2c	156	10	Isolate	isolate	VB
cord-302115-r39ser2c	156	11	-	-	HYPH
cord-302115-r39ser2c	156	12	Inform	inform	NN
cord-302115-r39ser2c	156	13	:	:	:
cord-302115-r39ser2c	156	14	a	a	DT
cord-302115-r39ser2c	156	15	modified	modify	VBN
cord-302115-r39ser2c	156	16	tool	tool	NN
cord-302115-r39ser2c	156	17	for	for	IN
cord-302115-r39ser2c	156	18	initial	initial	JJ
cord-302115-r39ser2c	156	19	detection	detection	NN
cord-302115-r39ser2c	156	20	and	and	CC
cord-302115-r39ser2c	156	21	management	management	NN
cord-302115-r39ser2c	156	22	of	of	IN
cord-302115-r39ser2c	156	23	Middle	Middle	NNP
cord-302115-r39ser2c	156	24	East	East	NNP
cord-302115-r39ser2c	156	25	Respiratory	Respiratory	NNP
cord-302115-r39ser2c	156	26	Syndrome	Syndrome	NNP
cord-302115-r39ser2c	156	27	patients	patient	NNS
cord-302115-r39ser2c	156	28	in	in	IN
cord-302115-r39ser2c	156	29	the	the	DT
cord-302115-r39ser2c	156	30	emergency	emergency	NN
cord-302115-r39ser2c	156	31	department	department	NN
cord-302115-r39ser2c	156	32	Effectiveness	Effectiveness	NNP
cord-302115-r39ser2c	156	33	of	of	IN
cord-302115-r39ser2c	156	34	convalescent	convalescent	JJ
cord-302115-r39ser2c	156	35	plasma	plasma	NN
cord-302115-r39ser2c	156	36	therapy	therapy	NN
cord-302115-r39ser2c	156	37	in	in	IN
cord-302115-r39ser2c	156	38	severe	severe	JJ
cord-302115-r39ser2c	156	39	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	156	40	patients	patient	NNS
cord-302115-r39ser2c	156	41	Treatment	Treatment	NNP
cord-302115-r39ser2c	156	42	of	of	IN
cord-302115-r39ser2c	156	43	5	5	CD
cord-302115-r39ser2c	157	1	Critically	critically	RB
cord-302115-r39ser2c	157	2	Ill	Ill	NNP
cord-302115-r39ser2c	157	3	Patients	Patients	NNPS
cord-302115-r39ser2c	157	4	With	with	IN
cord-302115-r39ser2c	157	5	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	158	1	With	with	IN
cord-302115-r39ser2c	158	2	Convalescent	Convalescent	NNP
cord-302115-r39ser2c	158	3	Plasma	Plasma	NNP
cord-302115-r39ser2c	159	1	Beyond	beyond	IN
cord-302115-r39ser2c	159	2	the	the	DT
cord-302115-r39ser2c	159	3	assistance	assistance	NN
cord-302115-r39ser2c	159	4	:	:	:
cord-302115-r39ser2c	159	5	additional	additional	JJ
cord-302115-r39ser2c	159	6	exposure	exposure	NN
cord-302115-r39ser2c	159	7	situations	situation	NNS
cord-302115-r39ser2c	159	8	to	to	TO
cord-302115-r39ser2c	159	9	COVID-19	covid-19	VB
cord-302115-r39ser2c	159	10	for	for	IN
cord-302115-r39ser2c	159	11	healthcare	healthcare	NN
cord-302115-r39ser2c	159	12	workers	worker	NNS
cord-302115-r39ser2c	159	13	Li	Li	NNP
cord-302115-r39ser2c	159	14	Wenliang	Wenliang	NNP
cord-302115-r39ser2c	159	15	,	,	,
cord-302115-r39ser2c	159	16	a	a	DT
cord-302115-r39ser2c	159	17	face	face	NN
cord-302115-r39ser2c	159	18	to	to	IN
cord-302115-r39ser2c	159	19	the	the	DT
cord-302115-r39ser2c	159	20	frontline	frontline	JJ
cord-302115-r39ser2c	159	21	healthcare	healthcare	NN
cord-302115-r39ser2c	159	22	worker	worker	NN
cord-302115-r39ser2c	159	23	.	.	.
cord-302115-r39ser2c	160	1	The	the	DT
cord-302115-r39ser2c	160	2	first	first	JJ
cord-302115-r39ser2c	160	3	doctor	doctor	NN
cord-302115-r39ser2c	160	4	to	to	TO
cord-302115-r39ser2c	160	5	notify	notify	VB
cord-302115-r39ser2c	160	6	the	the	DT
cord-302115-r39ser2c	160	7	emergence	emergence	NN
cord-302115-r39ser2c	160	8	of	of	IN
cord-302115-r39ser2c	160	9	the	the	DT
cord-302115-r39ser2c	160	10	SARS	SARS	NNP
cord-302115-r39ser2c	160	11	-	-	HYPH
cord-302115-r39ser2c	160	12	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	160	13	,	,	,
cord-302115-r39ser2c	160	14	(	(	-LRB-
cord-302115-r39ser2c	160	15	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	160	16	)	)	-RRB-
cord-302115-r39ser2c	160	17	,	,	,
cord-302115-r39ser2c	160	18	outbreak	outbreak	NN
cord-302115-r39ser2c	160	19	Viral	viral	JJ
cord-302115-r39ser2c	160	20	loads	load	NNS
cord-302115-r39ser2c	160	21	in	in	IN
cord-302115-r39ser2c	160	22	clinical	clinical	JJ
cord-302115-r39ser2c	160	23	specimens	specimen	NNS
cord-302115-r39ser2c	160	24	and	and	CC
cord-302115-r39ser2c	160	25	SARS	SARS	NNP
cord-302115-r39ser2c	160	26	manifestations	manifestation	NNS
cord-302115-r39ser2c	161	1	Influenza	Influenza	NNP
cord-302115-r39ser2c	161	2	Infectious	Infectious	NNP
cord-302115-r39ser2c	161	3	Dose	Dose	NNP
cord-302115-r39ser2c	161	4	May	May	NNP
cord-302115-r39ser2c	161	5	Explain	explain	VB
cord-302115-r39ser2c	161	6	the	the	DT
cord-302115-r39ser2c	161	7	High	High	NNP
cord-302115-r39ser2c	161	8	Mortality	Mortality	NNP
cord-302115-r39ser2c	161	9	of	of	IN
cord-302115-r39ser2c	161	10	the	the	DT
cord-302115-r39ser2c	161	11	Second	second	JJ
cord-302115-r39ser2c	161	12	and	and	CC
cord-302115-r39ser2c	161	13	Third	Third	NNP
cord-302115-r39ser2c	161	14	Wave	Wave	NNP
cord-302115-r39ser2c	161	15	of	of	IN
cord-302115-r39ser2c	161	16	1918	1918	CD
cord-302115-r39ser2c	161	17	-	-	SYM
cord-302115-r39ser2c	161	18	1919	1919	CD
cord-302115-r39ser2c	161	19	Influenza	Influenza	NNP
cord-302115-r39ser2c	161	20	Pandemic	Pandemic	NNP
cord-302115-r39ser2c	161	21	Summary	Summary	NNP
cord-302115-r39ser2c	161	22	of	of	IN
cord-302115-r39ser2c	161	23	a	a	DT
cord-302115-r39ser2c	161	24	Report	Report	NNP
cord-302115-r39ser2c	161	25	of	of	IN
cord-302115-r39ser2c	161	26	72	72	CD
cord-302115-r39ser2c	161	27	314	314	CD
cord-302115-r39ser2c	161	28	Cases	case	NNS
cord-302115-r39ser2c	161	29	From	from	IN
cord-302115-r39ser2c	161	30	the	the	DT
cord-302115-r39ser2c	161	31	Chinese	Chinese	NNP
cord-302115-r39ser2c	161	32	Center	Center	NNP
cord-302115-r39ser2c	161	33	for	for	IN
cord-302115-r39ser2c	161	34	Disease	Disease	NNP
cord-302115-r39ser2c	161	35	Control	Control	NNP
cord-302115-r39ser2c	161	36	and	and	CC
cord-302115-r39ser2c	161	37	Prevention	Prevention	NNP
cord-302115-r39ser2c	161	38	Epidemiological	epidemiological	JJ
cord-302115-r39ser2c	161	39	characteristics	characteristic	NNS
cord-302115-r39ser2c	161	40	of	of	IN
cord-302115-r39ser2c	161	41	2143	2143	CD
cord-302115-r39ser2c	161	42	pediatric	pediatric	JJ
cord-302115-r39ser2c	161	43	patients	patient	NNS
cord-302115-r39ser2c	161	44	with	with	IN
cord-302115-r39ser2c	161	45	2019	2019	CD
cord-302115-r39ser2c	161	46	coronavirus	coronavirus	NN
cord-302115-r39ser2c	161	47	disease	disease	NN
cord-302115-r39ser2c	161	48	in	in	IN
cord-302115-r39ser2c	161	49	China	China	NNP
cord-302115-r39ser2c	161	50	Disparities	Disparities	NNPS
cord-302115-r39ser2c	161	51	in	in	IN
cord-302115-r39ser2c	161	52	Age	Age	NNP
cord-302115-r39ser2c	161	53	-	-	HYPH
cord-302115-r39ser2c	161	54	Specific	Specific	NNP
cord-302115-r39ser2c	161	55	Morbidity	Morbidity	NNP
cord-302115-r39ser2c	161	56	and	and	CC
cord-302115-r39ser2c	161	57	Mortality	mortality	NN
cord-302115-r39ser2c	161	58	from	from	IN
cord-302115-r39ser2c	161	59	SARS	SARS	NNP
cord-302115-r39ser2c	161	60	-	-	HYPH
cord-302115-r39ser2c	161	61	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	161	62	in	in	IN
cord-302115-r39ser2c	161	63	China	China	NNP
cord-302115-r39ser2c	161	64	and	and	CC
cord-302115-r39ser2c	161	65	the	the	DT
cord-302115-r39ser2c	161	66	Republic	Republic	NNP
cord-302115-r39ser2c	161	67	of	of	IN
cord-302115-r39ser2c	161	68	Korea	Korea	NNP
cord-302115-r39ser2c	161	69	Baseline	Baseline	NNP
cord-302115-r39ser2c	161	70	Characteristics	Characteristics	NNP
cord-302115-r39ser2c	161	71	and	and	CC
cord-302115-r39ser2c	161	72	Outcomes	Outcomes	NNPS
cord-302115-r39ser2c	161	73	of	of	IN
cord-302115-r39ser2c	161	74	1591	1591	CD
cord-302115-r39ser2c	161	75	Patients	patient	NNS
cord-302115-r39ser2c	161	76	Infected	infect	VBN
cord-302115-r39ser2c	161	77	.	.	.
cord-302115-r39ser2c	162	1	With	with	IN
cord-302115-r39ser2c	162	2	SARS	SARS	NNP
cord-302115-r39ser2c	162	3	-	-	HYPH
cord-302115-r39ser2c	162	4	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	162	5	Admitted	admit	VBD
cord-302115-r39ser2c	162	6	to	to	IN
cord-302115-r39ser2c	162	7	ICUs	ICUs	NNP
cord-302115-r39ser2c	162	8	of	of	IN
cord-302115-r39ser2c	162	9	the	the	DT
cord-302115-r39ser2c	162	10	Lombardy	Lombardy	NNP
cord-302115-r39ser2c	162	11	Region	Region	NNP
cord-302115-r39ser2c	162	12	Accepted	Accepted	NNP
cord-302115-r39ser2c	162	13	Article	Article	NNP
cord-302115-r39ser2c	162	14	and	and	CC
cord-302115-r39ser2c	162	15	the	the	DT
cord-302115-r39ser2c	162	16	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	162	17	Susceptibility	Susceptibility	NNP
cord-302115-r39ser2c	162	18	.	.	.
cord-302115-r39ser2c	163	1	medRxiv	medRxiv	NNP
cord-302115-r39ser2c	163	2	PREPRINT	PREPRINT	NNP
cord-302115-r39ser2c	164	1	The	the	DT
cord-302115-r39ser2c	164	2	compelling	compelling	JJ
cord-302115-r39ser2c	164	3	link	link	NN
cord-302115-r39ser2c	164	4	between	between	IN
cord-302115-r39ser2c	164	5	physical	physical	JJ
cord-302115-r39ser2c	164	6	activity	activity	NN
cord-302115-r39ser2c	164	7	and	and	CC
cord-302115-r39ser2c	164	8	the	the	DT
cord-302115-r39ser2c	164	9	body	body	NN
cord-302115-r39ser2c	164	10	's	's	POS
cord-302115-r39ser2c	164	11	defense	defense	NN
cord-302115-r39ser2c	164	12	system	system	NN
cord-302115-r39ser2c	165	1	Arabatzis	Arabatzis	NNP
cord-302115-r39ser2c	165	2	K.	K.	NNP
cord-302115-r39ser2c	166	1	-Infectious	-infectious	JJ
cord-302115-r39ser2c	166	2	episodes	episode	NNS
cord-302115-r39ser2c	166	3	in	in	IN
cord-302115-r39ser2c	166	4	runners	runner	NNS
cord-302115-r39ser2c	166	5	before	before	IN
cord-302115-r39ser2c	166	6	and	and	CC
cord-302115-r39ser2c	166	7	after	after	IN
cord-302115-r39ser2c	166	8	the	the	DT
cord-302115-r39ser2c	166	9	Los	Los	NNP
cord-302115-r39ser2c	166	10	Angeles	Angeles	NNP
cord-302115-r39ser2c	166	11	Marathon	Marathon	NNP
cord-302115-r39ser2c	166	12	A	a	DT
cord-302115-r39ser2c	166	13	familial	familial	JJ
cord-302115-r39ser2c	166	14	cluster	cluster	NN
cord-302115-r39ser2c	166	15	of	of	IN
cord-302115-r39ser2c	166	16	pneumonia	pneumonia	NN
cord-302115-r39ser2c	166	17	associated	associate	VBN
cord-302115-r39ser2c	166	18	with	with	IN
cord-302115-r39ser2c	166	19	the	the	DT
cord-302115-r39ser2c	166	20	2019	2019	CD
cord-302115-r39ser2c	166	21	novel	novel	NN
cord-302115-r39ser2c	166	22	coronavirus	coronavirus	NN
cord-302115-r39ser2c	166	23	indicating	indicate	VBG
cord-302115-r39ser2c	166	24	person	person	NN
cord-302115-r39ser2c	166	25	-	-	HYPH
cord-302115-r39ser2c	166	26	to	to	IN
cord-302115-r39ser2c	166	27	-	-	HYPH
cord-302115-r39ser2c	166	28	person	person	NN
cord-302115-r39ser2c	166	29	transmission	transmission	NN
cord-302115-r39ser2c	166	30	:	:	:
cord-302115-r39ser2c	166	31	a	a	DT
cord-302115-r39ser2c	166	32	study	study	NN
cord-302115-r39ser2c	166	33	of	of	IN
cord-302115-r39ser2c	166	34	a	a	DT
cord-302115-r39ser2c	166	35	family	family	NN
cord-302115-r39ser2c	166	36	cluster	cluster	NN
cord-302115-r39ser2c	166	37	Common	common	JJ
cord-302115-r39ser2c	166	38	sports	sport	NNS
cord-302115-r39ser2c	166	39	-	-	HYPH
cord-302115-r39ser2c	166	40	related	relate	VBN
cord-302115-r39ser2c	166	41	infections	infection	NNS
cord-302115-r39ser2c	166	42	:	:	:
cord-302115-r39ser2c	166	43	a	a	DT
cord-302115-r39ser2c	166	44	review	review	NN
cord-302115-r39ser2c	166	45	on	on	IN
cord-302115-r39ser2c	166	46	clinical	clinical	JJ
cord-302115-r39ser2c	166	47	pictures	picture	NNS
cord-302115-r39ser2c	166	48	,	,	,
cord-302115-r39ser2c	166	49	management	management	NN
cord-302115-r39ser2c	166	50	and	and	CC
cord-302115-r39ser2c	166	51	time	time	NN
cord-302115-r39ser2c	166	52	to	to	TO
cord-302115-r39ser2c	166	53	return	return	VB
cord-302115-r39ser2c	166	54	to	to	IN
cord-302115-r39ser2c	166	55	sports	sport	NNS
cord-302115-r39ser2c	166	56	70	70	CD
cord-302115-r39ser2c	166	57	-Nehlsen	-Nehlsen	NNP
cord-302115-r39ser2c	166	58	-	-	HYPH
cord-302115-r39ser2c	166	59	Cannarella	Cannarella	NNP
cord-302115-r39ser2c	166	60	SL	SL	NNP
cord-302115-r39ser2c	166	61	,	,	,
cord-302115-r39ser2c	166	62	Nieman	Nieman	NNP
cord-302115-r39ser2c	166	63	DC	DC	NNP
cord-302115-r39ser2c	166	64	,	,	,
cord-302115-r39ser2c	166	65	Fagoaga	Fagoaga	NNP
cord-302115-r39ser2c	166	66	OR	OR	NNP
cord-302115-r39ser2c	166	67	,	,	,
cord-302115-r39ser2c	166	68	et	et	NNP
cord-302115-r39ser2c	166	69	al	al	NNP
cord-302115-r39ser2c	166	70	.	.	.
cord-302115-r39ser2c	167	1	Saliva	saliva	NN
cord-302115-r39ser2c	167	2	immunoglobulins	immunoglobulin	NNS
cord-302115-r39ser2c	167	3	in	in	IN
cord-302115-r39ser2c	167	4	elite	elite	JJ
cord-302115-r39ser2c	167	5	women	woman	NNS
cord-302115-r39ser2c	167	6	rowers	rower	NNS
cord-302115-r39ser2c	167	7	Exercise	Exercise	NNP
cord-302115-r39ser2c	167	8	,	,	,
cord-302115-r39ser2c	167	9	immunology	immunology	NN
cord-302115-r39ser2c	167	10	and	and	CC
cord-302115-r39ser2c	167	11	upper	upper	JJ
cord-302115-r39ser2c	167	12	respiratory	respiratory	JJ
cord-302115-r39ser2c	167	13	tract	tract	NN
cord-302115-r39ser2c	167	14	infections	infection	NNS
cord-302115-r39ser2c	168	1	All	all	DT
cord-302115-r39ser2c	168	2	rights	right	NNS
cord-302115-r39ser2c	168	3	reserved	reserve	VBD
cord-302115-r39ser2c	168	4	72	72	CD
cord-302115-r39ser2c	169	1	-Bouhuys	-bouhuy	VBZ
cord-302115-r39ser2c	169	2	A.	A.	NNP
cord-302115-r39ser2c	170	1	The	the	DT
cord-302115-r39ser2c	170	2	physiology	physiology	NN
cord-302115-r39ser2c	170	3	of	of	IN
cord-302115-r39ser2c	170	4	Breathing	breathing	NN
cord-302115-r39ser2c	170	5	.	.	.
cord-302115-r39ser2c	171	1	Grune	Grune	NNP
cord-302115-r39ser2c	171	2	&	&	CC
cord-302115-r39ser2c	171	3	Stratton	Stratton	NNP
cord-302115-r39ser2c	171	4	.	.	NNP
cord-302115-r39ser2c	171	5	1977	1977	CD
cord-302115-r39ser2c	171	6	.	.	.
cord-302115-r39ser2c	172	1	New	New	NNP
cord-302115-r39ser2c	172	2	York.p.60	York.p.60	NNP
cord-302115-r39ser2c	172	3	-	-	HYPH
cord-302115-r39ser2c	172	4	98	98	CD
cord-302115-r39ser2c	172	5	73	73	CD
cord-302115-r39ser2c	173	1	-Raymond	-Raymond	:
cord-302115-r39ser2c	173	2	Tellier	Tellier	NNP
cord-302115-r39ser2c	173	3	-Review	-Review	:
cord-302115-r39ser2c	173	4	of	of	IN
cord-302115-r39ser2c	173	5	Aerosol	Aerosol	NNP
cord-302115-r39ser2c	173	6	Transmission	Transmission	NNP
cord-302115-r39ser2c	173	7	of	of	IN
cord-302115-r39ser2c	173	8	Influenza	Influenza	NNP
cord-302115-r39ser2c	173	9	A	A	NNP
cord-302115-r39ser2c	173	10	Virus	virus	NN
cord-302115-r39ser2c	173	11	74	74	CD
cord-302115-r39ser2c	174	1	-Nieman	-Nieman	NNP
cord-302115-r39ser2c	174	2	DC	DC	NNP
cord-302115-r39ser2c	174	3	.	.	.
cord-302115-r39ser2c	175	1	Exercise	exercise	NN
cord-302115-r39ser2c	175	2	,	,	,
cord-302115-r39ser2c	175	3	upper	upper	JJ
cord-302115-r39ser2c	175	4	respiratory	respiratory	JJ
cord-302115-r39ser2c	175	5	tract	tract	NN
cord-302115-r39ser2c	175	6	infection	infection	NN
cord-302115-r39ser2c	175	7	,	,	,
cord-302115-r39ser2c	175	8	and	and	CC
cord-302115-r39ser2c	175	9	the	the	DT
cord-302115-r39ser2c	175	10	immune	immune	JJ
cord-302115-r39ser2c	175	11	system	system	NN
cord-302115-r39ser2c	175	12	Favorable	favorable	JJ
cord-302115-r39ser2c	175	13	outcome	outcome	NN
cord-302115-r39ser2c	175	14	of	of	IN
cord-302115-r39ser2c	175	15	COVID19	COVID19	NNP
cord-302115-r39ser2c	175	16	in	in	IN
cord-302115-r39ser2c	175	17	two	two	CD
cord-302115-r39ser2c	175	18	patients	patient	NNS
cord-302115-r39ser2c	175	19	with	with	IN
cord-302115-r39ser2c	175	20	X	x	NN
cord-302115-r39ser2c	175	21	-	-	HYPH
cord-302115-r39ser2c	175	22	linked	link	VBN
cord-302115-r39ser2c	175	23	agammaglobulinemia	agammaglobulinemia	NN
cord-302115-r39ser2c	175	24	A	a	DT
cord-302115-r39ser2c	175	25	possible	possible	JJ
cord-302115-r39ser2c	175	26	role	role	NN
cord-302115-r39ser2c	175	27	for	for	IN
cord-302115-r39ser2c	175	28	B	b	NN
cord-302115-r39ser2c	175	29	cells	cell	NNS
cord-302115-r39ser2c	175	30	in	in	IN
cord-302115-r39ser2c	175	31	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	175	32	?	?	.
cord-302115-r39ser2c	175	33	:	:	:
cord-302115-r39ser2c	176	1	Lesson	lesson	NN
cord-302115-r39ser2c	176	2	from	from	IN
cord-302115-r39ser2c	176	3	patients	patient	NNS
cord-302115-r39ser2c	176	4	with	with	IN
cord-302115-r39ser2c	176	5	Agammaglobulinemia	Agammaglobulinemia	NNP
cord-302115-r39ser2c	176	6	Defense	Defense	NNP
cord-302115-r39ser2c	176	7	mechanisms	mechanism	NNS
cord-302115-r39ser2c	176	8	against	against	IN
cord-302115-r39ser2c	176	9	influenza	influenza	NN
cord-302115-r39ser2c	176	10	virus	virus	NN
cord-302115-r39ser2c	176	11	infection	infection	NN
cord-302115-r39ser2c	176	12	in	in	IN
cord-302115-r39ser2c	176	13	the	the	DT
cord-302115-r39ser2c	176	14	respiratory	respiratory	JJ
cord-302115-r39ser2c	176	15	tract	tract	NN
cord-302115-r39ser2c	176	16	mucosa	mucosa	NN
cord-302115-r39ser2c	176	17	Invariance	invariance	NN
cord-302115-r39ser2c	176	18	and	and	CC
cord-302115-r39ser2c	176	19	restriction	restriction	NN
cord-302115-r39ser2c	176	20	toward	toward	IN
cord-302115-r39ser2c	176	21	a	a	DT
cord-302115-r39ser2c	176	22	limited	limited	JJ
cord-302115-r39ser2c	176	23	set	set	NN
cord-302115-r39ser2c	176	24	of	of	IN
cord-302115-r39ser2c	176	25	self	self	NN
cord-302115-r39ser2c	176	26	-	-	HYPH
cord-302115-r39ser2c	176	27	antigens	antigen	NNS
cord-302115-r39ser2c	176	28	characterize	characterize	VBP
cord-302115-r39ser2c	176	29	neonatal	neonatal	JJ
cord-302115-r39ser2c	176	30	IgM	IgM	NNP
cord-302115-r39ser2c	176	31	antibody	antibody	NN
cord-302115-r39ser2c	176	32	repertoires	repertoire	NNS
cord-302115-r39ser2c	176	33	and	and	CC
cord-302115-r39ser2c	176	34	prevail	prevail	VBP
cord-302115-r39ser2c	176	35	in	in	IN
cord-302115-r39ser2c	176	36	autoreactive	autoreactive	JJ
cord-302115-r39ser2c	176	37	repertoires	repertoire	NNS
cord-302115-r39ser2c	176	38	of	of	IN
cord-302115-r39ser2c	176	39	healthy	healthy	JJ
cord-302115-r39ser2c	176	40	adults	adult	NNS
cord-302115-r39ser2c	177	1	Natural	natural	JJ
cord-302115-r39ser2c	177	2	autoantibodies	autoantibody	NNS
cord-302115-r39ser2c	177	3	Accepted	accept	VBD
cord-302115-r39ser2c	177	4	Article	Article	NNP
cord-302115-r39ser2c	178	1	This	this	DT
cord-302115-r39ser2c	178	2	article	article	NN
cord-302115-r39ser2c	178	3	is	be	VBZ
cord-302115-r39ser2c	178	4	protected	protect	VBN
cord-302115-r39ser2c	178	5	by	by	IN
cord-302115-r39ser2c	178	6	copyright	copyright	NN
cord-302115-r39ser2c	178	7	.	.	.
cord-302115-r39ser2c	179	1	All	all	DT
cord-302115-r39ser2c	179	2	rights	right	NNS
cord-302115-r39ser2c	179	3	reserved	reserve	VBD
cord-302115-r39ser2c	179	4	83	83	CD
cord-302115-r39ser2c	180	1	-Panda	-Panda	NNP
cord-302115-r39ser2c	180	2	S	S	NNP
cord-302115-r39ser2c	180	3	,	,	,
cord-302115-r39ser2c	180	4	Ding	Ding	NNP
cord-302115-r39ser2c	180	5	JL	JL	NNP
cord-302115-r39ser2c	180	6	.	.	.
cord-302115-r39ser2c	181	1	Natural	natural	JJ
cord-302115-r39ser2c	181	2	antibodies	antibody	NNS
cord-302115-r39ser2c	181	3	bridge	bridge	VBP
cord-302115-r39ser2c	181	4	innate	innate	JJ
cord-302115-r39ser2c	181	5	and	and	CC
cord-302115-r39ser2c	181	6	adaptive	adaptive	JJ
cord-302115-r39ser2c	181	7	immunity	immunity	NN
cord-302115-r39ser2c	182	1	A	a	DT
cord-302115-r39ser2c	182	2	study	study	NN
cord-302115-r39ser2c	182	3	of	of	IN
cord-302115-r39ser2c	182	4	serum	serum	NN
cord-302115-r39ser2c	182	5	immunoglobulin	immunoglobulin	NN
cord-302115-r39ser2c	182	6	levels	level	NNS
cord-302115-r39ser2c	182	7	in	in	IN
cord-302115-r39ser2c	182	8	elderly	elderly	JJ
cord-302115-r39ser2c	182	9	persons	person	NNS
cord-302115-r39ser2c	182	10	that	that	WDT
cord-302115-r39ser2c	182	11	provides	provide	VBZ
cord-302115-r39ser2c	182	12	new	new	JJ
cord-302115-r39ser2c	182	13	insights	insight	NNS
cord-302115-r39ser2c	182	14	into	into	IN
cord-302115-r39ser2c	182	15	B	b	NN
cord-302115-r39ser2c	182	16	cell	cell	NN
cord-302115-r39ser2c	182	17	immunosenescence	immunosenescence	IN
cord-302115-r39ser2c	182	18	Influence	influence	NN
cord-302115-r39ser2c	182	19	of	of	IN
cord-302115-r39ser2c	182	20	sex	sex	NN
cord-302115-r39ser2c	182	21	and	and	CC
cord-302115-r39ser2c	182	22	age	age	NN
cord-302115-r39ser2c	182	23	on	on	IN
cord-302115-r39ser2c	182	24	serum	serum	NN
cord-302115-r39ser2c	182	25	immunoglobulin	immunoglobulin	NN
cord-302115-r39ser2c	182	26	concentrations	concentration	NNS
cord-302115-r39ser2c	182	27	in	in	IN
cord-302115-r39ser2c	182	28	healthy	healthy	JJ
cord-302115-r39ser2c	182	29	subjects	subject	NNS
cord-302115-r39ser2c	182	30	89	89	CD
cord-302115-r39ser2c	183	1	-Cooling	-coole	VBG
cord-302115-r39ser2c	183	2	L.	L.	NNP
cord-302115-r39ser2c	183	3	Blood	Blood	NNP
cord-302115-r39ser2c	183	4	Groups	Groups	NNPS
cord-302115-r39ser2c	183	5	in	in	IN
cord-302115-r39ser2c	183	6	Infection	Infection	NNP
cord-302115-r39ser2c	183	7	and	and	CC
cord-302115-r39ser2c	183	8	Host	Host	NNP
cord-302115-r39ser2c	183	9	Susceptibility	Susceptibility	NNP
cord-302115-r39ser2c	183	10	ABO	ABO	NNP
cord-302115-r39ser2c	183	11	Blood	Blood	NNP
cord-302115-r39ser2c	183	12	Group	Group	NNP
cord-302115-r39ser2c	183	13	and	and	CC
cord-302115-r39ser2c	183	14	Susceptibility	Susceptibility	NNP
cord-302115-r39ser2c	183	15	to	to	IN
cord-302115-r39ser2c	183	16	Severe	severe	JJ
cord-302115-r39ser2c	183	17	Acute	acute	JJ
cord-302115-r39ser2c	183	18	Respiratory	Respiratory	NNP
cord-302115-r39ser2c	183	19	Syndrome	Syndrome	NNP
cord-302115-r39ser2c	183	20	Inhibition	Inhibition	NNP
cord-302115-r39ser2c	183	21	of	of	IN
cord-302115-r39ser2c	183	22	the	the	DT
cord-302115-r39ser2c	183	23	interaction	interaction	NN
cord-302115-r39ser2c	183	24	between	between	IN
cord-302115-r39ser2c	183	25	the	the	DT
cord-302115-r39ser2c	183	26	SARS	SARS	NNP
cord-302115-r39ser2c	183	27	-	-	HYPH
cord-302115-r39ser2c	183	28	CoV	CoV	NNP
cord-302115-r39ser2c	183	29	spike	spike	NN
cord-302115-r39ser2c	183	30	protein	protein	NN
cord-302115-r39ser2c	183	31	and	and	CC
cord-302115-r39ser2c	183	32	its	-PRON-	PRP$
cord-302115-r39ser2c	183	33	cellular	cellular	JJ
cord-302115-r39ser2c	183	34	receptor	receptor	NN
cord-302115-r39ser2c	183	35	by	by	IN
cord-302115-r39ser2c	183	36	anti	anti	JJ
cord-302115-r39ser2c	183	37	-	-	JJ
cord-302115-r39ser2c	183	38	histoblood	histoblood	JJ
cord-302115-r39ser2c	183	39	group	group	NN
cord-302115-r39ser2c	183	40	antibodies	antibody	NNS
cord-302115-r39ser2c	183	41	Human	Human	NNP
cord-302115-r39ser2c	183	42	serum	serum	NN
cord-302115-r39ser2c	183	43	mannose	mannose	NN
cord-302115-r39ser2c	183	44	binding	bind	VBG
cord-302115-r39ser2c	183	45	protein	protein	NN
cord-302115-r39ser2c	183	46	(	(	-LRB-
cord-302115-r39ser2c	183	47	MBP	MBP	NNP
cord-302115-r39ser2c	183	48	)	)	-RRB-
cord-302115-r39ser2c	184	1	:	:	:
cord-302115-r39ser2c	184	2	development	development	NN
cord-302115-r39ser2c	184	3	of	of	IN
cord-302115-r39ser2c	184	4	an	an	DT
cord-302115-r39ser2c	184	5	enzyme	enzyme	NN
cord-302115-r39ser2c	184	6	-	-	HYPH
cord-302115-r39ser2c	184	7	linked	link	VBN
cord-302115-r39ser2c	184	8	immunosorbent	immunosorbent	JJ
cord-302115-r39ser2c	184	9	assay	assay	NN
cord-302115-r39ser2c	184	10	(	(	-LRB-
cord-302115-r39ser2c	184	11	ELISA	ELISA	NNP
cord-302115-r39ser2c	184	12	)	)	-RRB-
cord-302115-r39ser2c	184	13	and	and	CC
cord-302115-r39ser2c	184	14	determination	determination	NN
cord-302115-r39ser2c	184	15	of	of	IN
cord-302115-r39ser2c	184	16	levels	level	NNS
cord-302115-r39ser2c	184	17	in	in	IN
cord-302115-r39ser2c	184	18	serum	serum	NN
cord-302115-r39ser2c	184	19	from	from	IN
cord-302115-r39ser2c	184	20	1085	1085	CD
cord-302115-r39ser2c	184	21	normal	normal	JJ
cord-302115-r39ser2c	184	22	Japanese	Japanese	NNPS
cord-302115-r39ser2c	184	23	and	and	CC
cord-302115-r39ser2c	184	24	in	in	IN
cord-302115-r39ser2c	184	25	some	some	DT
cord-302115-r39ser2c	184	26	body	body	NN
cord-302115-r39ser2c	184	27	fluids	fluid	VBZ
cord-302115-r39ser2c	184	28	96	96	CD
cord-302115-r39ser2c	185	1	-Terai	-Terai	.
cord-302115-r39ser2c	186	1	I	-PRON-	PRP
cord-302115-r39ser2c	186	2	,	,	,
cord-302115-r39ser2c	186	3	Kobayashi	Kobayashi	NNP
cord-302115-r39ser2c	186	4	K.	K.	NNP
cord-302115-r39ser2c	186	5	Perinatal	Perinatal	NNP
cord-302115-r39ser2c	186	6	changes	change	VBZ
cord-302115-r39ser2c	186	7	in	in	IN
cord-302115-r39ser2c	186	8	serum	serum	NN
cord-302115-r39ser2c	186	9	mannose	mannose	NN
cord-302115-r39ser2c	186	10	-	-	HYPH
cord-302115-r39ser2c	186	11	binding	bind	VBG
cord-302115-r39ser2c	186	12	protein	protein	NN
cord-302115-r39ser2c	186	13	(	(	-LRB-
cord-302115-r39ser2c	186	14	MBP)levels	mbp)level	NNS
cord-302115-r39ser2c	187	1	Childhood	childhood	NN
cord-302115-r39ser2c	187	2	levels	level	NNS
cord-302115-r39ser2c	187	3	of	of	IN
cord-302115-r39ser2c	187	4	immunoglobulins	immunoglobulin	NNS
cord-302115-r39ser2c	187	5	and	and	CC
cord-302115-r39ser2c	187	6	mannan	mannan	NN
cord-302115-r39ser2c	187	7	-	-	HYPH
cord-302115-r39ser2c	187	8	binding	bind	VBG
cord-302115-r39ser2c	187	9	lectin	lectin	NN
cord-302115-r39ser2c	187	10	in	in	IN
cord-302115-r39ser2c	187	11	relation	relation	NN
cord-302115-r39ser2c	187	12	to	to	IN
cord-302115-r39ser2c	187	13	infections	infection	NNS
cord-302115-r39ser2c	187	14	and	and	CC
cord-302115-r39ser2c	187	15	allergy	allergy	NN
cord-302115-r39ser2c	187	16	Functional	functional	JJ
cord-302115-r39ser2c	187	17	polymorphisms	polymorphism	NNS
cord-302115-r39ser2c	187	18	of	of	IN
cord-302115-r39ser2c	187	19	the	the	DT
cord-302115-r39ser2c	187	20	CCL2	CCL2	NNP
cord-302115-r39ser2c	187	21	and	and	CC
cord-302115-r39ser2c	187	22	MBL	MBL	NNP
cord-302115-r39ser2c	187	23	genes	gene	NNS
cord-302115-r39ser2c	187	24	cumulatively	cumulatively	RB
cord-302115-r39ser2c	187	25	increase	increase	VBP
cord-302115-r39ser2c	187	26	susceptibility	susceptibility	NN
cord-302115-r39ser2c	187	27	to	to	IN
cord-302115-r39ser2c	187	28	severe	severe	JJ
cord-302115-r39ser2c	187	29	acute	acute	JJ
cord-302115-r39ser2c	187	30	respiratory	respiratory	JJ
cord-302115-r39ser2c	187	31	syndrome	syndrome	NN
cord-302115-r39ser2c	187	32	coronavirus	coronavirus	NN
cord-302115-r39ser2c	187	33	infection	infection	NN
cord-302115-r39ser2c	188	1	A	a	DT
cord-302115-r39ser2c	188	2	Single	single	JJ
cord-302115-r39ser2c	188	3	Asparagine	asparagine	NN
cord-302115-r39ser2c	188	4	-	-	HYPH
cord-302115-r39ser2c	188	5	Linked	link	VBN
cord-302115-r39ser2c	188	6	Glycosylation	Glycosylation	NNP
cord-302115-r39ser2c	188	7	Site	site	NN
cord-302115-r39ser2c	188	8	of	of	IN
cord-302115-r39ser2c	188	9	the	the	DT
cord-302115-r39ser2c	188	10	Severe	severe	JJ
cord-302115-r39ser2c	188	11	Acute	acute	JJ
cord-302115-r39ser2c	188	12	Respiratory	Respiratory	NNP
cord-302115-r39ser2c	188	13	Syndrome	Syndrome	NNP
cord-302115-r39ser2c	188	14	Coronavirus	Coronavirus	NNP
cord-302115-r39ser2c	188	15	Spike	Spike	NNP
cord-302115-r39ser2c	188	16	Glycoprotein	Glycoprotein	NNP
cord-302115-r39ser2c	189	1	Accepted	Accepted	NNP
cord-302115-r39ser2c	189	2	Article	Article	NNP
cord-302115-r39ser2c	190	1	This	this	DT
cord-302115-r39ser2c	190	2	article	article	NN
cord-302115-r39ser2c	190	3	is	be	VBZ
cord-302115-r39ser2c	190	4	protected	protect	VBN
cord-302115-r39ser2c	190	5	by	by	IN
cord-302115-r39ser2c	190	6	copyright	copyright	NN
cord-302115-r39ser2c	190	7	.	.	.
cord-302115-r39ser2c	191	1	All	all	DT
cord-302115-r39ser2c	191	2	rights	right	NNS
cord-302115-r39ser2c	191	3	reserved	reserve	VBN
cord-302115-r39ser2c	191	4	Facilitates	facilitate	VBZ
cord-302115-r39ser2c	191	5	Inhibition	inhibition	NN
cord-302115-r39ser2c	191	6	by	by	IN
cord-302115-r39ser2c	191	7	Mannose	Mannose	NNP
cord-302115-r39ser2c	191	8	-	-	HYPH
cord-302115-r39ser2c	191	9	Binding	bind	VBG
cord-302115-r39ser2c	191	10	Lectin	Lectin	NNP
cord-302115-r39ser2c	191	11	through	through	IN
cord-302115-r39ser2c	191	12	Multiple	Multiple	NNP
cord-302115-r39ser2c	191	13	Mechanisms	Mechanisms	NNPS
cord-302115-r39ser2c	191	14	Highly	highly	RB
cord-302115-r39ser2c	191	15	pathogenic	pathogenic	JJ
cord-302115-r39ser2c	191	16	coronavirus	coronavirus	NN
cord-302115-r39ser2c	191	17	N	n	CD
cord-302115-r39ser2c	191	18	protein	protein	NN
cord-302115-r39ser2c	191	19	aggravates	aggravate	VBZ
cord-302115-r39ser2c	191	20	lung	lung	NN
cord-302115-r39ser2c	191	21	injury	injury	NN
cord-302115-r39ser2c	191	22	by	by	IN
cord-302115-r39ser2c	191	23	MASP-2-mediated	masp-2-mediate	VBN
cord-302115-r39ser2c	191	24	complement	complement	VB
cord-302115-r39ser2c	191	25	over	over	IN
cord-302115-r39ser2c	191	26	-	-	HYPH
cord-302115-r39ser2c	191	27	activation	activation	NN
cord-302115-r39ser2c	191	28	.	.	.
cord-302115-r39ser2c	192	1	medRxiv	medRxiv	NNP
cord-302115-r39ser2c	192	2	preprint	preprint	NN
cord-302115-r39ser2c	192	3	2020	2020	CD
cord-302115-r39ser2c	193	1	How	how	WRB
cord-302115-r39ser2c	193	2	does	do	VBZ
cord-302115-r39ser2c	193	3	COVID-19	covid-19	VB
cord-302115-r39ser2c	193	4	kill	kill	VB
cord-302115-r39ser2c	193	5	?	?	.
cord-302115-r39ser2c	194	1	Uncertainty	uncertainty	NN
cord-302115-r39ser2c	194	2	is	be	VBZ
cord-302115-r39ser2c	194	3	hampering	hamper	VBG
cord-302115-r39ser2c	194	4	doctors	doctor	NNS
cord-302115-r39ser2c	194	5	'	'	POS
cord-302115-r39ser2c	194	6	ability	ability	NN
cord-302115-r39ser2c	194	7	to	to	TO
cord-302115-r39ser2c	194	8	choose	choose	VB
cord-302115-r39ser2c	194	9	treatments	treatment	NNS
cord-302115-r39ser2c	194	10	Comparative	comparative	JJ
cord-302115-r39ser2c	194	11	replication	replication	NN
cord-302115-r39ser2c	194	12	and	and	CC
cord-302115-r39ser2c	194	13	immune	immune	JJ
cord-302115-r39ser2c	194	14	activation	activation	NN
cord-302115-r39ser2c	194	15	profiles	profile	NNS
cord-302115-r39ser2c	194	16	of	of	IN
cord-302115-r39ser2c	194	17	SARS	SARS	NNP
cord-302115-r39ser2c	194	18	-	-	HYPH
cord-302115-r39ser2c	194	19	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	194	20	and	and	CC
cord-302115-r39ser2c	194	21	SARS	SARS	NNP
cord-302115-r39ser2c	194	22	-	-	HYPH
cord-302115-r39ser2c	194	23	CoV	CoV	NNP
cord-302115-r39ser2c	194	24	in	in	IN
cord-302115-r39ser2c	194	25	human	human	JJ
cord-302115-r39ser2c	194	26	lungs	lung	NNS
cord-302115-r39ser2c	194	27	:	:	:
cord-302115-r39ser2c	194	28	an	an	DT
cord-302115-r39ser2c	194	29	ex	ex	FW
cord-302115-r39ser2c	194	30	vivo	vivo	NN
cord-302115-r39ser2c	194	31	study	study	NN
cord-302115-r39ser2c	194	32	with	with	IN
cord-302115-r39ser2c	194	33	implications	implication	NNS
cord-302115-r39ser2c	194	34	for	for	IN
cord-302115-r39ser2c	194	35	the	the	DT
cord-302115-r39ser2c	194	36	pathogenesis	pathogenesis	NN
cord-302115-r39ser2c	194	37	of	of	IN
cord-302115-r39ser2c	194	38	COVID-19	COVID-19	NNP
cord-302115-r39ser2c	194	39	Level	Level	NNP
cord-302115-r39ser2c	194	40	of	of	IN
cord-302115-r39ser2c	194	41	IL-6	IL-6	NNP
cord-302115-r39ser2c	194	42	predicts	predict	VBZ
cord-302115-r39ser2c	194	43	respiratory	respiratory	JJ
cord-302115-r39ser2c	194	44	failure	failure	NN
cord-302115-r39ser2c	194	45	in	in	IN
cord-302115-r39ser2c	194	46	hospitalized	hospitalize	VBN
cord-302115-r39ser2c	194	47	symptomatic	symptomatic	JJ
cord-302115-r39ser2c	194	48	COVID-19	covid-19	CD
cord-302115-r39ser2c	194	49	patients	patient	NNS
cord-302115-r39ser2c	194	50	Off	off	IN
cord-302115-r39ser2c	194	51	-	-	HYPH
cord-302115-r39ser2c	194	52	label	label	NN
cord-302115-r39ser2c	194	53	Use	use	NN
cord-302115-r39ser2c	194	54	of	of	IN
cord-302115-r39ser2c	194	55	Tocilizumab	Tocilizumab	NNP
cord-302115-r39ser2c	194	56	in	in	IN
cord-302115-r39ser2c	194	57	Patients	patient	NNS
cord-302115-r39ser2c	194	58	with	with	IN
cord-302115-r39ser2c	194	59	SARS	SARS	NNP
cord-302115-r39ser2c	194	60	-	-	HYPH
cord-302115-r39ser2c	194	61	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	194	62	Infection	Infection	NNP
cord-302115-r39ser2c	194	63	Pathological	pathological	JJ
cord-302115-r39ser2c	194	64	study	study	NN
cord-302115-r39ser2c	194	65	of	of	IN
cord-302115-r39ser2c	194	66	the	the	DT
cord-302115-r39ser2c	194	67	2019	2019	CD
cord-302115-r39ser2c	194	68	novel	novel	JJ
cord-302115-r39ser2c	194	69	coronavirus	coronavirus	NN
cord-302115-r39ser2c	194	70	disease	disease	NN
cord-302115-r39ser2c	194	71	(	(	-LRB-
cord-302115-r39ser2c	194	72	COVID-19	covid-19	VB
cord-302115-r39ser2c	194	73	)	)	-RRB-
cord-302115-r39ser2c	194	74	through	through	IN
cord-302115-r39ser2c	194	75	postmortem	postmortem	JJ
cord-302115-r39ser2c	194	76	core	core	NN
cord-302115-r39ser2c	194	77	biopsies	biopsy	NNS
cord-302115-r39ser2c	195	1	Abnormal	abnormal	JJ
cord-302115-r39ser2c	195	2	coagulation	coagulation	NN
cord-302115-r39ser2c	195	3	parameters	parameter	NNS
cord-302115-r39ser2c	195	4	are	be	VBP
cord-302115-r39ser2c	195	5	associated	associate	VBN
cord-302115-r39ser2c	195	6	with	with	IN
cord-302115-r39ser2c	195	7	poor	poor	JJ
cord-302115-r39ser2c	195	8	prognosis	prognosis	NN
cord-302115-r39ser2c	195	9	in	in	IN
cord-302115-r39ser2c	195	10	patients	patient	NNS
cord-302115-r39ser2c	195	11	with	with	IN
cord-302115-r39ser2c	195	12	novel	novel	JJ
cord-302115-r39ser2c	195	13	coronavirus	coronavirus	NN
cord-302115-r39ser2c	195	14	pneumonia	pneumonia	NN
cord-302115-r39ser2c	195	15	Accepted	Accepted	NNP
cord-302115-r39ser2c	195	16	Article	Article	NNP
cord-302115-r39ser2c	195	17	thrombomodulin	thrombomodulin	NNP
cord-302115-r39ser2c	195	18	is	be	VBZ
cord-302115-r39ser2c	195	19	associated	associate	VBN
cord-302115-r39ser2c	195	20	with	with	IN
cord-302115-r39ser2c	195	21	organ	organ	NN
cord-302115-r39ser2c	195	22	failure	failure	NN
cord-302115-r39ser2c	195	23	and	and	CC
cord-302115-r39ser2c	195	24	mortality	mortality	NN
cord-302115-r39ser2c	195	25	in	in	IN
cord-302115-r39ser2c	195	26	children	child	NNS
cord-302115-r39ser2c	195	27	with	with	IN
cord-302115-r39ser2c	195	28	acute	acute	JJ
cord-302115-r39ser2c	195	29	respiratory	respiratory	JJ
cord-302115-r39ser2c	195	30	distress	distress	NN
cord-302115-r39ser2c	195	31	syndrome	syndrome	NN
cord-302115-r39ser2c	195	32	(	(	-LRB-
cord-302115-r39ser2c	195	33	ARDS	ARDS	NNP
cord-302115-r39ser2c	195	34	)	)	-RRB-
cord-302115-r39ser2c	195	35	:	:	:
cord-302115-r39ser2c	195	36	a	a	DT
cord-302115-r39ser2c	195	37	prospective	prospective	JJ
cord-302115-r39ser2c	195	38	observational	observational	JJ
cord-302115-r39ser2c	195	39	cohort	cohort	NN
cord-302115-r39ser2c	195	40	study	study	NN
cord-302115-r39ser2c	195	41	Analytical	analytical	JJ
cord-302115-r39ser2c	195	42	performances	performance	NNS
cord-302115-r39ser2c	195	43	of	of	IN
cord-302115-r39ser2c	195	44	a	a	DT
cord-302115-r39ser2c	195	45	chemiluminescence	chemiluminescence	NN
cord-302115-r39ser2c	195	46	immunoassay	immunoassay	NN
cord-302115-r39ser2c	195	47	for	for	IN
cord-302115-r39ser2c	195	48	SARS	SARS	NNP
cord-302115-r39ser2c	195	49	-	-	HYPH
cord-302115-r39ser2c	195	50	CoV-2	CoV-2	NNP
cord-302115-r39ser2c	195	51	IgM	IgM	NNP
cord-302115-r39ser2c	195	52	/	/	SYM
cord-302115-r39ser2c	195	53	IgG	IgG	NNP
cord-302115-r39ser2c	195	54	and	and	CC
cord-302115-r39ser2c	195	55	antibody	antibody	NN
cord-302115-r39ser2c	195	56	kinetics	kinetics	NNP
cord-302115-r39ser2c	195	57	Microvascular	Microvascular	NNP
cord-302115-r39ser2c	195	58	COVID-19	covid-19	POS
cord-302115-r39ser2c	195	59	lung	lung	NN
cord-302115-r39ser2c	195	60	vessels	vessel	NNS
cord-302115-r39ser2c	196	1	obstructive	obstructive	JJ
cord-302115-r39ser2c	196	2	thromboinflammatory	thromboinflammatory	NNP
cord-302115-r39ser2c	196	3	syndrome	syndrome	NN
cord-302115-r39ser2c	196	4	(	(	-LRB-
cord-302115-r39ser2c	196	5	MicroCLOTS	MicroCLOTS	NNP
cord-302115-r39ser2c	196	6	)	)	-RRB-
cord-302115-r39ser2c	196	7	:	:	:
cord-302115-r39ser2c	197	1	an	an	DT
cord-302115-r39ser2c	197	2	atypical	atypical	JJ
cord-302115-r39ser2c	197	3	acute	acute	JJ
cord-302115-r39ser2c	197	4	respiratory	respiratory	JJ
cord-302115-r39ser2c	197	5	distress	distress	NN
cord-302115-r39ser2c	197	6	syndrome	syndrome	NN
cord-302115-r39ser2c	197	7	working	work	VBG
cord-302115-r39ser2c	197	8	hypothesis	hypothesis	NN
cord-302115-r39ser2c	197	9	Unexpected	unexpected	JJ
cord-302115-r39ser2c	197	10	receptor	receptor	NN
cord-302115-r39ser2c	197	11	functional	functional	JJ
cord-302115-r39ser2c	197	12	mimicry	mimicry	NN
cord-302115-r39ser2c	197	13	elucidates	elucidate	VBZ
cord-302115-r39ser2c	197	14	activation	activation	NN
cord-302115-r39ser2c	197	15	of	of	IN
cord-302115-r39ser2c	197	16	coronavirus	coronavirus	NN
cord-302115-r39ser2c	197	17	fusion	fusion	NN
cord-302115-r39ser2c	197	18	Accepted	accept	VBN
cord-302115-r39ser2c	197	19	Article	Article	NNP
cord-302115-r39ser2c	198	1	The	the	DT
cord-302115-r39ser2c	198	2	text	text	NN
cord-302115-r39ser2c	198	3	contains	contain	VBZ
cord-302115-r39ser2c	198	4	the	the	DT
cord-302115-r39ser2c	198	5	personal	personal	JJ
cord-302115-r39ser2c	198	6	opinion	opinion	NN
cord-302115-r39ser2c	198	7	of	of	IN
cord-302115-r39ser2c	198	8	the	the	DT
cord-302115-r39ser2c	198	9	Authors	author	NNS
cord-302115-r39ser2c	198	10	,	,	,
cord-302115-r39ser2c	198	11	not	not	RB
cord-302115-r39ser2c	198	12	of	of	IN
cord-302115-r39ser2c	198	13	their	-PRON-	PRP$
cord-302115-r39ser2c	198	14	Institutions	institution	NNS
cord-302115-r39ser2c	198	15	:	:	:
cord-302115-r39ser2c	198	16	Charité	Charité	NNP
cord-302115-r39ser2c	198	17	Universitaetsmedizin	Universitaetsmedizin	NNP
cord-302115-r39ser2c	198	18	Berlin	Berlin	NNP
cord-302115-r39ser2c	198	19	,	,	,
cord-302115-r39ser2c	198	20	Germany	Germany	NNP
cord-302115-r39ser2c	198	21	(	(	-LRB-
cord-302115-r39ser2c	198	22	PMM	PMM	NNP
cord-302115-r39ser2c	198	23	)	)	-RRB-
cord-302115-r39ser2c	198	24	and	and	CC
cord-302115-r39ser2c	198	25	Istituto	Istituto	NNP
cord-302115-r39ser2c	198	26	Superiore	Superiore	NNP
cord-302115-r39ser2c	198	27	di	di	NNP
cord-302115-r39ser2c	198	28	Sanità	Sanità	NNP
cord-302115-r39ser2c	198	29	,	,	,
cord-302115-r39ser2c	198	30	Rome	Rome	NNP
cord-302115-r39ser2c	198	31	,	,	,
cord-302115-r39ser2c	198	32	Italy	Italy	NNP
cord-302115-r39ser2c	199	1	(	(	-LRB-
cord-302115-r39ser2c	199	2	RN).All	RN).All	``
cord-302115-r39ser2c	199	3	authors	author	NNS
cord-302115-r39ser2c	199	4	declare	declare	VBP
cord-302115-r39ser2c	199	5	no	no	DT
cord-302115-r39ser2c	199	6	conflict	conflict	NN
cord-302115-r39ser2c	199	7	of	of	IN
cord-302115-r39ser2c	199	8	interest	interest	NN
cord-302115-r39ser2c	199	9	.	.	.